[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 5761
1. Mourton SM, Temple LK, Abu-Rustum NR, Gemignani ML, Sonoda Y, Bochner BH, Barakat RR, Chi DS: Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol; 2005 Dec;99(3):608-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Studies from the colorectal literature have shown that factors associated with anastomotic leak after colorectal resection include long surgical time (>2 h), multiple blood transfusions, and short distance to the anal verge.
  • The aim of this study was to assess the morbidity associated with en bloc resection of ovarian carcinoma with low anterior resection and anastomosis in patients undergoing primary cytoreductive surgery for advanced disease.
  • [MeSH-major] Colon, Sigmoid / surgery. Ovarian Neoplasms / surgery. Rectum / surgery


2. Giger ML, Chan HP, Boone J: Anniversary paper: History and status of CAD and quantitative image analysis: the role of Medical Physics and AAPM. Med Phys; 2008 Dec;35(12):5799-820
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The roles of physicists in medical imaging have expanded over the years, from the study of imaging systems (sources and detectors) and dose to the assessment of image quality and perception, the development of image processing techniques, and the development of image analysis methods to assist in detection and diagnosis.
  • In the mid-1980s, however, medical physicists and radiologists began major research efforts for computer-aided detection or computer-aided diagnosis (CAD), that is, using the computer output as an aid to radiologists-as opposed to a completely automatic computer interpretation-focusing initially on methods for the detection of lesions on chest radiographs and mammograms.
  • Since then, extensive investigations of computerized image analysis for detection or diagnosis of abnormalities in a variety of 2D and 3D medical images have been conducted.
  • [MeSH-major] Diagnosis, Computer-Assisted / methods. Radiometry / methods
  • [MeSH-minor] Breast Neoplasms / diagnosis. Breast Neoplasms / pathology. Diagnostic Imaging / methods. False Positive Reactions. Humans. Image Processing, Computer-Assisted. Imaging, Three-Dimensional. Mammography / methods. ROC Curve. Societies, Medical. Time Factors

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Med Phys. 2001 Aug;28(8):1552-61 [11548926.001]
  • [Cites] Med Phys. 2001 Aug;28(8):1652-9 [11548934.001]
  • [Cites] Eur Radiol. 2001;11(10):1968-74 [11702130.001]
  • [Cites] Radiology. 2001 Dec;221(3):657-67 [11719660.001]
  • [Cites] Med Phys. 2001 Nov;28(11):2309-17 [11764038.001]
  • [Cites] Med Phys. 2001 Dec;28(12):2394-402 [11797941.001]
  • [Cites] AJR Am J Roentgenol. 2002 Feb;178(2):457-63 [11804918.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1209-14 [11811821.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1215-27 [11811822.001]
  • [Cites] Radiographics. 2002 Jul-Aug;22(4):963-79 [12110726.001]
  • [Cites] Radiology. 2002 Aug;224(2):560-8 [12147857.001]
  • [Cites] Acad Radiol. 2002 Sep;9(9):1036-43 [12238545.001]
  • [Cites] Radiology. 2002 Nov;225(2):391-9 [12409571.001]
  • [Cites] Radiology. 2002 Nov;225(2):519-26 [12409590.001]
  • [Cites] Acad Radiol. 2002 Nov;9(11):1264-77 [12449359.001]
  • [Cites] Med Phys. 2002 Nov;29(11):2552-8 [12462722.001]
  • [Cites] Radiology. 2002 Dec;225(3):685-92 [12461246.001]
  • [Cites] Radiology. 2002 Dec;225(3):907-16 [12461278.001]
  • [Cites] Invest Radiol. 1972 Jul-Aug;7(4):187-205 [5070786.001]
  • [Cites] J Bone Joint Surg Am. 1973 Jul;55(5):1098-9 [4760098.001]
  • [Cites] Med Phys. 1974;1(1):11-24 [4457746.001]
  • [Cites] J Clin Ultrasound. 1976 Apr;4(2):83-4 [816821.001]
  • [Cites] AJR Am J Roentgenol. 1976 Jun;126(6):1233-8 [179387.001]
  • [Cites] Med Phys. 1977 Jul-Aug;4(4):279-96 [882063.001]
  • [Cites] Semin Nucl Med. 1978 Apr;8(2):107-12 [684438.001]
  • [Cites] IEEE Trans Biomed Eng. 1979 Apr;26(4):213-9 [437802.001]
  • [Cites] Med Instrum. 1979 May-Jun;13(3):147-51 [440173.001]
  • [Cites] Semin Nucl Med. 1978 Oct;8(4):283-98 [112681.001]
  • [Cites] Comput Biomed Res. 1980 Aug;13(4):350-62 [7408456.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 1980 Jun 25;289(1037):483-7 [6106222.001]
  • [Cites] Radiology. 2003 Apr;227(1):192-200 [12616008.001]
  • [Cites] Trans Am Neurol Assoc. 1979;104:154-6 [317935.001]
  • [Cites] Perception. 1980;9(3):339-44 [7454514.001]
  • [Cites] Radiology. 1981 May;139(2):273-6 [7012918.001]
  • [Cites] Invest Radiol. 1981 Jul-Aug;16(4):269-74 [7275538.001]
  • [Cites] Radiology. 1981 Sep;140(3):813-5 [7280252.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1228-41 [11811823.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1242-50 [11811824.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1275-84 [11811827.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Dec;20(12):1285-92 [11811828.001]
  • [Cites] Med Phys. 2002 Feb;29(2):157-64 [11865987.001]
  • [Cites] Med Phys. 2002 Feb;29(2):238-47 [11865995.001]
  • [Cites] IEEE Trans Med Imaging. 2002 Feb;21(2):150-8 [11929102.001]
  • [Cites] Acad Radiol. 2002 Apr;9(4):386-97 [11942653.001]
  • [Cites] Radiology. 2002 May;223(2):489-93 [11997558.001]
  • [Cites] Med Phys. 2002 May;29(5):701-8 [12033565.001]
  • [Cites] Med Phys. 2002 May;29(5):755-70 [12033572.001]
  • [Cites] Radiology. 2002 Jul;224(1):217-24 [12091686.001]
  • [Cites] Phys Med Biol. 1999 Oct;44(10):2579-95 [10533930.001]
  • [Cites] Med Phys. 1999 Oct;26(10):2176-82 [10535635.001]
  • [Cites] Radiology. 1999 Nov;213(2):407-12 [10551220.001]
  • [Cites] J Med Screen. 1999;6(3):152-8 [10572847.001]
  • [Cites] Radiology. 1999 Dec;213(3):723-6 [10580945.001]
  • [Cites] Med Phys. 1999 Dec;26(12):2654-68 [10619251.001]
  • [Cites] Med Phys. 1999 Dec;26(12):2669-79 [10619252.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • [Cites] Med Phys. 2000 Jan;27(1):4-12 [10659732.001]
  • [Cites] Med Phys. 2000 Jan;27(1):13-22 [10659733.001]
  • [Cites] Med Phys. 2000 Jan;27(1):75-85 [10659740.001]
  • [Cites] Med Image Anal. 1999 Dec;3(4):321-37 [10709699.001]
  • [Cites] Radiology. 2000 Mar;214(3):823-30 [10715052.001]
  • [Cites] IEEE Trans Med Imaging. 2000 Feb;19(2):115-26 [10784283.001]
  • [Cites] Acad Radiol. 1999 Nov;6(11):665-74 [10894069.001]
  • [Cites] Acad Radiol. 1999 Mar;6(3):156-63 [10898034.001]
  • [Cites] Radiol Clin North Am. 2000 Jul;38(4):725-40 [10943274.001]
  • [Cites] J Nucl Med. 2000 Aug;41(8):1369-79 [10945530.001]
  • [Cites] Med Phys. 2000 Jul;27(7):1509-22 [10947254.001]
  • [Cites] AJR Am J Roentgenol. 2000 Nov;175(5):1347-52 [11044039.001]
  • [Cites] Phys Med Biol. 2000 Oct;45(10):2843-57 [11049175.001]
  • [Cites] Acad Radiol. 2000 Dec;7(12):1077-84 [11131052.001]
  • [Cites] Med Phys. 2001 Feb;28(2):259-66 [11243351.001]
  • [Cites] Acad Radiol. 2001 Mar;8(3):219-24 [11249085.001]
  • [Cites] Radiology. 2001 Apr;219(1):192-202 [11274556.001]
  • [Cites] Acad Radiol. 2001 May;8(5):447-50 [11345275.001]
  • [Cites] J Magn Reson Imaging. 2001 Jun;13(6):889-95 [11382949.001]
  • [Cites] Med Phys. 2001 Jun;28(6):1070-9 [11439476.001]
  • [Cites] Med Phys. 2001 Jul;28(7):1455-65 [11488579.001]
  • [Cites] Radiology. 2001 Sep;220(3):781-6 [11526282.001]
  • [Cites] Radiology. 2001 Sep;220(3):787-94 [11526283.001]
  • [Cites] Med Phys. 1993 Jan-Feb;20(1):71-8 [8455515.001]
  • [Cites] Invest Radiol. 1993 Jun;28(6):473-81 [8320064.001]
  • [Cites] AJR Am J Roentgenol. 1993 Dec;161(6):1167-72 [8249720.001]
  • [Cites] AJR Am J Roentgenol. 1994 Mar;162(3):699-708 [8109525.001]
  • [Cites] Semin Nucl Med. 1994 Jan;24(1):38-65 [8122128.001]
  • [Cites] Radiology. 1994 May;191(2):331-7 [8153302.001]
  • [Cites] Cancer Lett. 1994 Mar 15;77(2-3):173-81 [8168064.001]
  • [Cites] Cancer Lett. 1994 Mar 15;77(2-3):201-11 [8168067.001]
  • [Cites] Invest Radiol. 1994 Feb;29(2):134-40 [8169086.001]
  • [Cites] Ultrason Imaging. 1993 Oct;15(4):267-85 [8171752.001]
  • [Cites] Med Phys. 1994 Feb;21(2):265-9 [8177159.001]
  • [Cites] Med Phys. 1994 Mar;21(3):445-52 [8208220.001]
  • [Cites] Med Phys. 1994 Mar;21(3):453-61 [8208221.001]
  • [Cites] Acta Radiol. 1994 Jul;35(4):340-4 [8011382.001]
  • [Cites] Magn Reson Med. 1994 May;31(5):557-60 [8015411.001]
  • [Cites] Invest Radiol. 1994 Apr;29(4):459-65 [8034453.001]
  • [Cites] Med Phys. 1994 Apr;21(4):503-8 [8058015.001]
  • [Cites] Med Phys. 1994 Apr;21(4):517-24 [8058017.001]
  • [Cites] Acad Radiol. 2003 Jan;10(1):1-3 [12529022.001]
  • [Cites] IEEE Trans Med Imaging. 2002 Dec;21(12):1461-7 [12588030.001]
  • [Cites] IEEE Trans Med Imaging. 2002 Dec;21(12):1517-23 [12588035.001]
  • [Cites] IEEE Trans Med Imaging. 2002 Dec;21(12):1552-63 [12588039.001]
  • [Cites] Med Phys. 2003 Mar;30(3):365-80 [12674237.001]
  • [Cites] Med Phys. 2003 Mar;30(3):387-94 [12674239.001]
  • [Cites] IEEE Trans Med Imaging. 2003 Feb;22(2):170-7 [12715993.001]
  • [Cites] Ultrasound Med Biol. 2003 May;29(5):679-86 [12754067.001]
  • [Cites] Med Phys. 2003 May;30(5):823-31 [12772990.001]
  • [Cites] Med Image Anal. 2003 Jun;7(2):187-204 [12868621.001]
  • [Cites] Med Phys. 2003 Jul;30(7):1602-17 [12906178.001]
  • [Cites] Med Phys. 2003 Jul;30(7):1781-7 [12906196.001]
  • [Cites] Med Phys. 2003 Jul;30(7):1833-42 [12906202.001]
  • [Cites] Med Phys. 2003 Aug;30(8):2123-30 [12945977.001]
  • [Cites] Radiology. 2003 Sep;228(3):842-50 [12881585.001]
  • [Cites] J Natl Cancer Inst. 2003 Sep 17;95(18):1384-93 [13130114.001]
  • [Cites] Radiology. 2003 Oct;229(1):261-8 [12888621.001]
  • [Cites] Med Phys. 2003 Oct;30(10):2584-93 [14596294.001]
  • [Cites] AJR Am J Roentgenol. 2004 Feb;182(2):505-10 [14736690.001]
  • [Cites] Radiology. 2004 Feb;230(2):347-52 [14752180.001]
  • [Cites] J Natl Cancer Inst. 2004 Feb 4;96(3):185-90 [14759985.001]
  • [Cites] Med Phys. 2004 Jan;31(1):81-90 [14761024.001]
  • [Cites] Med Phys. 2004 Feb;31(2):314-26 [15000617.001]
  • [Cites] Acad Radiol. 2004 Mar;11(3):272-80 [15035517.001]
  • [Cites] Radiology. 2004 Apr;231(1):208-14 [14990808.001]
  • [Cites] J Comput Assist Tomogr. 2004 May-Jun;28(3):318-26 [15100534.001]
  • [Cites] Med Phys. 2004 Apr;31(4):744-54 [15124991.001]
  • [Cites] Med Phys. 2004 Apr;31(4):860-72 [15125004.001]
  • [Cites] Acad Radiol. 2004 May;11(5):526-35 [15147617.001]
  • [Cites] Ultrasound Med Biol. 2004 May;30(5):625-32 [15183228.001]
  • [Cites] Med Phys. 2004 May;31(5):958-71 [15191279.001]
  • [Cites] Med Phys. 2004 May;31(5):1076-82 [15191295.001]
  • [Cites] IEEE Trans Med Imaging. 2004 Jul;23(7):891-5 [15250641.001]
  • [Cites] Med Phys. 2004 Jun;31(6):1512-20 [15259655.001]
  • [Cites] Magn Reson Med. 2004 Aug;52(2):420-9 [15282828.001]
  • [Cites] J Natl Cancer Inst. 2004 Aug 18;96(16):1260-1; author reply 1261 [15316065.001]
  • [Cites] Radiology. 2004 Sep;232(3):739-48 [15333795.001]
  • [Cites] Eur Radiol. 2004 Oct;14(10):1930-8 [15235812.001]
  • [Cites] Radiology. 2004 Oct;233(1):255-65 [15317954.001]
  • [Cites] Radiology. 2004 Oct;233(1):266-72 [15454623.001]
  • [Cites] Invest Radiol. 2004 Nov;39(11):649-55 [15486524.001]
  • [Cites] AJR Am J Roentgenol. 2004 Nov;183(5):1209-15 [15505279.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1966 Jul;97(3):772-5 [5927621.001]
  • [Cites] Radiology. 1969 Aug;93(2):315-20 [5822705.001]
  • [Cites] Radiol Clin North Am. 1969 Dec;7(3):419-33 [5382257.001]
  • [Cites] Radiology. 1972 Oct;105(1):199-200 [5057304.001]
  • [Cites] Acad Radiol. 1999 Oct;6(10):575-85 [10516859.001]
  • [Cites] N Engl J Med. 1955 Apr 7;252(14):580-5 [14356384.001]
  • [Cites] J Nucl Med. 1964 Jul;5:515-31 [14216630.001]
  • [Cites] Radiology. 1964 Dec;83:1029-34 [14226800.001]
  • [Cites] IEEE Trans Biomed Eng. 1964 Jul;11:67-72 [14254233.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1956 Jun;75(6):1027-39 [13313871.001]
  • [Cites] Radiology. 1963 Aug;81:185-200 [14053755.001]
  • [Cites] Radiology. 2005 Jan;234(1):274-83 [15537839.001]
  • [Cites] Med Phys. 2004 Dec;31(12):3417-24 [15651624.001]
  • [Cites] Acad Radiol. 2005 Feb;12(2):191-201 [15721596.001]
  • [Cites] J Comput Assist Tomogr. 2005 Mar-Apr;29(2):215-22 [15772540.001]
  • [Cites] IEEE Trans Med Imaging. 2005 May;24(5):584-92 [15889546.001]
  • [Cites] Br J Radiol. 2005;78 Spec No 1:S57-62 [15917447.001]
  • [Cites] Acad Radiol. 2005 Jun;12(6):681-6 [15935966.001]
  • [Cites] Acad Radiol. 2005 Jun;12(6):782-92 [15935977.001]
  • [Cites] Radiology. 2005 Jul;236(1):286-93 [15955862.001]
  • [Cites] Acad Radiol. 2005 Jul;12(7):806-14 [16039534.001]
  • [Cites] Radiology. 2005 Aug;236(2):451-7 [16040901.001]
  • [Cites] Science. 1981 Nov 13;214(4522):761-5 [7292009.001]
  • [Cites] Med Phys. 1981 Jul-Aug;8(4):510-2 [7322070.001]
  • [Cites] J Nucl Med. 1982 Feb;23(2):97-102 [6977021.001]
  • [Cites] Med Phys. 1982 Jul-Aug;9(4):540-9 [7110085.001]
  • [Cites] J Comput Assist Tomogr. 1982 Dec;6(6):1075-87 [7174924.001]
  • [Cites] Rev Sci Instrum. 1982 Sep;53(9):1319-37 [6294818.001]
  • [Cites] Med Phys. 1984 May-Jun;11(3):287-95 [6738452.001]
  • [Cites] Phys Med Biol. 1984 Jul;29(7):837-56 [6473512.001]
  • [Cites] J Oral Maxillofac Surg. 1984 Dec;42(12):782-7 [6334147.001]
  • [Cites] Med Phys. 1984 Nov-Dec;11(6):797-805 [6513887.001]
  • [Cites] Bone. 1985;6(1):1-7 [3994856.001]
  • [Cites] Med Phys. 1985 Mar-Apr;12(2):201-8 [4000077.001]
  • [Cites] Invest Radiol. 1985 Nov;20(8):874-7 [4077441.001]
  • [Cites] Prog Cardiovasc Dis. 1986 Jan-Feb;28(4):245-55 [3511508.001]
  • [Cites] Invest Radiol. 1986 Sep;21(9):720-33 [3095258.001]
  • [Cites] Radiology. 1987 May;163(2):555-8 [3550885.001]
  • [Cites] Med Phys. 1987 Jul-Aug;14(4):538-48 [3626993.001]
  • [Cites] Med Phys. 1987 Jul-Aug;14(4):549-56 [3626994.001]
  • [Cites] Radiology. 1987 Oct;165(1):95-7 [3628795.001]
  • [Cites] AJR Am J Roentgenol. 1987 Nov;149(5):907-12 [2890288.001]
  • [Cites] Radiology. 1988 Feb;166(2):509-22 [3275985.001]
  • [Cites] Invest Radiol. 1988 Apr;23(4):240-52 [3372189.001]
  • [Cites] Med Phys. 1988 Mar-Apr;15(2):158-66 [3386584.001]
  • [Cites] Med Phys. 1988 May-Jun;15(3):311-9 [3405134.001]
  • [Cites] Radiology. 1988 Nov;169(2):333-7 [3174981.001]
  • [Cites] Radiology. 1989 Jan;170(1 Pt 1):129-31 [2909085.001]
  • [Cites] Radiology. 1989 Aug;172(2):487-93 [2664871.001]
  • [Cites] Radiographics. 1990 Jan;10(1):41-51 [2296696.001]
  • [Cites] Magn Reson Annu. 1988;:299-333 [3079300.001]
  • [Cites] Phys Med Biol. 1990 Aug;35(8):1111-8 [2217536.001]
  • [Cites] Med Phys. 1990 Sep-Oct;17(5):861-5 [2233573.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72 [2124706.001]
  • [Cites] Invest Radiol. 1990 Oct;25(10):1102-10 [2079409.001]
  • [Cites] Med Decis Making. 1991 Jan-Mar;11(1):9-18 [2034078.001]
  • [Cites] Comput Biomed Res. 1991 Jun;24(3):273-95 [1868696.001]
  • [Cites] Clin Radiol. 1991 Jul;44(1):13-5 [1873944.001]
  • [Cites] Med Phys. 1991 Sep-Oct;18(5):1002-15 [1961140.001]
  • [Cites] Med Phys. 1991 Sep-Oct;18(5):955-63 [1961160.001]
  • [Cites] Invest Radiol. 1992 Jan;27(1):71-7 [1733885.001]
  • [Cites] Comput Biomed Res. 1992 Jun;25(3):218-37 [1611889.001]
  • [Cites] Radiology. 1992 Sep;184(3):613-7 [1509041.001]
  • [Cites] Radiology. 1992 Sep;184(3):619-22 [1509042.001]
  • [Cites] J Nucl Med. 1992 Oct;33(10):1881-7 [1403162.001]
  • [Cites] Med Phys. 1992 Sep-Oct;19(5):1153-60 [1435592.001]
  • [Cites] Magn Reson Med. 1992 Dec;28(2):275-89 [1461126.001]
  • [Cites] Radiology. 1993 Apr;187(1):81-7 [8451441.001]
  • [Cites] Comput Med Imaging Graph. 2007 Jun-Jul;31(4-5):236-47 [17369019.001]
  • [Cites] Comput Med Imaging Graph. 2007 Jun-Jul;31(4-5):224-35 [17386998.001]
  • [Cites] Radiology. 2007 May;243(2):360-7 [17456866.001]
  • [Cites] Acad Radiol. 2007 Jun;14(6):659-69 [17502255.001]
  • [Cites] Acad Radiol. 2007 Jun;14(6):723-48 [17502262.001]
  • [Cites] IEEE Trans Med Imaging. 2007 Jul;26(7):945-53 [17649908.001]
  • [Cites] Med Phys. 2007 Aug;34(8):3334-44 [17879797.001]
  • [Cites] Acad Radiol. 2007 Dec;14(12):1455-63 [18035275.001]
  • [Cites] Acad Radiol. 2007 Dec;14(12):1464-74 [18035276.001]
  • [Cites] Acad Radiol. 2007 Dec;14(12):1475-85 [18035277.001]
  • [Cites] Med Phys. 2007 Nov;34(11):4173-9 [18072481.001]
  • [Cites] Med Phys. 2007 Nov;34(11):4180-93 [18072482.001]
  • [Cites] Med Phys. 2007 Nov;34(11):4399-408 [18072505.001]
  • [Cites] Med Phys. 2007 Dec;34(12):4860-75 [18196812.001]
  • [Cites] Med Phys. 2007 Dec;34(12):4876-89 [18196813.001]
  • [Cites] Acad Radiol. 2008 Feb;15(2):139-52 [18206613.001]
  • [Cites] Med Phys. 2008 Jan;35(1):280-90 [18293583.001]
  • [Cites] Med Phys. 2008 Jan;35(1):377-87 [18293592.001]
  • [Cites] Cancer. 1994 Dec 1;74(11):2944-8 [7954258.001]
  • [Cites] Magn Reson Med. 1995 Mar;33(3):453-9 [7760717.001]
  • [Cites] Radiology. 1995 Jul;196(1):123-34 [7784555.001]
  • [Cites] Radiology. 1995 Sep;196(3):817-22 [7644649.001]
  • [Cites] Radiology. 1995 Sep;196(3):823-9 [7644650.001]
  • [Cites] Med Phys. 1995 Oct;22(10):1555-67 [8551980.001]
  • [Cites] Med Phys. 1995 Oct;22(10):1569-79 [8551981.001]
  • [Cites] Arch Intern Med. 1996 Jan 22;156(2):209-13 [8546556.001]
  • [Cites] Radiology. 1996 Mar;198(3):671-8 [8628853.001]
  • [Cites] Radiology. 1996 Jun;199(3):843-8 [8638015.001]
  • [Cites] Radiol Clin North Am. 1996 May;34(3):565-96 [8657872.001]
  • [Cites] IEEE Trans Biomed Eng. 1996 Feb;43(2):123-32 [8682523.001]
  • [Cites] Phys Med Biol. 1996 May;41(5):909-23 [8735257.001]
  • [Cites] Acad Radiol. 1996 Aug;3(8):621-7 [8796725.001]
  • [Cites] J Nucl Cardiol. 1996 Jan-Feb;3(1):55-64 [8799228.001]
  • [Cites] Radiology. 1996 Dec;201(3):745-50 [8939225.001]
  • [Cites] Med Phys. 1996 Oct;23(10):1685-96 [8946366.001]
  • [Cites] Radiology. 1997 Apr;203(1):159-63 [9122385.001]
  • [Cites] Phys Med Biol. 1997 Mar;42(3):549-67 [9080535.001]
  • [Cites] Med Phys. 1997 Jun;24(6):903-14 [9198026.001]
  • [Cites] Med Phys. 1997 Jun;24(6):915-24 [9198027.001]
  • [Cites] Cancer. 1997 Jul 1;80(1):66-74 [9210710.001]
  • [Cites] Med Phys. 1997 Sep;24(9):1395-403 [9304567.001]
  • [Cites] Radiology. 1997 Nov;205(2):399-406 [9356620.001]
  • [Cites] J Nucl Med. 1997 Oct;38(10):1528-35 [9379187.001]
  • [Cites] Acad Radiol. 1995 Aug;2(8):655-62 [9419620.001]
  • [Cites] Acad Radiol. 1995 Nov;2(11):959-66 [9419667.001]
  • [Cites] J Nucl Cardiol. 1995 Nov-Dec;2(6):513-24 [9420834.001]
  • [Cites] Acad Radiol. 1998 Mar;5(3):155-68 [9522881.001]
  • [Cites] Acad Radiol. 1998 Apr;5(4):306-11 [9561264.001]
  • [Cites] Med Phys. 1998 Apr;25(4):516-26 [9571620.001]
  • [Cites] Radiology. 1998 May;207(2):465-71 [9577496.001]
  • [Cites] Med Phys. 1998 Jun;25(6):957-64 [9650186.001]
  • [Cites] Med Phys. 1998 Sep;25(9):1647-54 [9775369.001]
  • [Cites] Med Phys. 1998 Oct;25(10):2046-53 [9800714.001]
  • [Cites] IEEE Trans Med Imaging. 1998 Aug;17(4):510-7 [9845307.001]
  • [Cites] Acad Radiol. 1999 Jan;6(1):22-33 [9891149.001]
  • [Cites] IEEE Trans Med Imaging. 1998 Dec;17(6):872-80 [10048844.001]
  • [Cites] Lancet. 1999 Jul 10;354(9173):99-105 [10408484.001]
  • [Cites] IEEE Trans Med Imaging. 1999 May;18(5):369-78 [10416798.001]
  • [Cites] Med Phys. 1999 Jul;26(7):1320-9 [10435534.001]
  • [Cites] Med Phys. 1999 Jul;26(7):1330-40 [10435535.001]
  • [Cites] Med Phys. 1999 Jun;26(6):880-8 [10436888.001]
  • [Cites] Radiology. 1999 Sep;212(3):817-27 [10478252.001]
  • [Cites] Med Phys. 1999 Aug;26(8):1642-54 [10501064.001]
  • [Cites] IEEE Trans Med Imaging. 1999 Jul;18(7):628-39 [10504096.001]
  • [Cites] Acad Radiol. 2005 Aug;12(8):970-9 [16087091.001]
  • [Cites] Med Phys. 2005 Jul;32(7):2295-304 [16121585.001]
  • [Cites] Chest. 2005 Sep;128(3):1517-23 [16162752.001]
  • [Cites] AJR Am J Roentgenol. 2005 Oct;185(4):944-50 [16177413.001]
  • [Cites] Acad Radiol. 2005 Oct;12(10):1301-9 [16179207.001]
  • [Cites] Acad Radiol. 2005 Oct;12(10):1310-9 [16179208.001]
  • [Cites] Med Phys. 2005 Aug;32(8):2443-54 [16193773.001]
  • [Cites] Med Phys. 2005 Aug;32(8):2629-38 [16193793.001]
  • [Cites] Radiology. 2005 Nov;237(2):444-9 [16244252.001]
  • [Cites] Radiology. 2005 Dec;237(3):834-40 [16304105.001]
  • [Cites] Phys Med Biol. 2006 Jan 21;51(2):425-41 [16394348.001]
  • [Cites] Acad Radiol. 2006 Jan;13(1):63-72 [16399033.001]
  • [Cites] Med Phys. 2005 Dec;32(12):3602-16 [16475759.001]
  • [Cites] Med Phys. 2006 Jan;33(1):111-7 [16485416.001]
  • [Cites] AJR Am J Roentgenol. 2006 Mar;186(3):696-702 [16498097.001]
  • [Cites] Med Phys. 2006 Feb;33(2):320-8 [16532936.001]
  • [Cites] Med Phys. 2006 Feb;33(2):394-401 [16532946.001]
  • [Cites] Med Phys. 2006 Feb;33(2):482-91 [16532956.001]
  • [Cites] IEEE Trans Med Imaging. 2006 Apr;25(4):385-405 [16608056.001]
  • [Cites] Radiology. 2006 May;239(2):375-83 [16569779.001]
  • [Cites] IEEE Trans Med Imaging. 2006 May;25(5):571-81 [16689261.001]
  • [Cites] Radiology. 2006 Jun;239(3):768-76 [16714460.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jul;187(1):20-8 [16794150.001]
  • [Cites] Acad Radiol. 2006 Aug;13(8):943-50 [16843846.001]
  • [Cites] Radiology. 2006 Aug;240(2):357-68 [16864666.001]
  • [Cites] Med Phys. 2006 Jun;33(6):1810-7 [16872088.001]
  • [Cites] Med Phys. 2006 Jun;33(6):1911-9 [16872098.001]
  • [Cites] Med Phys. 2006 Jul;33(7):2574-85 [16898462.001]
  • [Cites] Med Phys. 2006 Aug;33(8):2878-87 [16964864.001]
  • [Cites] Med Phys. 2006 Aug;33(8):2975-88 [16964876.001]
  • [Cites] Med Phys. 2006 Aug;33(8):3006-17 [16964879.001]
  • [Cites] Osteoporos Int. 2006 Oct;17(10):1472-82 [16838099.001]
  • [Cites] Acad Radiol. 2006 Oct;13(10):1254-65 [16979075.001]
  • [Cites] Radiology. 2006 Oct;241(1):47-53 [16990670.001]
  • [Cites] Med Phys. 2006 Sep;33(9):3135-43 [17022205.001]
  • [Cites] IEEE Trans Vis Comput Graph. 2006 Sep-Oct;12(5):885-92 [17080813.001]
  • [Cites] Med Phys. 2006 Oct;33(10):3781-95 [17089843.001]
  • [Cites] Med Phys. 2006 Oct;33(10):3814-24 [17089846.001]
  • [Cites] AJR Am J Roentgenol. 2006 Dec;187(6):1483-91 [17114541.001]
  • [Cites] Med Phys. 2006 Nov;33(11):4157-68 [17153394.001]
  • [Cites] Med Phys. 2006 Dec;33(12):4664-74 [17278819.001]
  • [Cites] Acad Radiol. 2007 Mar;14(3):363-70 [17307670.001]
  • [Cites] Eur Radiol. 2007 Apr;17(4):888-901 [17047961.001]
  • [Cites] N Engl J Med. 2007 Apr 5;356(14):1399-409 [17409321.001]
  • [Cites] Med Phys. 2007 Mar;34(3):898-905 [17441235.001]
  • [Cites] Comput Med Imaging Graph. 2007 Jun-Jul;31(4-5):198-211 [17349778.001]
  • [Cites] IEEE Trans Med Imaging. 2008 Feb;27(2):215-27 [18334443.001]
  • [Cites] AJR Am J Roentgenol. 2008 Apr;190(4):854-9 [18356428.001]
  • [Cites] Acad Radiol. 2008 May;15(5):535-55 [18423310.001]
  • [Cites] Med Phys. 2008 Apr;35(4):1559-70 [18491550.001]
  • [Cites] Med Phys. 2008 May;35(5):2110-23 [18561687.001]
  • [Cites] Acad Radiol. 2008 Nov;15(11):1446-57 [18995195.001]
  • [Cites] J Digit Imaging. 2006 Dec;19(4):376-82 [16763934.001]
  • [Cites] Acad Radiol. 2007 Jan;14(1):28-37 [17178363.001]
  • [Cites] Gastroenterology. 2006 Dec;131(6):1690-9 [17087934.001]
  • [Cites] AJR Am J Roentgenol. 2007 Feb;188(2):377-84 [17242245.001]
  • [Cites] Med Phys. 2007 Jan;34(1):25-36 [17278486.001]
  • [Cites] Med Phys. 2007 Jan;34(1):140-50 [17278499.001]
  • [Cites] Med Phys. 2007 Jan;34(1):275-81 [17278513.001]
  • (PMID = 19175137.001).
  • [ISSN] 0094-2405
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R01 EB002138
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Number-of-references] 399
  • [Other-IDs] NLM/ PMC2673617
  •  go-up   go-down


3. Hashimoto K, Sasaki Y, Yokoyama S, Naitou A, Hiraki M, Matsumoto S, Matsuyama J, Morita S, Morimoto T, Fukushima Y, Nishisho I, Nomura T, Takeda M: [Hepatectomy with microwave coagulation therapy for multiple liver metastases of rectal carcinoid--a case report]. Gan To Kagaku Ryoho; 2009 Nov;36(12):2198-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While exploring for the primary site, we observed a flat tumor, 10 mm in diameter, in the rectum at 10 cm from the anal ring, and local resection of the tumor was performed transanally.
  • Hepatectomy with microwave coagulation therapy is believed to be locally effective in multiple liver metastases of rectal carcinoid tumor.
  • [MeSH-major] Carcinoid Tumor / pathology. Electrocoagulation / methods. Hepatectomy. Liver Neoplasms / secondary. Liver Neoplasms / therapy. Microwaves / therapeutic use. Rectal Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20037369.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


Advertisement
4. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG: US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol; 2009 Mar 1;27(7):1116-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
  • PURPOSE: The US Gastrointestinal Intergroup Radiation Therapy Oncology Group 98-11 anal carcinoma trial showed that cisplatin-based concurrent chemoradiotherapy resulted in a significantly higher rate of colostomy compared with mitomycin-based therapy.
  • Established prognostic variables for patients with anal carcinoma include tumor diameter, clinical nodal status, and sex, but pretreatment variables that would predict the likelihood of colostomy are unknown.
  • Univariate and multivariate analyses were carried out to correlate overall survival (OS), disease-free survival, and time to colostomy (TTC) with pretreatment and treatment variables.
  • In the multivariate analysis, tumor-related prognosticators for poorer OS included node-positive cancer (P < or = .0001), large (> 5 cm) tumor diameter (P = .01), and male sex (P = .016).
  • In the pretreatment variables category, only large tumor diameter independently predicted for TTC (P = .008).
  • Similarly, the cumulative 5-year colostomy rate was statistically significantly higher for large tumor diameter than for small tumor diameter (Gray's test; P = .0074).
  • CONCLUSION: The combined analysis of the two arms of RTOG 98-11, representing the largest prospective database, reveals that tumor diameter (irrespective of the nodal status) is the only independent pretreatment variable that predicts TTC and 5-year colostomy rate in patients with anal carcinoma.

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Chemother Rep. 1966 Mar;50(3):163-70 [5910392.001]
  • [Cites] Cancer. 1983 May 15;51(10):1826-9 [6831348.001]
  • [Cites] J Natl Cancer Inst. 1989 Jun 7;81(11):850-6 [2724350.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):67-73 [7690019.001]
  • [Cites] J Clin Oncol. 1996 Sep;14(9):2527-39 [8823332.001]
  • [Cites] J Am Coll Surg. 1997 Nov;185(5):494-505 [9358099.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):92-102 [15629599.001]
  • [Cites] J Clin Oncol. 2005 May 1;23(13):3008-15 [15860857.001]
  • [Cites] Curr Opin Oncol. 2007 Jul;19(4):396-400 [17545807.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] JAMA. 2008 Apr 23;299(16):1914-21 [18430910.001]
  • [Cites] Radiother Oncol. 2008 Jun;87(3):383-90 [18501454.001]
  • [CommentIn] J Clin Oncol. 2009 Jun 20;27(18):3064; author reply 3065 [19414660.001]
  • (PMID = 19139424.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / UL1 RR025741; United States / NCI NIH HHS / CA / CA21661; United States / NCI NIH HHS / CA / U10 CA37422; United States / NCI NIH HHS / CA / U10 CA037422; United States / NCI NIH HHS / CA / U10 CA021661; United States / NCI NIH HHS / CA / U10CA32115; United States / NCI NIH HHS / CA / U10 CA032115
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 50SG953SK6 / Mitomycin; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  • [Other-IDs] NLM/ PMC2667813
  •  go-up   go-down


5. Cho SD, Herzig DO, Douthit MA, Deveney KE: Treatment strategies and outcomes for rectal villous adenoma from a single-center experience. Arch Surg; 2008 Sep;143(9):866-70; discussion 871-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DESIGN: Retrospective review of patient and tumor characteristics, procedure, recurrence, and complications.
  • Mean tumor size was 3.0 cm (range, 0.5-11 cm) and the mean distance of the tumor from the anal verge was 4.9 cm (range, 0-10 cm).
  • Tumor size did not correlate with malignancy.
  • There were 4 (12.5%) benign recurrences, all after transanal excisions.
  • [MeSH-major] Adenoma, Villous / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy. Endosonography. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Neoplasm Recurrence, Local / pathology. Retrospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18794424.001).
  • [ISSN] 1538-3644
  • [Journal-full-title] Archives of surgery (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Pollack J, Holm T, Cedermark B, Altman D, Holmström B, Glimelius B, Mellgren A: Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg; 2006 Dec;93(12):1519-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Overall, patients who had preoperative radiotherapy experienced significantly more late complications than those who did not (69 versus 43 per cent; P = 0.002).
  • This morbidity consisted mainly of cardiovascular disease (35 versus 19 per cent; P = 0.032), faecal incontinence (12 of 21 versus 11 of 42 patients having anterior resection; P = 0.013) and urinary incontinence (45 versus 27 per cent; P = 0.023).
  • CONCLUSION: Preoperative short-course, high-dose radiotherapy in patients with rectal cancer increases the risk of anal and urinary dysfunction, and may lead to increased cardiovascular morbidity, at long-term follow-up.
  • [MeSH-major] Quality of Life. Radiotherapy, Adjuvant / adverse effects. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17054311.001).
  • [ISSN] 0007-1323
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


7. Giorgini S, Barbisan F, Morichetti D, Mazzucchelli R, Marzioni D: PUNLMP or not PUNLMP? This is the problem. Anal Quant Cytol Histol; 2009 Jun;31(3):184-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PUNLMP or not PUNLMP? This is the problem.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19634789.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Letter
  • [Publication-country] United States
  •  go-up   go-down


8. Case BW: Asbestos, smoking, and lung cancer: interaction and attribution. Occup Environ Med; 2006 Aug;63(8):507-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Asbestos / adverse effects. Lung Neoplasms / etiology. Smoking / adverse effects

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Asbestos.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ASBESTOS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1983 Mar;43(3):1251-5 [6297722.001]
  • [Cites] Free Radic Biol Med. 2000 Apr 15;28(8):1295-9 [10889460.001]
  • [Cites] Ann Occup Hyg. 2000 Dec;44(8):565-601 [11108782.001]
  • [Cites] Occup Environ Med. 2006 Aug;63(8):509-12 [16849527.001]
  • [Cites] Ann Occup Hyg. 1998 Jan;42(1):3-5 [9566110.001]
  • [Cites] Risk Anal. 2005 Aug;25(4):937-43 [16268941.001]
  • [Cites] Ann Occup Hyg. 2006 Jan;50(1):29-38 [16126764.001]
  • [CommentOn] Occup Environ Med. 2006 Aug;63(8):509-12 [16849527.001]
  • (PMID = 16849526.001).
  • [ISSN] 1470-7926
  • [Journal-full-title] Occupational and environmental medicine
  • [ISO-abbreviation] Occup Environ Med
  • [Language] eng
  • [Publication-type] Comment; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 1332-21-4 / Asbestos
  • [Other-IDs] NLM/ PMC2078131
  •  go-up   go-down


9. Pronio A, Di Filippo A, Narilli P, Mancini B, Caporilli D, Piroli S, Vestri A, Montesani C: [Anastomotic dehiscence in colorectal surgery. Analysis of 1290 patients]. Chir Ital; 2007 Sep-Oct;59(5):599-609
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The variables considered were the following: age; sex; type of disease; elective or emergency surgery; type of surgery; type, design and site (intra or extra peritoneal) of the anastomosis; stapled or manual anastomosis; distance from anal verge of the colorectal anastomosis; intraoperative complications; protective stoma.
  • Significant factors were: the type of surgery (higher risk after restorative proctocolectomy or rectal resection), the site extra peritoneal of the anastomosis, the type of the anastomosis (higher risk after coloanal or ileal-pouch anal or colorectal), the stapled anastomosis, the intraoperative complications.
  • [MeSH-major] Colon / surgery. Colorectal Neoplasms / surgery. Proctocolectomy, Restorative. Rectum / surgery. Surgical Wound Dehiscence / etiology
  • [MeSH-minor] Adult. Aged. Anal Canal / surgery. Anastomosis, Surgical. Female. Humans. Male. Middle Aged. Retrospective Studies. Risk Assessment. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18019632.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


10. Shrikhande SV, Saoji RR, Barreto SG, Kakade AC, Waterford SD, Ahire SB, Goliwale FM, Shukla PJ: Outcomes of resection for rectal cancer in India: the impact of the double stapling technique. World J Surg Oncol; 2007;5:35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: A total of 77 out of 78 patients in the SST group had Astler Coller B and C disease while the number was 132/138 in the DST group.
  • The mean distance of the tumor from anal verge was 7.6 cm (2.5-15 cm) and 8.0 cm (4-15 cm) in the DST and SST groups, respectively.
  • The observed improvement of surgical outcomes with DST needs further studies to significantly prove these findings in a population where the tumors at presentation are predominantly Astler Coller Stage B and C.
  • [MeSH-major] Adenocarcinoma / surgery. Rectal Neoplasms / surgery. Rectum / surgery. Surgical Stapling

  • Genetic Alliance. consumer health - Rectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1983 Feb;26(2):87-90 [6822175.001]
  • [Cites] Surgery. 1980 Nov;88(5):710-4 [7434211.001]
  • [Cites] Am J Surg. 1984 Apr;147(4):524-30 [6711755.001]
  • [Cites] Br J Surg. 1985 Aug;72(8):603-5 [3896372.001]
  • [Cites] Lancet. 1986 Jun 28;1(8496):1479-82 [2425199.001]
  • [Cites] Dis Colon Rectum. 1986 Dec;29(12):885-90 [2431844.001]
  • [Cites] Int Surg. 1988 Jan-Mar;73(1):19-22 [3360572.001]
  • [Cites] Br J Surg. 1990 May;77(5):510-2 [2354332.001]
  • [Cites] Dis Colon Rectum. 1991 Apr;34(4):317-22 [2007349.001]
  • [Cites] Br J Surg. 1991 Mar;78(3):308-11 [2021845.001]
  • [Cites] Dis Colon Rectum. 1991 Jun;34(6):495-7 [2036929.001]
  • [Cites] Am Surg. 1992 Apr;58(4):270-2 [1586088.001]
  • [Cites] Br J Surg. 1992 Aug;79(8):836-8 [1393488.001]
  • [Cites] Surg Gynecol Obstet. 1992 Oct;175(4):333-6 [1329243.001]
  • [Cites] World J Surg. 1992 Sep-Oct;16(5):866-71 [1462621.001]
  • [Cites] Br J Surg. 1993 Jul;80(7):924-7 [8369941.001]
  • [Cites] Dis Colon Rectum. 1994 Feb;37(2 Suppl):S35-41 [8313790.001]
  • [Cites] Dis Colon Rectum. 1995 May;38(5):480-6; discussion 486-7 [7736878.001]
  • [Cites] Dis Colon Rectum. 1995 Dec;38(12):1246-50 [7497834.001]
  • [Cites] Dis Colon Rectum. 1997 Jan;40(1):25-9 [9102256.001]
  • [Cites] Br J Surg. 1997 Apr;84(4):525-8 [9112908.001]
  • [Cites] Dis Colon Rectum. 1997 Jul;40(7):747-51 [9221846.001]
  • [Cites] Surg Today. 1997;27(8):706-9 [9306583.001]
  • [Cites] Aust N Z J Surg. 1997 Sep;67(9):599-602 [9322694.001]
  • [Cites] Surgery. 1997 Oct;122(4):779-84; discussion 784-5 [9347856.001]
  • [Cites] Br J Surg. 1998 Aug;85(8):1118-20 [9718010.001]
  • [Cites] Oncology. 1999 Apr;56(3):193-7 [10202273.001]
  • [Cites] Eur J Surg Oncol. 1999 Jun;25(3):284-91 [10336809.001]
  • [Cites] Indian J Gastroenterol. 1999 Jul-Sep;18(3):118-21 [10407566.001]
  • [Cites] Tech Coloproctol. 2004 Nov;8 Suppl 1:s79-81 [15655652.001]
  • [Cites] Trop Gastroenterol. 2001 Apr-Jun;22(2):83-6 [11552491.001]
  • [Cites] Br J Surg. 2001 Dec;88(12):1607-12 [11736973.001]
  • [Cites] Surg Clin North Am. 2002 Oct;82(5):983-93 [12507204.001]
  • [Cites] Int J Colorectal Dis. 2003 Nov;18(6):463-9 [14517685.001]
  • [Cites] Surg Today. 2004;34(1):32-9 [14714226.001]
  • [Cites] Br J Surg. 1980 Mar;67(3):198-200 [7362961.001]
  • [Cites] Dis Colon Rectum. 1983 Apr;26(4):231-5 [6839891.001]
  • (PMID = 17374176.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1839092
  • [General-notes] NLM/ Original DateCompleted: 20070726
  •  go-up   go-down


11. Triantafillidis JK, Nasioulas G, Kosmidis PA: Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res; 2009 Jul;29(7):2727-37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
  • Patients with long-standing ulcerative colitis and Crohn's disease have an increased risk of developing colorectal cancer and patients with small intestinal Crohn's disease are at increased risk of small bowel adenocarcinoma.
  • Colorectal cancer appearing on the ground of inflammatory bowel disease is the result of a process which is believed to begin from no dysplasia progressing to indefinite dysplasia, low-grade dysplasia, high-grade dysplasia and finally to invasive adenocarcinoma, although colorectal cancer can arise without proceeding through each of these steps.
  • Ulcerative colitis patients with total proctocolectomy and ileal pouch anal-anastomosis have a rather low risk of dysplasia in the ileal pouch, although the anal transition zone should be monitored periodically, especially if chronic pouchitis is present with associated severe villous atrophy.
  • Concerning the risk factors predisposing to colorectal cancer in the setting of ulcerative colitis or Crohn's disease, it seems that the risk increases with longer duration and greater anatomic extent of colitis, the degree of inflammation, and the presence of primary sclerosing cholangitis and family history of colorectal cancer.
  • [MeSH-major] Cell Transformation, Neoplastic. Colorectal Neoplasms / epidemiology. Inflammatory Bowel Diseases / epidemiology

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19596953.001).
  • [ISSN] 1791-7530
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Greece
  • [Number-of-references] 94
  •  go-up   go-down


12. Mistrangelo M, Cassoni P, Scozzari G, Castellano I, Gavello G, Corno F, Morino M: Perianal granular cell tumor: report of a case and review of the literature. Tumori; 2009 Jul-Aug;95(4):538-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perianal granular cell tumor: report of a case and review of the literature.
  • INTRODUCTION: Granular cell tumor was first described by Abrikossoff in 1926.
  • Over the years several cases of this neoplasm have been reported, with a variety of localizations.
  • We here report a case of perianal granular cell tumor and discuss its histogenesis and its relevance to clinical practice.
  • Pathological examination revealed a granular cell tumor.
  • A literature search produced only 25 other cases of anal and perianal granular cell tumors.
  • CONCLUSIONS: Granular cell tumors are rarely observed in the perianal region.
  • Their existence must always be borne in mind in the differential diagnosis of perianal neoplasms.
  • In most cases surgical excision is curative, but potential malignant transformation must be considered during therapeutic procedures and follow-up.
  • [MeSH-major] Anus Neoplasms / pathology
  • [MeSH-minor] Female. Granular Cell Tumor / pathology. Granular Cell Tumor / surgery. Humans. Middle Aged

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19856672.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  •  go-up   go-down


13. Lopez-Beltran A: Urothelial changes induced by therapeutic procedures for bladder cancer. Anal Quant Cytol Histol; 2006 Dec;28(6):339
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urothelial changes induced by therapeutic procedures for bladder cancer.

  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Anal Quant Cytol Histol. 2005 Feb;27(1):27-34 [15794449.001]
  • (PMID = 17220148.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  •  go-up   go-down


14. Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, Joon ML, See A, Feigen M, Rykers K, Kai C, Zupan E, Scott A: Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol; 2008 Jun;87(3):376-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessing the impact of FDG-PET in the management of anal cancer.
  • PURPOSE: To assess the utility of FDG-PET in anal cancer for staging and impact on radiotherapy planning (RTP), response and detection of recurrent disease.
  • METHODS AND MATERIALS: Fifty histopathological anal cancer patients were reviewed between 1996 and 2006.
  • Impact on management, disease response, recurrence and metastases was evaluated.
  • The primary was strongly FDG avid in 98% with non-excised tumors compared to CT (58%).
  • PET upstaged 17% with unsuspected pelvic/inguinal nodal disease.
  • CONCLUSIONS: Anal cancer is FDG-PET avid.
  • PET can aid in anal cancer staging and identification of residual disease, recurrent/metastatic disease but warrants further prospective studies.
  • [MeSH-major] Anus Neoplasms / radionuclide imaging. Carcinoma, Squamous Cell / radionuclide imaging. Fluorodeoxyglucose F18. Positron-Emission Tomography. Radiopharmaceuticals

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18453023.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


15. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I: Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys; 2010 Sep 1;501(1):79-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Regulation of SIRT1 in cellular functions: role of polyphenols.
  • Sirtuin 1 (SIRT1) is known to deacetylate histones and non-histone proteins including transcription factors thereby regulating metabolism, stress resistance, cellular survival, cellular senescence/aging, inflammation-immune function, endothelial functions, and circadian rhythms.
  • Naturally occurring dietary polyphenols, such as resveratrol, curcumin, quercetin, and catechins, have antioxidant and anti-inflammatory properties via modulating different pathways, such as NF-kappaB- and mitogen activated protein kinase-dependent signaling pathways.
  • In addition, these polyphenols have also been shown to activate SIRT1 directly or indirectly in a variety of models.
  • Therefore, activation of SIRT1 by polyphenols is beneficial for regulation of calorie restriction, oxidative stress, inflammation, cellular senescence, autophagy/apoptosis, autoimmunity, metabolism, adipogenesis, circadian rhythm, skeletal muscle function, mitochondria biogenesis and endothelial dysfunction.
  • In this review, we describe the regulation of SIRT1 by dietary polyphenols in various cellular functions in response to environmental and pro-inflammatory stimuli.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier Inc. All rights reserved.
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1071-7 [19211721.001]
  • [Cites] J Biol Chem. 2004 Jul 9;279(28):28873-9 [15126506.001]
  • [Cites] Science. 2004 Jul 16;305(5682):390-2 [15205477.001]
  • [Cites] Nature. 2004 Aug 5;430(7000):686-9 [15254550.001]
  • [Cites] Trends Cell Biol. 2004 Aug;14(8):408-12 [15308206.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L774-83 [15180920.001]
  • [Cites] PLoS Biol. 2004 Sep;2(9):E296 [15328540.001]
  • [Cites] Br J Cancer. 2004 Nov 1;91(9):1742-50 [15477867.001]
  • [Cites] PLoS One. 2008;3(12):e4020 [19107194.001]
  • [Cites] J Biol Chem. 2008 Aug 8;283(32):21837-41 [18445586.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L497-504 [18586954.001]
  • [Cites] Cancer Lett. 2008 Oct 8;269(2):315-25 [18467024.001]
  • [Cites] Free Radic Biol Med. 2008 Oct 1;45(7):1027-34 [18694817.001]
  • [Cites] Exp Cell Res. 2008 Oct 1;314(16):3069-74 [18687325.001]
  • [Cites] Nat Rev Drug Discov. 2008 Oct;7(10):841-53 [18827827.001]
  • [Cites] PLoS One. 2008;3(10):e3316 [18830406.001]
  • [Cites] J Biol Chem. 2008 Oct 10;283(41):27628-35 [18687677.001]
  • [Cites] J Biol Chem. 2008 Oct 17;283(42):28370-9 [18687687.001]
  • [Cites] Mol Cell. 2008 Oct 10;32(1):11-20 [18851829.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G833-42 [18755807.001]
  • [Cites] Cardiovasc Res. 2008 Nov 1;80(2):191-9 [18689793.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Nov 28;376(4):793-6 [18823944.001]
  • [Cites] Int J Biochem Cell Biol. 2009 Jan;41(1):81-6 [18817890.001]
  • [Cites] J Med Food. 2008 Dec;11(4):773-83 [19053873.001]
  • [Cites] Atherosclerosis. 2009 Jan;202(1):58-67 [18436224.001]
  • [Cites] Cancer Res. 2009 Mar 1;69(5):1702-5 [19244112.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Jan 16;378(3):389-93 [19059213.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Jan 23;378(4):836-41 [19071085.001]
  • [Cites] Nature. 2001 Mar 8;410(6825):227-30 [11242085.001]
  • [Cites] Cell. 2001 Oct 19;107(2):137-48 [11672522.001]
  • [Cites] Cell. 2001 Oct 19;107(2):149-59 [11672523.001]
  • [Cites] J Biol Chem. 2002 Apr 12;277(15):12632-41 [11812793.001]
  • [Cites] Annu Rev Biochem. 2002;71:307-31 [12045099.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1211-8 [17209140.001]
  • [Cites] Circ Res. 2007 May 25;100(10):1512-21 [17446436.001]
  • [Cites] Autophagy. 2007 Jul-Aug;3(4):405-7 [17471015.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Aug 3;359(3):665-71 [17560549.001]
  • [Cites] Mol Cell Biol. 2007 Jul;27(13):4698-707 [17452443.001]
  • [Cites] Cell Physiol Biochem. 2007;20(1-4):45-54 [17595514.001]
  • [Cites] Ageing Res Rev. 2007 Aug;6(2):128-40 [17512264.001]
  • [Cites] Cancer Res. 2007 Jul 15;67(14):6612-8 [17638871.001]
  • [Cites] Int J Obes (Lond). 2005 Jun;29(6):615-23 [15738931.001]
  • [Cites] Front Biosci (Landmark Ed). 2009;14:2983-95 [19273250.001]
  • [Cites] Curr Opin Lipidol. 2009 Apr;20(2):98-105 [19276888.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2008;3(4):637-58 [19281080.001]
  • [Cites] Int Immunopharmacol. 2009 Apr;9(4):418-24 [19185061.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Mar 13;380(3):644-9 [19285015.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Apr 10;381(3):372-7 [19236849.001]
  • [Cites] BMC Syst Biol. 2009;3:31 [19284563.001]
  • [Cites] Mech Ageing Dev. 2009 Aug;130(8):518-27 [19549533.001]
  • [Cites] Nature. 2009 Jul 30;460(7255):587-91 [19641587.001]
  • [Cites] J Biol Chem. 2009 Aug 14;284(33):21872-80 [19553684.001]
  • [Cites] Oncogene. 2009 Aug 13;28(32):2882-93 [19503100.001]
  • [Cites] PLoS One. 2009;4(8):e6611 [19680552.001]
  • [Cites] Cancer Sci. 2009 Sep;100(9):1655-62 [19496785.001]
  • [Cites] Circ Res. 2009 Aug 28;105(5):481-91 [19661458.001]
  • [Cites] Atherosclerosis. 2009 Sep;206(1):47-53 [19264308.001]
  • [Cites] Exp Gerontol. 1982;17(3):213-7 [7140862.001]
  • [Cites] J Allergy Clin Immunol. 1984 Jun;73(6):801-9 [6327791.001]
  • [Cites] Cancer Res. 1997 Oct 1;57(19):4414-9 [9331105.001]
  • [Cites] Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 2):S1-40 [10194189.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15998-6003 [15520384.001]
  • [Cites] J Biol Chem. 2004 Dec 3;279(49):50754-63 [15381699.001]
  • [Cites] Mol Cell. 2004 Dec 3;16(5):839-47 [15574338.001]
  • [Cites] Int Immunopharmacol. 2005 Feb;5(2):393-406 [15652768.001]
  • [Cites] Br J Cancer. 2005 Feb 14;92(3):499-502 [15685239.001]
  • [Cites] Cell Cycle. 2005 Jan;4(1):37-8 [15611669.001]
  • [Cites] Nature. 2005 Mar 3;434(7029):113-8 [15744310.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 Apr;6(4):298-305 [15768047.001]
  • [Cites] J Biol Chem. 2005 Apr 29;280(17):17038-45 [15684413.001]
  • [Cites] J Biol Chem. 2005 Apr 29;280(17):17187-95 [15749705.001]
  • [Cites] Carcinogenesis. 2000 Oct;21(10):1885-90 [11023547.001]
  • [Cites] FASEB J. 2005 May;19(7):840-1 [15734790.001]
  • [Cites] Nature. 2000 Feb 17;403(6771):795-800 [10693811.001]
  • [Cites] Cancer Res. 2007 Dec 15;67(24):12007-17 [18089832.001]
  • [Cites] Curr Opin Clin Nutr Metab Care. 2007 Nov;10(6):724-8 [18089954.001]
  • [Cites] Cell. 2008 Jan 25;132(2):171-6 [18243090.001]
  • [Cites] Toxicology. 2008 Mar 12;245(1-2):147-53 [18243466.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3374-9 [18296641.001]
  • [Cites] PLoS One. 2008;3(3):e1759 [18335035.001]
  • [Cites] Nature. 2008 Mar 27;452(7186):492-6 [18337721.001]
  • [Cites] Circ Res. 2008 Mar 28;102(6):703-10 [18239138.001]
  • [Cites] Curr Opin Chem Biol. 2008 Feb;12(1):11-7 [18282481.001]
  • [Cites] Am J Respir Crit Care Med. 2008 Apr 15;177(8):861-70 [18174544.001]
  • [Cites] Curr Opin Investig Drugs. 2008 Apr;9(4):371-8 [18393104.001]
  • [Cites] PLoS One. 2008;3(4):e2020 [18414679.001]
  • [Cites] PLoS Genet. 2008 Feb;4(2):e24 [18282106.001]
  • [Cites] Dev Cell. 2008 May;14(5):661-73 [18477450.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2721-35 [18424637.001]
  • [Cites] Metabolism. 2008 Jul;57(7 Suppl 1):S39-46 [18555853.001]
  • [Cites] J Biol Chem. 2008 Jul 18;283(29):20015-26 [18482975.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9793-8 [18599449.001]
  • [Cites] Cell Cycle. 2008 Jul 15;7(14):2117-22 [18641460.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Sep 5;373(4):545-9 [18586010.001]
  • [Cites] Cell. 2008 Jul 25;134(2):212-4 [18662537.001]
  • [Cites] Cell. 2008 Jul 25;134(2):317-28 [18662546.001]
  • [Cites] Cell. 2008 Jul 25;134(2):329-40 [18662547.001]
  • [Cites] Blood. 2010 Feb 4;115(5):965-74 [19996091.001]
  • [Cites] Aging (Albany NY). 2009 Jun;1(6):515-28 [20157535.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Feb 12;392(3):264-70 [20060806.001]
  • [Cites] J Allergy Clin Immunol. 2010 Feb;125(2):449-460.e14 [19864008.001]
  • [Cites] PLoS One. 2010;5(2):e9199 [20169165.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E419-28 [19996381.001]
  • [Cites] J Pharmacol Exp Ther. 2010 Mar;332(3):829-39 [19940103.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H833-43 [20008278.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Feb 26;393(1):66-72 [20102704.001]
  • [Cites] Diabetes. 2010 Mar;59(3):554-63 [19934007.001]
  • [Cites] J Biol Chem. 2010 Mar 5;285(10):7097-110 [20042607.001]
  • [Cites] J Biol Chem. 2010 Mar 12;285(11):8340-51 [20061378.001]
  • [Cites] J Biol Chem. 2010 Mar 12;285(11):8375-82 [20089851.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):749-57 [20093625.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E751-60 [20103737.001]
  • [Cites] J Clin Invest. 2010 Apr;120(4):1043-55 [20335657.001]
  • [Cites] Cell Mol Life Sci. 2009 Oct;66(19):3219-34 [19672559.001]
  • [Cites] Mol Pharmacol. 2009 Oct;76(4):884-95 [19620254.001]
  • [Cites] J Biol Chem. 2009 Oct 2;284(40):27042-53 [19651778.001]
  • [Cites] Anal Biochem. 2009 Dec 15;395(2):205-10 [19682970.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17343-8 [19805165.001]
  • [Cites] Cancer Res. 2009 Jan 15;69(2):583-92 [19147572.001]
  • [Cites] Curr Pharm Des. 2009;15(1):12-9 [19149598.001]
  • [Cites] Free Radic Biol Med. 2009 Mar 1;46(5):573-8 [19071213.001]
  • [Cites] Nature. 2002 Sep 19;419(6904):316-21 [12239572.001]
  • [Cites] Diabetes. 2002 Oct;51(10):2944-50 [12351431.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45099-107 [12297502.001]
  • [Cites] EMBO J. 2002 Dec 2;21(23):6539-48 [12456660.001]
  • [Cites] Endocr Rev. 2003 Feb;24(1):78-90 [12588810.001]
  • [Cites] Mol Cell Biol. 2003 May;23(9):3173-85 [12697818.001]
  • [Cites] Nature. 2003 May 8;423(6936):181-5 [12736687.001]
  • [Cites] Free Radic Biol Med. 2003 Jul 15;35(2):140-8 [12853070.001]
  • [Cites] Arch Pharm Res. 2003 Jul;26(7):559-63 [12934649.001]
  • [Cites] Nature. 2003 Sep 11;425(6954):191-6 [12939617.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10794-9 [12960381.001]
  • [Cites] Biochem Pharmacol. 2003 Dec 15;66(12):2427-35 [14637200.001]
  • [Cites] Cell. 2004 Feb 20;116(4):551-63 [14980222.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2259-64 [14982997.001]
  • [Cites] Science. 2004 Mar 26;303(5666):2011-5 [14976264.001]
  • [Cites] EMBO J. 2004 Jun 16;23(12):2369-80 [15152190.001]
  • [Cites] Nature. 2004 Jun 17;429(6993):771-6 [15175761.001]
  • [Cites] Mech Ageing Dev. 2006 Jul;127(7):618-27 [16603228.001]
  • [Cites] Science. 2006 Jun 2;312(5778):1312; author reply 1312 [16741098.001]
  • [Cites] Annu Rev Biochem. 2006;75:435-65 [16756498.001]
  • [Cites] Nat Rev Drug Discov. 2006 Jun;5(6):493-506 [16732220.001]
  • [Cites] Cell. 2006 Sep 8;126(5):837-9 [16959562.001]
  • [Cites] Aging Cell. 2006 Oct;5(5):413-22 [16939484.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1545-53 [16632544.001]
  • [Cites] Cell. 2006 Nov 3;127(3):635-48 [17081983.001]
  • [Cites] Nature. 2006 Nov 16;444(7117):337-42 [17086191.001]
  • [Cites] Cell. 2006 Dec 15;127(6):1109-22 [17112576.001]
  • [Cites] Clin Exp Immunol. 2007 Jan;147(1):155-63 [17177975.001]
  • [Cites] J Biol Chem. 2006 Dec 29;281(52):39915-24 [17090532.001]
  • [Cites] AAPS J. 2006;8(4):E632-43 [17233528.001]
  • [Cites] Oncogene. 2007 Feb 1;26(5):673-82 [16862172.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L567-76 [17041012.001]
  • [Cites] J Biol Chem. 2007 Mar 2;282(9):6823-32 [17197703.001]
  • [Cites] J Mol Cell Cardiol. 2007 Mar;42(3):508-16 [17188708.001]
  • [Cites] Curr Opin Cell Biol. 2007 Apr;19(2):230-7 [17317138.001]
  • [Cites] Circ Res. 2007 Mar 30;100(6):914-22 [17332429.001]
  • [Cites] Biol Pharm Bull. 2007 Apr;30(4):621-6 [17409491.001]
  • [Cites] EMBO J. 2007 Apr 4;26(7):1913-23 [17347648.001]
  • [Cites] Biochem J. 2007 May 15;404(1):1-13 [17447894.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7217-22 [17438283.001]
  • [Cites] Autophagy. 2009 Feb;5(2):235-7 [19066468.001]
  • [Cites] Autophagy. 2009 Feb;5(2):273-6 [19139632.001]
  • [Cites] Int Immunopharmacol. 2009 Mar;9(3):261-7 [19061976.001]
  • [Cites] J Cell Biochem. 2009 Mar 1;106(4):643-50 [19160423.001]
  • [Cites] EMBO J. 2005 Apr 6;24(7):1311-7 [15775985.001]
  • [Cites] Obes Res. 2005 Jun;13(6):982-90 [15976140.001]
  • [Cites] Am J Respir Cell Mol Biol. 2005 Aug;33(2):121-9 [15845867.001]
  • [Cites] Cell Metab. 2005 Aug;2(2):105-17 [16098828.001]
  • [Cites] Cell. 2005 Nov 4;123(3):437-48 [16269335.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Dec 30;338(4):1805-10 [16289039.001]
  • [Cites] J Hypertens. 2006 Jan;24(1):75-84 [16331104.001]
  • [Cites] Science. 2005 Dec 9;310(5754):1641 [16339438.001]
  • [Cites] J Biol Chem. 2005 Dec 30;280(52):43121-30 [16207712.001]
  • [Cites] Curr Biol. 2006 Feb 7;16(3):296-300 [16461283.001]
  • [Cites] PLoS Biol. 2006 Feb;4(2):e31 [16366736.001]
  • [Cites] Sci Am. 2006 Mar;294(3):48-51, 54-7 [16502611.001]
  • [Cites] Cell. 2006 May 5;125(3):497-508 [16678094.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2006 Jun;290(6):R1550-6 [16410398.001]
  • [Cites] Cell Cycle. 2006 Apr;5(8):873-7 [16628003.001]
  • [Cites] Nature. 2009 Apr 23;458(7241):1056-60 [19262508.001]
  • [Cites] Cell. 2009 May 1;137(3):560-70 [19410549.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):889-94 [19286634.001]
  • [Cites] Mol Cell Biol. 2009 Aug;29(15):4116-29 [19470756.001]
  • [Cites] J Biol Chem. 2009 Jul 24;284(30):20408-17 [19478080.001]
  • [Cites] FASEB J. 2009 Sep;23(9):2810-9 [19376817.001]
  • [Cites] Proc Am Thorac Soc. 2009 Sep 15;6(6):527-31 [19741262.001]
  • [Cites] FEBS Lett. 2009 Sep 17;583(18):3081-5 [19716821.001]
  • [Cites] Cancer Res. 2009 Sep 15;69(18):7449-58 [19738051.001]
  • [Cites] Aging Cell. 2009 Apr;8(2):100-12 [19302375.001]
  • [Cites] J Nutr. 2009 May;139(5):952-7 [19321592.001]
  • [Cites] J Immunol. 2000 Jun 15;164(12):6509-19 [10843709.001]
  • [Cites] Science. 2000 Sep 22;289(5487):2126-8 [11000115.001]
  • [Cites] J Clin Invest. 2010 Apr;120(4):1056-68 [20335659.001]
  • [Cites] Endocrinology. 2010 Jun;151(6):2504-14 [20339025.001]
  • [Cites] J Atheroscler Thromb. 2010 May;17(5):431-5 [20215708.001]
  • [Cites] Mol Med. 2010 Jul-Aug;16(7-8):235-46 [20386866.001]
  • [Cites] Antioxid Redox Signal. 2010 Oct 1;13(7):1023-32 [20392170.001]
  • [Cites] FASEB J. 2010 Sep;24(9):3145-59 [20385619.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1179-86 [19724016.001]
  • [Cites] Free Radic Biol Med. 2007 Sep 1;43(5):720-9 [17664136.001]
  • [Cites] Clin Cancer Res. 2007 Sep 1;13(17):5162-9 [17785572.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14855-60 [17785417.001]
  • [Cites] Mol Cell. 2007 Oct 12;28(1):91-106 [17936707.001]
  • [Cites] J Mol Cell Cardiol. 2007 Nov;43(5):571-9 [17916362.001]
  • [Cites] Front Biosci. 2008;13:3046-82 [17981777.001]
  • [Cites] Ann N Y Acad Sci. 2007 Oct;1114:407-18 [17804521.001]
  • [Cites] Aging Cell. 2007 Dec;6(6):759-67 [17877786.001]
  • [Cites] J Biol Chem. 2007 Nov 23;282(47):34066-76 [17884810.001]
  • [Cites] Mol Pharmacol. 2007 Dec;72(6):1508-21 [17872969.001]
  • [Cites] Trends Biochem Sci. 2007 Dec;32(12):555-60 [17980602.001]
  • [Cites] Nature. 2007 Nov 29;450(7170):712-6 [18046409.001]
  • [Cites] Nature. 2007 Dec 13;450(7172):1086-90 [18075593.001]
  • [Cites] Autophagy. 2009 Oct;5(7):1055-6 [19657235.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1876-81 [19749157.001]
  • [Cites] Chem Biol Drug Des. 2009 Dec;74(6):619-24 [19843076.001]
  • [Cites] Am J Respir Cell Mol Biol. 2009 Dec;41(6):651-60 [19265175.001]
  • [Cites] Endocrinology. 2009 Dec;150(12):5326-33 [19819963.001]
  • [Cites] Autophagy. 2009 Nov;5(8):1229-31 [19855187.001]
  • [Cites] PLoS One. 2009;4(12):e8414 [20027304.001]
  • [Cites] J Biol Chem. 2010 Jan 8;285(2):1283-95 [19887452.001]
  • [Cites] Cardiovasc Res. 2010 Feb 1;85(3):514-9 [19815564.001]
  • [Cites] J Clin Invest. 2009 Oct;119(10):3048-58 [19729833.001]
  • [Cites] Med Sci Sports Exerc. 2010 Feb;42(2):338-45 [19927026.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Jan 1;391(1):6-10 [19912989.001]
  • (PMID = 20450879.001).
  • [ISSN] 1096-0384
  • [Journal-full-title] Archives of biochemistry and biophysics
  • [ISO-abbreviation] Arch. Biochem. Biophys.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL092842-02; United States / NHLBI NIH HHS / HL / R01 HL085613-02W1; United States / NHLBI NIH HHS / HL / R01 HL085613-01A2; United States / NHLBI NIH HHS / HL / R01 HL085613-03; United States / NIEHS NIH HHS / ES / P30 ES001247; United States / NHLBI NIH HHS / HL / 1R01HL097751; United States / NHLBI NIH HHS / HL / R01 HL085613-04; United States / NHLBI NIH HHS / HL / R01 HL085613; United States / NHLBI NIH HHS / HL / R01 HL092842; United States / NHLBI NIH HHS / HL / R01 HL097751-02; United States / NIEHS NIH HHS / ES / P30-ES01247; United States / NHLBI NIH HHS / HL / R01 HL092842-01A2; United States / NHLBI NIH HHS / HL / 1R01HL092842; United States / NHLBI NIH HHS / HL / 1R01HL085613; United States / NHLBI NIH HHS / HL / R01 HL097751; United States / NHLBI NIH HHS / HL / R01 HL097751-01; United States / NHLBI NIH HHS / HL / R01 HL085613-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Flavonoids; 0 / Phenols; 0 / Polyphenols; 0U46U6E8UK / NAD; EC 2.4.2.30 / Poly(ADP-ribose) Polymerases; EC 3.5.1.- / Sirtuin 1
  • [Number-of-references] 230
  • [Other-IDs] NLM/ NIHMS208121; NLM/ PMC2930135
  •  go-up   go-down


16. Peeters ST, Lebesque JV, Heemsbergen WD, van Putten WL, Slot A, Dielwart MF, Koper PC: Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys; 2006 Mar 15;64(4):1151-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
  • PURPOSE: To identify dosimetric parameters derived from anorectal, rectal, and anal wall dose distributions that correlate with different late gastrointestinal (GI) complications after three-dimensional conformal radiotherapy for prostate cancer.
  • The variables derived from dose-volume histogram of anorectal, rectal, and anal wall were as follows: % receiving > or =5-70 Gy (V5-V70), maximum dose (Dmax), and mean dose (D(mean)).
  • The anus was defined as the most caudal 3 cm of the anorectum.
  • RESULTS: Anal dosimetric variables were associated with RTOG/EORTC Grade > or =2 (V5-V40, D(mean)) and incontinence (V5-V70, D(mean)).
  • Use of steroids was weakly related to anal variables.
  • Therefore, to evaluate the risk of late GI toxicity, not only intermediate and high doses to the anorectal wall volume should be taken into account, but also the dose to the anal wall.
  • [MeSH-major] Anal Canal / radiation effects. Prostatic Neoplasms / radiotherapy. Radiotherapy, Conformal / adverse effects. Rectum / radiation effects

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16414208.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


17. Yücesoy AN, Ercan Bülbül E, Bahat R, Cafer Köşkeroğlu C: Transvaginal low anterior resection for rectal cancer. Tech Coloproctol; 2008 Mar;12(1):83-5; discussion 85-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have performed a low anterior resection for rectal cancer in a 69-year-old woman with mobilisation of the tumour and anastomosis performed transvaginally without a covering stoma.
  • This way we could get good exposure of the lower rectum and anal sphincters.
  • [MeSH-major] Adenocarcinoma / surgery. Digestive System Surgical Procedures / methods. Rectal Neoplasms / surgery. Vagina

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg. 1996 Nov;224(5):603-8 [8916875.001]
  • [Cites] Colorectal Dis. 2004 Jul;6(4):275-9 [15206973.001]
  • [Cites] Dis Colon Rectum. 1996 May;39(5):582-3 [8620813.001]
  • [Cites] Rozhl Chir. 1983 Mar;62(3):176-80 [6845034.001]
  • [Cites] Dis Colon Rectum. 1991 Jun;34(6):495-7 [2036929.001]
  • [Cites] Cancer Control. 2003 May-Jun;10(3):212-8 [12794619.001]
  • [Cites] Tex Med. 1973 Sep;69(9):65-9 [4745938.001]
  • (PMID = 18512019.001).
  • [ISSN] 1123-6337
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


18. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, Villalon-Gomez JM, Williams MA, Cress RD: Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer; 2008 Nov 15;113(10 Suppl):2892-900
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Understanding the burden of human papillomavirus-associated anal cancers in the US.
  • BACKGROUND: Anal cancer is an uncommon malignancy in the US; up to 93% of anal cancers are associated with human papillomavirus.
  • The following anal cancer histologies were included in the analysis: squamous cell, adenocarcinoma, and small cell/neuroendocrine carcinomas.
  • RESULTS: From 1998 through 2003, the annual age-adjusted invasive anal cancer incidence rate was 1.5 per 100,000 persons.
  • Squamous cell carcinoma (SCC) was the most common histology overall, accounting for 18,105 of 21,395 (84.6%) cases of anal cancer.
  • Women had a higher rate of SCC (1.5 per 100,000) than men (1.0).
  • Incidence rates of anal SCC increased 2.6% per year on average.
  • API were more likely to be diagnosed with regional or distant stage disease than were other racial/ethnic groups (27.5% and 11.8%, respectively).
  • Males had lower 5-year relative survival than females for all stages of disease.
  • CONCLUSIONS: Rates of anal SCC varied by sex, race, and ethnicity.
  • Continued surveillance and additional research are needed to assess the potential impact of the HPV vaccine on the anal cancer burden in the US.

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10 [10995805.001]
  • [Cites] Cancer. 2000 Mar 15;88(6):1464-9 [10717631.001]
  • [Cites] Clin Infect Dis. 2002 Nov 1;35(9):1127-34 [12384848.001]
  • [Cites] AIDS. 2003 Feb 14;17(3):311-20 [12556684.001]
  • [Cites] Prev Med. 2003 May;36(5):555-60 [12689800.001]
  • [Cites] Dis Colon Rectum. 2003 Nov;46(11):1517-23; discussion 1523-4; author reply 1524 [14605572.001]
  • [Cites] Cancer Causes Control. 2003 Nov;14(9):837-46 [14682441.001]
  • [Cites] Lancet Oncol. 2004 Mar;5(3):149-57 [15003197.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):270-80 [15241823.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):281-8 [15241824.001]
  • [Cites] N Engl J Med. 1987 Oct 15;317(16):973-7 [2821396.001]
  • [Cites] Gastroenterology. 1988 Jul;95(1):107-11 [2836255.001]
  • [Cites] Am J Epidemiol. 1992 Jan 15;135(2):180-9 [1311142.001]
  • [Cites] Am J Epidemiol. 1992 Jul 1;136(1):54-8 [1329500.001]
  • [Cites] Am J Epidemiol. 1994 Apr 15;139(8):772-80 [8178790.001]
  • [Cites] Am J Epidemiol. 1994 Jul 1;140(1):12-9 [8017399.001]
  • [Cites] N Engl J Med. 1997 Nov 6;337(19):1350-8 [9358129.001]
  • [Cites] Semin Cancer Biol. 1998 Aug;8(4):307-13 [9870037.001]
  • [Cites] Cancer Res. 1999 Feb 1;59(3):753-7 [9973228.001]
  • [Cites] JAMA. 1999 May 19;281(19):1822-9 [10340370.001]
  • [Cites] Clin Infect Dis. 2006 Jul 15;43(2):223-33 [16779751.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2006 Oct 27;55(42):1145-8 [17065979.001]
  • [Cites] Stat Methods Med Res. 2006 Dec;15(6):547-69 [17260923.001]
  • [Cites] Lancet Oncol. 2007 Apr;8(4):311-6 [17395104.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):919-25 [17527081.001]
  • [Cites] Clin Microbiol Rev. 2007 Jul;20(3):478-88, table of contents [17630336.001]
  • [Cites] Sex Transm Infect. 2007 Jul;83(4):257-66 [17664359.001]
  • [Cites] Cancer Causes Control. 2007 Dec;18(10):1175-86 [17805982.001]
  • [Cites] Cancer. 2008 Nov 15;113(10 Suppl):2841-54 [18980203.001]
  • [Cites] Dermatol Ther. 2005 Jan-Feb;18(1):67-76 [15842614.001]
  • [Cites] Dan Med Bull. 2002 Aug;49(3):194-209 [12238281.001]
  • (PMID = 18980293.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] None / None / / N01 PC035137; United States / NCCDPHP CDC HHS / DP / U50 DP424071; United States / NCI NIH HHS / PC / N01 PC035137; United States / NCCDPHP CDC HHS / DP / U50 DP424071-04
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS104103; NLM/ PMC2729501
  •  go-up   go-down


19. Al-Niaimi F, Lyon CC: Primary adenocarcinoma in peristomal skin: a case study. Ostomy Wound Manage; 2010 Jan 1;56(1):45-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Biopsy of newly developing lesions in the peristomal area of long-standing stomas is essential in order to avoid delayed diagnosis and limit complications.
  • The lesion was removed surgically, an ileo-anal J pouch was created, and the patient is currently receiving long-term follow-up and monitoring for any possible future complications.
  • [MeSH-major] Adenocarcinoma / complications. Colitis, Ulcerative / surgery. Ileostomy / adverse effects. Skin Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20093717.001).
  • [ISSN] 1943-2720
  • [Journal-full-title] Ostomy/wound management
  • [ISO-abbreviation] Ostomy Wound Manage
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Bellutti M, Fry LC, Schmitt J, Seemann M, Klose S, Malfertheiner P, Mönkemüller K: Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy. Dig Dis Sci; 2009 May;54(5):1050-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy.
  • BACKGROUND: Neuroendocrine tumors (NET) account for one-third of all small bowel neoplasms.
  • The search for the primary tumor in NET is important, even though it is difficult to localize, as its surgical excision leads to a better prognosis, even in metastasized stages of the disease.
  • The objective of this study was to evaluate the use of double balloon enteroscopy (DBE) for the detection of the primary tumor in patients with NET.
  • METHODS: Twelve consecutive patients (eight women, four men) with suspected carcinoid syndrome, either metastatic to the liver (n=5), symptoms of a neuroendocrine tumor with elevated tumor markers (n=5), or obscure gastrointestinal bleeding (n=2) underwent DBE for the search of the primary tumor or the source of bleeding.
  • The CT scan and sonography of the abdomen as well as EGD and ileocolonoscopy were unable to detect the primary tumor in any patient.
  • A submucosal tumor of the ileum or the jejunum could be detected by DBE was detected in seven patients (58%) (anal route, n=4; oral route, n=3).
  • In four of these patients (33%) this finding could be confirmed by the surgical resection of a NET.
  • In two patients (17%) with a submucosal ileum protrusion suspicious for NET, laparotomy and intraoperative endoscopy did not confirm the tumor.
  • CONCLUSIONS: In this study, the diagnostic yield of DBE for primary tumor search in patients with metastatic or suspected NET was 33%.
  • Although endoscopic small bowel investigation by DBE seems to enrich the diagnostic possibilities for the diagnosis of small bowel-NET, at the present time DBE should only be performed in selected cases, possibly based on a positive previous work-up.
  • [MeSH-major] Endoscopy, Gastrointestinal / methods. Gastrointestinal Hemorrhage / etiology. Intestinal Neoplasms / pathology. Intestine, Small / pathology. Liver Neoplasms / secondary. Malignant Carcinoid Syndrome / pathology. Neuroendocrine Tumors / pathology

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroendocrinology. 2004;80(6):394-424 [15838182.001]
  • [Cites] Endoscopy. 2003 Dec;35(12):985-91 [14648408.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):42-8 [16429354.001]
  • [Cites] Endoscopy. 2005 Sep;37(9):827-32 [16116533.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):717-28 [16253896.001]
  • [Cites] Gastrointest Endosc. 2006 Apr;63(4):660-5 [16564869.001]
  • [Cites] AJR Am J Roentgenol. 2004 Mar;182(3):559-67 [14975946.001]
  • [Cites] Hepatogastroenterology. 2005 May-Jun;52(63):731-41 [15966194.001]
  • [Cites] Gastrointest Endosc. 2006 Nov;64(5):740-50 [17055868.001]
  • [Cites] J Clin Gastroenterol. 2006 Aug;40(7):572-82 [16917396.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1717-51 [15887161.001]
  • [Cites] Gastrointest Endosc. 2006 Jul;64(1):66-72 [16813805.001]
  • [Cites] N Engl J Med. 1999 Mar 18;340(11):858-68 [10080850.001]
  • [Cites] Dig Dis Sci. 2005 Jun;50(6):1041-5 [15986851.001]
  • [Cites] Gastroenterology. 2003 Nov;125(5):1556; author reply 1556-7 [14628813.001]
  • [Cites] Gastrointest Endosc. 2005 Aug;62(2):315-8 [16047008.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):67-72 [16429357.001]
  • [Cites] Gastrointest Endosc. 2007 Apr;65(4):633-9 [17383460.001]
  • [Cites] Eur J Radiol. 2001 Jan;37(1):8-17 [11274833.001]
  • [Cites] Ann Surg. 2005 Jun;241(6):839-45; discussion 845-6 [15912033.001]
  • [Cites] Eur J Endocrinol. 2004 Jul;151(1):15-27 [15248818.001]
  • (PMID = 18770038.001).
  • [ISSN] 1573-2568
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; RWM8CCW8GP / Octreotide
  •  go-up   go-down


21. Barr E, Sings HL: Prophylactic HPV vaccines: new interventions for cancer control. Vaccine; 2008 Nov 18;26(49):6244-57
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal, vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory papillomatosis (RRP).
  • Together these four types cause 30-50% of all cervical intraepithelial neoplasia such as those detected by Papinicalou screening.
  • [MeSH-major] Genital Neoplasms, Female / prevention & control. Papillomavirus Vaccines / therapeutic use
  • [MeSH-minor] Adolescent. Adult. Animals. Condylomata Acuminata / immunology. Condylomata Acuminata / prevention & control. Cost of Illness. Female. Humans. Immunization Programs. Male. Neoplasms, Squamous Cell / immunology. Neoplasms, Squamous Cell / pathology. Neoplasms, Squamous Cell / prevention & control. Papillomavirus Infections / economics. Papillomavirus Infections / transmission. Rectal Neoplasms / immunology. Rectal Neoplasms / prevention & control. Uterine Cervical Neoplasms / immunology. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / prevention & control. Vaginal Neoplasms / immunology. Vaginal Neoplasms / pathology. Vaginal Neoplasms / prevention & control. Vulvar Neoplasms / immunology. Vulvar Neoplasms / pathology. Vulvar Neoplasms / prevention & control. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18694795.001).
  • [ISSN] 0264-410X
  • [Journal-full-title] Vaccine
  • [ISO-abbreviation] Vaccine
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Papillomavirus Vaccines
  • [Number-of-references] 116
  •  go-up   go-down


22. Kreuter A, Wieland U, Gambichler T, Altmeyer P, Pfister H, Tenner-Racz K, Racz P, Potthoff A, Brockmeyer NH, German Network of Competence HIV/AIDS: p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol; 2007 Sep;157(3):523-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load.
  • In this context, a drastically increased relative risk for anal intraepithelial neoplasia (AIN) exists in HIV-infected men having sex with men (MSM).
  • [MeSH-major] Aminoquinolines / therapeutic use. Antineoplastic Agents / therapeutic use. Anus Neoplasms / drug therapy. Carcinoma in Situ / drug therapy. Cyclin-Dependent Kinase Inhibitor p16 / metabolism. Precancerous Conditions / drug therapy
  • [MeSH-minor] AIDS-Related Opportunistic Infections / complications. Administration, Cutaneous. Adult. Biomarkers, Tumor / metabolism. DNA, Viral / analysis. Homosexuality, Male. Humans. Ki-67 Antigen / metabolism. Male. Papillomaviridae / genetics. Papillomavirus Infections / complications. Papillomavirus Infections / metabolism. Pilot Projects. Viral Load

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. Imiquimod .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17573882.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00365729
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Aminoquinolines; 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / DNA, Viral; 0 / Ki-67 Antigen; 99011-02-6 / imiquimod
  •  go-up   go-down


23. Orsenigo E, Di Palo S, Vignali A, Staudacher C: Laparoscopic intersphincteric resection for low rectal cancer. Surg Oncol; 2007 Dec;16 Suppl 1:S117-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nevertheless, all progress in the development of oncologic therapy (i.e., radiation and chemotherapy), radical surgical removal of the tumour is the only chance for permanent cure of rectal cancer.
  • Information concerning the depth of tumour penetration through the rectal wall, lymph node involvement, and presence of distant metastatic disease is of crucial importance when planning a curative rectal cancer resection.
  • Laparoscope-assisted anal sphincter-preserving operation preceded by transanal procedure.
  • Colorectal Disease 2003;5:451-3; Rullier E, Sa Cunha A, Couderc P, Rullier A, Gontier R, Saric J.
  • Laparoscopic ultralow anterior resection combined with per anum intersphincteric rectal dissection for lower rectal cancer.
  • Hopefully, randomized controlled trials, which utilize these alternative procedures, will in future determine the results of laparoscopic ISR in terms of sphincter function, faecal continence, disease free and overall survival.
  • [MeSH-major] Anal Canal / surgery. Digestive System Surgical Procedures / methods. Laparoscopy. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18023571.001).
  • [ISSN] 0960-7404
  • [Journal-full-title] Surgical oncology
  • [ISO-abbreviation] Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


24. Sahni VA, Silverman SG: Biopsy of renal masses: when and why. Cancer Imaging; 2009;9:44-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although once reserved for the diagnosis of unresectable renal cell carcinoma, metastases, lymphoma, and infection, today percutaneous image-guided biopsy has an expanded role.
  • There is increasing awareness that a substantial proportion of small, solid renal masses are benign neoplasms.
  • Based largely on advances in cytological techniques, percutaneous biopsy can be now be used to diagnose benign neoplasms and thus prevent them from being treated unnecessarily.
  • [MeSH-major] Biopsy, Needle / methods. Kidney Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Computer-Assisted / methods. Diagnosis, Differential. Humans. Kidney Diseases / pathology. Patient Selection. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1999 May;161(5):1470-4 [10210375.001]
  • [Cites] JAMA. 1999 May 5;281(17):1628-31 [10235157.001]
  • [Cites] J Comput Assist Tomogr. 1999 May-Jun;23(3):441-4 [10348452.001]
  • [Cites] Magn Reson Imaging Clin N Am. 1999 May;7(2):337-48 [10382165.001]
  • [Cites] Emerg Radiol. 2007 Apr;14(1):13-22 [17318482.001]
  • [Cites] AJR Am J Roentgenol. 2007 Jun;188(6):1500-5 [17515368.001]
  • [Cites] Mod Pathol. 2007 Jul;20(7):722-8 [17483815.001]
  • [Cites] Radiographics. 2007 Jul-Aug;27(4):1131-43 [17620471.001]
  • [Cites] J Urol. 2007 Oct;178(4 Pt 1):1184-8; discussion 1188 [17698122.001]
  • [Cites] Oncologist. 2007 Dec;12(12):1404-15 [18165617.001]
  • [Cites] Eur Radiol. 2008 Feb;18(2):365-75 [17899106.001]
  • [Cites] J Urol. 2008 Apr;179(4):1227-33; discussion 1233-4 [18280512.001]
  • [Cites] Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):167-71 [18603673.001]
  • [Cites] J Urol. 2008 Sep;180(3):844-8; discussion 848 [18635230.001]
  • [Cites] Radiology. 2008 Oct;249(1):16-31 [18796665.001]
  • [Cites] Radiographics. 2000 Jan-Feb;20(1):197-212 [10682781.001]
  • [Cites] Urology. 2000 Mar;55(3):348-52 [10699608.001]
  • [Cites] Eur Urol. 2000 Apr;37(4):484-7 [10765081.001]
  • [Cites] AJR Am J Roentgenol. 2000 Aug;175(2):339-42 [10915671.001]
  • [Cites] Radiology. 2000 Aug;216(2):506-10 [10924578.001]
  • [Cites] J Urol. 2000 Oct;164(4):1143-7 [10992354.001]
  • [Cites] AJR Am J Roentgenol. 2000 Oct;175(4):945-55 [11000140.001]
  • [Cites] J Nephrol. 2000 Sep-Oct;13(5):367-72 [11063141.001]
  • [Cites] Radiology. 2000 Dec;217(3):665-72 [11110926.001]
  • [Cites] Mayo Clin Proc. 2000 Dec;75(12):1236-42 [11126830.001]
  • [Cites] J Urol. 2001 Mar;165(3):773-6 [11176465.001]
  • [Cites] J Histochem Cytochem. 2001 Jul;49(7):919-20 [11410616.001]
  • [Cites] J Ultrasound Med. 2001 Jul;20(7):749-53; quiz 755 [11444733.001]
  • [Cites] Curr Opin Urol. 2001 Sep;11(5):463-9 [11493766.001]
  • [Cites] J Urol. 2002 Jan;167(1):10-5 [11743264.001]
  • [Cites] J Urol. 1986 Dec;136(6):1292-3 [3773108.001]
  • [Cites] Br J Radiol. 1985 Dec;58(696):1217-9 [3916167.001]
  • [Cites] AJR Am J Roentgenol. 1988 Sep;151(3):497-501 [3044036.001]
  • [Cites] J Urol. 1988 Sep;140(3):487-90 [3411657.001]
  • [Cites] J Urol. 1990 May;143(5):999-1001 [2184260.001]
  • [Cites] Radiology. 1990 Nov;177(2):495-7 [2217790.001]
  • [Cites] Acta Radiol. 1991 Jan;32(1):50-2 [2012730.001]
  • [Cites] Radiology. 1991 May;179(2):307-17 [2014269.001]
  • [Cites] Urol Radiol. 1991;13(2):83-90 [1897073.001]
  • [Cites] Radiology. 1992 May;183(2):509-13 [1561359.001]
  • [Cites] Acta Cytol. 1993 May-Jun;37(3):367-72 [8498138.001]
  • [Cites] Br J Urol. 1993 Sep;72(3):274-6 [8220985.001]
  • [Cites] AJR Am J Roentgenol. 1993 Dec;161(6):1303-5 [8249747.001]
  • [Cites] Pathology. 1994 Apr;26(2):170-5 [8090589.001]
  • [Cites] Cancer. 2001 Dec 25;93(6):390-7 [11748579.001]
  • [Cites] AJR Am J Roentgenol. 2002 Aug;179(2):373-8 [12130435.001]
  • [Cites] Eur Radiol. 2002 Oct;12(10):2518-24 [12271393.001]
  • [Cites] J Urol. 2002 Oct;168(4 Pt 1):1315-25 [12352384.001]
  • [Cites] Urology. 2002 Dec;60(6):1003-9 [12475658.001]
  • [Cites] Radiology. 2003 Jan;226(1):33-46 [12511666.001]
  • [Cites] AJR Am J Roentgenol. 2003 Mar;180(3):755-8 [12591691.001]
  • [Cites] AJR Am J Roentgenol. 2003 Apr;180(4):1055-61 [12646454.001]
  • [Cites] AJR Am J Roentgenol. 2003 May;180(5):1281-7 [12704038.001]
  • [Cites] AJR Am J Roentgenol. 2003 Jun;180(6):1503-8 [12760909.001]
  • [Cites] Urology. 2003 Nov;62(5):827-30 [14624902.001]
  • [Cites] J Urol. 2003 Dec;170(6 Pt 1):2217-20 [14634382.001]
  • [Cites] J Urol. 2003 Dec;170(6 Pt 1):2237-40 [14634387.001]
  • [Cites] Int J Urol. 2004 Feb;11(2):63-7 [14706008.001]
  • [Cites] AJR Am J Roentgenol. 2004 Mar;182(3):551-7 [14975944.001]
  • [Cites] Radiology. 2004 Mar;230(3):677-84 [14990834.001]
  • [Cites] J Urol. 2004 May;171(5):1802-5 [15076280.001]
  • [Cites] AJR Am J Roentgenol. 2004 Sep;183(3):575-82 [15333338.001]
  • [Cites] AJR Am J Roentgenol. 1977 Oct;129(4):725-7 [409251.001]
  • [Cites] South Med J. 1979 Jul;72(7):806-7 [451686.001]
  • [Cites] Radiology. 1979 Sep;132(3):553-61 [382239.001]
  • [Cites] AJR Am J Roentgenol. 1980 Jul;135(1):87-92 [6772002.001]
  • [Cites] AJR Am J Roentgenol. 1981 Dec;137(6):1221-6 [6976096.001]
  • [Cites] Urol Radiol. 1981;3(3):135-42 [7340024.001]
  • [Cites] Br J Urol. 1983 Jun;55(3):249-53 [6850236.001]
  • [Cites] Urology. 1984 Sep;24(3):293-6 [6474646.001]
  • [Cites] Invest Radiol. 1984 Sep-Oct;19(5):447-54 [6392155.001]
  • [Cites] Cancer. 1985 Jul 1;56(1):200-5 [2988734.001]
  • [Cites] Radiology. 1986 Jan;158(1):1-10 [3510019.001]
  • [Cites] J Urol. 1986 Aug;136(2):446-8 [3735515.001]
  • [Cites] Radiology. 1995 Oct;197(1):175-81 [7568819.001]
  • [Cites] Int J Urol. 1995 May;2(2):77-80 [7553292.001]
  • [Cites] Radiology. 1995 Dec;197(3):589-97 [7480724.001]
  • [Cites] Semin Urol Oncol. 1995 Nov;13(4):254-61 [8595548.001]
  • [Cites] Semin Urol Oncol. 1995 Nov;13(4):267-72 [8595550.001]
  • [Cites] Radiology. 1996 Mar;198(3):638-41 [8628846.001]
  • [Cites] J Urol. 1996 Jul;156(1):28-30 [8648823.001]
  • [Cites] N Engl J Med. 1996 Sep 19;335(12):865-75 [8778606.001]
  • [Cites] Br J Urol. 1996 Jul;78(1):29-32 [8795396.001]
  • [Cites] Cancer. 1997 Apr 25;81(2):71-88 [9126135.001]
  • [Cites] Acta Cytol. 1997 Jul-Aug;41(4):987-94 [9250289.001]
  • [Cites] Radiology. 1997 Nov;205(2):497-502 [9356635.001]
  • [Cites] Ann Surg Oncol. 1997 Oct-Nov;4(7):570-4 [9367023.001]
  • [Cites] Urology. 1998 Feb;51(2):203-5 [9495698.001]
  • [Cites] Diagn Cytopathol. 1998 Apr;18(4):297-300 [9557267.001]
  • [Cites] Am Fam Physician. 1998 May 1;57(9):2155-64, 2169-70 [9606306.001]
  • [Cites] J Magn Reson Imaging. 1998 May-Jun;8(3):690-4 [9626888.001]
  • [Cites] Diagn Cytopathol. 1999 Jul;21(1):35-8 [10405806.001]
  • [Cites] Am J Surg Pathol. 1999 Sep;23(9):1094-101 [10478670.001]
  • [Cites] Cancer. 1950 Jan;3(1):74-85 [15405683.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2195-201 [15470708.001]
  • [Cites] Clin Lab Med. 2005 Jun;25(2):247-57 [15848735.001]
  • [Cites] Radiology. 2005 Aug;236(2):716-24 [16040927.001]
  • [Cites] Radiology. 2006 Jul;240(1):6-22 [16709793.001]
  • [Cites] Anal Quant Cytol Histol. 2006 Aug;28(4):228-36 [16927643.001]
  • [Cites] N Engl J Med. 2007 Jan 11;356(2):115-24 [17215529.001]
  • [Cites] N Engl J Med. 2007 Jan 11;356(2):125-34 [17215530.001]
  • [Cites] AJR Am J Roentgenol. 2007 Feb;188(2):563-70 [17242269.001]
  • [Cites] AJR Am J Roentgenol. 2007 Mar;188(3):792-7 [17312070.001]
  • [Cites] Histopathology. 2007 Apr;50(5):642-7 [17394501.001]
  • [Cites] Eur J Radiol. 2002 Jan;41(1):65-9 [11750155.001]
  • [Cites] Urology. 2002 May;59(5):635-42 [11992832.001]
  • [Cites] Histopathology. 2002 Jun;40(6):563-7 [12047768.001]
  • [Cites] Mod Pathol. 2002 Jul;15(7):712-7 [12118108.001]
  • (PMID = 19602467.001).
  • [ISSN] 1470-7330
  • [Journal-full-title] Cancer imaging : the official publication of the International Cancer Imaging Society
  • [ISO-abbreviation] Cancer Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 112
  • [Other-IDs] NLM/ PMC2739685
  •  go-up   go-down


25. Simeonov R, Simeonova G: Computerized cytomorphometric analysis of nuclear area, nuclear perimeter and mean nuclear diameter in spontaneous canine mammary gland tumours. Vet Res Commun; 2007 Jul;31(5):553-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A minimum of 100 nuclei per lesion were examined.
  • The statistical analysis revealed statistically significant differences between benign and malignant neoplasms.
  • The results indicated that computer-assisted nuclear morphometry could be used as an additional method for differentiation of benign from malignant canine mammary gland tumours in cytological specimens.
  • [MeSH-major] Cell Nucleus. Cytological Techniques / veterinary. Dog Diseases / pathology. Histological Techniques / veterinary. Mammary Neoplasms, Animal / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comp Pathol. 1997 Aug;117(2):99-105 [9352434.001]
  • [Cites] Anticancer Res. 2000 Sep-Oct;20(5A):3273-80 [11062753.001]
  • [Cites] J Clin Pathol. 1997 May;50(5):365-70 [9215116.001]
  • [Cites] J Comp Pathol. 1995 May;112(4):429-33 [7593765.001]
  • [Cites] J Comp Pathol. 2002 Aug-Oct;127(2-3):114-7 [12354521.001]
  • [Cites] Anal Quant Cytol Histol. 2000 Jun;22(3):185-92 [10872033.001]
  • [Cites] Am J Vet Res. 1998 Oct;59(10):1238-42 [9781454.001]
  • [Cites] Am J Vet Res. 2002 Mar;63(3):363-9 [11926179.001]
  • [Cites] Am J Vet Res. 1995 Feb;56(2):185-7 [7717583.001]
  • [Cites] Vet Clin Pathol. 2002;31(1):16-8 [12019473.001]
  • [Cites] J Comp Pathol. 2004 Feb-Apr;130(2-3):143-51 [15003472.001]
  • [Cites] Vet Pathol. 2003 May;40(3):268-75 [12724567.001]
  • [Cites] Res Vet Sci. 1995 May;58(3):277-81 [7659856.001]
  • [Cites] Am J Vet Res. 2000 Sep;61(9):1074-9 [10976739.001]
  • [Cites] J Comp Pathol. 2001 Aug-Oct;125(2-3):117-21 [11578126.001]
  • [Cites] Am J Vet Res. 1992 Mar;53(3):300-3 [1595955.001]
  • (PMID = 17221362.001).
  • [ISSN] 0165-7380
  • [Journal-full-title] Veterinary research communications
  • [ISO-abbreviation] Vet. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


26. Fernández-Fernández FJ, Buño-Ramilo B, Alvarez-Fernández JC, Brage-Gómez MS, Nogueira C: [Paraneoplastic hypercalcemia associated with a rectal epidermoid tumor in a patient with a long-standing anal fistula]. Gastroenterol Hepatol; 2010 Aug-Sep;33(7):551-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Paraneoplastic hypercalcemia associated with a rectal epidermoid tumor in a patient with a long-standing anal fistula].
  • [Transliterated title] Hipercalcemia paraneoplásica asociada a una tumoración epidermoide rectal en una paciente con fístula anal de larga duración.
  • [MeSH-major] Carcinoma, Squamous Cell / complications. Hypercalcemia / etiology. Paraneoplastic Syndromes / etiology. Rectal Fistula / complications. Rectal Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20381202.001).
  • [ISSN] 0210-5705
  • [Journal-full-title] Gastroenterología y hepatología
  • [ISO-abbreviation] Gastroenterol Hepatol
  • [Language] spa
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Spain
  •  go-up   go-down


27. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort: Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst; 2005 Mar 16;97(6):425-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Statistically significantly elevated SIRs were also observed for anal cancer (SIR = 33.4, 95% CI = 10.5 to 78.6); Hodgkin lymphoma (SIR = 17.3, 95% CI = 10.2 to 27.4); cancers of the cervix (SIR = 8.0, 95% CI = 2.9 to 17.4); liver (SIR = 7.0, 95% CI = 2.2 to 16.5); lip, mouth, and pharynx (SIR = 4.1, 95% CI = 2.1 to 7.4); trachea, lung, and bronchus (SIR = 3.2, 95% CI = 1.7 to 5.4); and skin, nonmelanomatous (SIR = 3.2, 95% CI = 2.2 to 4.5).
  • [MeSH-major] Antiretroviral Therapy, Highly Active. CD4-Positive T-Lymphocytes. HIV Infections / complications. HIV Infections / drug therapy. Neoplasms / epidemiology. Neoplasms / etiology. Smoking / adverse effects
  • [MeSH-minor] Adult. Aged. Cohort Studies. Confounding Factors (Epidemiology). Female. Humans. Incidence. Lymphocyte Count. Lymphoma, AIDS-Related / epidemiology. Lymphoma, Non-Hodgkin / epidemiology. Lymphoma, Non-Hodgkin / virology. Male. Medical Record Linkage. Middle Aged. Odds Ratio. Papillomaviridae. Prospective Studies. Registries. Research Design. Risk Assessment. Risk Factors. Sarcoma, Kaposi / epidemiology. Sarcoma, Kaposi / virology. Switzerland / epidemiology. Uterine Cervical Neoplasms / epidemiology. Uterine Cervical Neoplasms / virology


28. Liu BS, Xu L, Yan J, Liu C, Zheng YC: [Experience of ultralow anterior excision for rectal cancer: 508 cases analysis]. Zhonghua Wai Ke Za Zhi; 2008 Nov 15;46(22):1712-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From October 1996 to October 2006, 508 cases with rectal carcinoma at or below the peritoneal reflection with potential to preserve the anal function were divided into two groups.
  • Of the patients, 365 cases underwent ultralow anterior excision and instrumental anastomosis, and 143 cases underwent manual colon-anal anastomosis (Parks operation).
  • In the Parks operation group, the anastomosis was carried out manually at the anus and in abdominal cavity.
  • [MeSH-major] Anastomosis, Surgical / methods. Rectal Neoplasms / surgery
  • [MeSH-minor] Anal Canal / surgery. Follow-Up Studies. Humans. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19094730.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


29. Roldán GB, Chan AK, Buckner M, Magliocco AM, Doll CM: The prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapy. Dis Colon Rectum; 2010 Aug;53(8):1127-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The prognostic value of hemoglobin in patients with anal cancer treated with chemoradiotherapy.
  • PURPOSE: This study aimed to evaluate the impact of hemoglobin level on clinical outcome (local response, progression-free survival, and overall survival) in patients with carcinoma of the anal canal treated with definitive chemoradiotherapy.
  • METHODS: This is a retrospective study of patients with anal cancer treated between 1992 and 2005 with definitive chemoradiotherapy at Tom Baker Cancer Centre.
  • The median age was 56 years, the male-to-female ratio was 1:2, and the median tumor size was 3.5 cm.
  • CONCLUSIONS: Hemoglobin status was correlated with progression-free and overall survival, and distant relapse, but not clinical response, in patients with carcinoma of the anal canal treated with chemoradiotherapy.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Anus Neoplasms / blood. Hemoglobins / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / blood. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Radiotherapy, Adjuvant. Retrospective Studies

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628275.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 0 / Hemoglobins
  •  go-up   go-down


30. Riethmuller D: [Ano-genital papillomavirus infections in women]. Rev Prat; 2006 Nov 15;56(17):1893-900
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ano-genital papillomavirus infections in women].
  • [Transliterated title] Lésions ano-génitales a papillomavirus chez la femme.
  • Ano-genital papillomavirus infections in women are caused by high-risk human papillomaviruses (HPV) involved in cervical carcinogenesis (but also, to a lesser extent, in vaginal, vulvar and anal carcinogenesis) or by low-risk HPV responsible for condylomata acuminata, which may be peri-anal, perineal, vulvar or vaginal (less often cervical).
  • [MeSH-major] Papillomavirus Infections / transmission. Uterine Cervical Dysplasia / virology. Uterine Cervical Neoplasms / virology


31. Zhou BJ, Song WQ, Yan QH, Cai JH, Wang FA, Liu J, Zhang GJ, Duan GQ, Zhang ZX: Ultrasonically activated scalpel versus monopolar electrocautery shovel in laparoscopic total mesorectal excision for rectal cancer. World J Gastroenterol; 2008 Jul 7;14(25):4065-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: To investigate the feasibility and safety of monopolar electrocautery shovel (ES) in laparoscopic total mesorectal excision (TME) with anal sphincter preservation for rectal cancer in order to reduce the cost of the laparoscopic operation, and to compare ES with the ultrasonically activated scalpel (US).
  • METHODS: Forty patients with rectal cancer, who underwent laparoscopic TME with anal sphincter preservation from June 2005 to June 2007, were randomly divided into ultrasonic scalpel group and monopolar ES group, prospectively.
  • White blood cells (WBC) were measured before and after operation, operative time, blood loss, pelvic volume of drainage, time of anal exhaust, visual analogue scales (VAS) and surgery-related complications were recorded.
  • No significant differences were observed in terms of preoperative and postoperative d 1 and d 3 WBC counts (P=0.493, P=0.375, P=0.559), operation time (P=0.235), blood loss (P=0.296), anal exhaust time (P=0.431), pelvic drainage volume and VAS in postoperative d 1 (P=0.431, P=0.426) and d 3 (P=0.844, P=0.617) between ES group and US group.
  • CONCLUSION: ES is a safe and feasible tool as same as US used in laparoscopic TME with anal sphincter preservation for rectal cancer on the basis of the skillful laparoscopic technique and the complete understanding of laparoscopic pelvic anatomy.
  • [MeSH-major] Digestive System Surgical Procedures / instrumentation. Electrocoagulation / instrumentation. Laparoscopy. Rectal Neoplasms / surgery. Ultrasonography, Interventional / instrumentation

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Today. 2005;35(7):598-602 [15976960.001]
  • [Cites] Surgeon. 2004 Aug;2(4):221-4 [15570830.001]
  • [Cites] Surg Endosc. 2005 Nov;19(11):1468-74 [16222464.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2005 Dec;15(6):611-4 [16366868.001]
  • [Cites] World J Gastroenterol. 2006 Jan 28;12(4):553-5 [16489667.001]
  • [Cites] Ann Surg. 2006 Mar;243(3):353-8 [16495700.001]
  • [Cites] Int J Colorectal Dis. 2006 May;21(4):308-13 [16059690.001]
  • [Cites] Gastroenterol Nurs. 2006 Mar-Apr;29(2):126-32; quiz 132-4 [16609307.001]
  • [Cites] Surg Endosc. 2006 Aug;20(8):1329-31 [16763925.001]
  • [Cites] Int J Colorectal Dis. 2006 Oct;21(7):652-6 [16463181.001]
  • [Cites] Surg Endosc. 2006 Oct;20(10):1521-5 [16897284.001]
  • [Cites] Hepatogastroenterology. 2006 Jul-Aug;53(70):531-5 [16995455.001]
  • [Cites] Dis Colon Rectum. 2007 Feb;50(2):176-83 [17180257.001]
  • [Cites] Dig Dis. 2007;25(1):94-9 [17384514.001]
  • [Cites] Hepatogastroenterology. 2007 Jan-Feb;54(73):85-90 [17419237.001]
  • [Cites] World J Gastroenterol. 2007 May 7;13(17):2514-8 [17552038.001]
  • [Cites] Ann Surg Oncol. 2007 Jul;14(7):1972-9 [17431725.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2007 Aug;17(4):458-60 [17705726.001]
  • [Cites] Dis Colon Rectum. 2007 Sep;50(9):1324-31 [17665258.001]
  • [Cites] Gen Thorac Cardiovasc Surg. 2007 Dec;55(12):518-20 [18066647.001]
  • [Cites] Ann Chir. 2001 May;126(4):330-5 [11413813.001]
  • [Cites] Surg Endosc. 2002 May;16(5):814-9 [11997829.001]
  • [Cites] Chirurgia (Bucur). 2000 May-Jun;95(3):305-8 [14768339.001]
  • [Cites] Surg Endosc. 2004 Feb;18(2):281-9 [14691716.001]
  • [Cites] Clin Otolaryngol Allied Sci. 2004 Oct;29(5):530-4 [15373868.001]
  • [Cites] Endoscopy. 1984 Mar;16(2):43-6 [6714174.001]
  • [Cites] Surg Laparosc Endosc. 1991 Sep;1(3):144-50 [1688289.001]
  • [Cites] Surg Laparosc Endosc. 1994 Apr;4(2):92-9 [8180774.001]
  • [Cites] JSLS. 2004 Oct-Dec;8(4):352-5 [15554279.001]
  • [Cites] Surg Endosc. 2005 Jul;19(7):892-6 [15920688.001]
  • (PMID = 18609692.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2725347
  •  go-up   go-down


32. Matter M, Paroz A, Calmes JM, Suter M, Brunisholz Y, Vuilleumier H, Tempia-Caliera AA, Givel JC: [Visceral surgery]. Rev Med Suisse; 2006 Jan 11;2(48):97-100, 103-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They involve more specifically endocrine surgery, obesity, ovarian cancer, rectocele and cystic pancreatic neoplasia.
  • New techniques also emerge, such as electrical gastric stimulation for obesity or Stapled Trans Anal Rectal Resection (STARR) for anterior rectocele.
  • Accurate diagnosis criteria allow better management of cystic pancreatic neoplasia, especially to choose the best treatment of this condition.
  • [MeSH-minor] Bariatric Surgery. Endocrine Glands / surgery. Female. Humans. Ovarian Neoplasms / surgery. Pancreatic Neoplasms / surgery. Rectocele / surgery

  • MedlinePlus Health Information. consumer health - Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16463793.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 66
  •  go-up   go-down


33. Sato Y, Araki Y, Ogata Y, Shirouzu K: Physiological study of anal sphincteric resection in an experimental porcine model. Kurume Med J; 2008;55(1-2):7-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Physiological study of anal sphincteric resection in an experimental porcine model.
  • This study was conducted to compare and evaluate the extent of anal sphincteric resection and the degree of anal dysfunction in sphincter saving operations for lower rectal cancer using experimental porcine models.
  • The anal maximum resting pressure (AMRP) decreased from 45.1 cmH(2)O in the control group to 14.8, 14.3 and 11.1 cmH(2)O one month after surgery, and to 15.2, 8.8 and 5.2 cmH(2)O three months after surgery, in the ISR, ESR-25% and ESR-50% groups, respectively.
  • The anal maximum squeezing pressure (AMSP) decreased from 81.7 cmH(2)O in the control group to 42.1, 40.1 and 41.1 cmH(2)O one month after surgery in the ISR, ESR-25% and ESR-50% groups, respectively.
  • Three months after surgery, the potential ratio of EMG was increased almost to the preoperative level both in the ISR and ESR-25% groups, but the ratio of the potential difference in the ESR-50% group with redness, sore and soiling around anus was 0.19 and significantly lower compared with other groups.
  • The results of this study indicate that porcine models with additional resection of less than one quarter of the external anal sphincter have little anal dysfunction.
  • [MeSH-major] Anal Canal / physiology. Anal Canal / surgery
  • [MeSH-minor] Animals. Defecation. Digestive System Surgical Procedures. Electromyography. Humans. Models, Animal. Rectal Neoplasms / physiopathology. Rectal Neoplasms / surgery. Swine. Swine, Miniature

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981679.001).
  • [ISSN] 1881-2090
  • [Journal-full-title] The Kurume medical journal
  • [ISO-abbreviation] Kurume Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


34. Lin GL, Qiu HZ, Xiao Y, Wu B, Meng WC: [Transanal endoscopic microsurgery for rectal intraepithelial neoplasia and early rectal carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan;11(1):39-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Transanal endoscopic microsurgery for rectal intraepithelial neoplasia and early rectal carcinoma].
  • OBJECTIVE: To investigate the clinical value of transanal endoscopic microsurgery (TEM) for rectal intraepithelial neoplasia (IN) and early rectal carcinoma.
  • METHODS: Fifteen patients with rectal tumor were selected to undergo local excision by TEM.
  • The pre-operative diagnosis by biopsy and endoanal ultrasonography (EUS): rectal low-grade IN in 8 cases, high-grade IN in 4 and early rectal carcinoma in 3.
  • The average distance of tumors from the anal verge was 7.2(4-15) cm.
  • The average tumor size was 1.8(1-4) cm.
  • RESULTS: All the 15 rectal tumors were achieved complete excision (submucosal excision in 5, full-thickness excision in 10), and all the resection margins were clear.
  • The post-operative pathological diagnosis: rectal low-grade IN in 5 cases, high-grade IN in 6, early submucous invasive carcinoma (pT(1)) in 2, advanced carcinoma (pT(2)) in 2.
  • The diagnostic accuracy of EUS in assessing invasive depth of rectal tumor was 86.7% (13/15).
  • CONCLUSION: TEM is an ideal minimally invasive procedure for the treatment of rectal IN and early rectal carcinoma, with excellent exposure and accurate excision, providing a high-quality tumor specimen for pathological staging.
  • [MeSH-major] Anal Canal / surgery. Microsurgery. Rectal Neoplasms / surgery. Rectum / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18197492.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


35. Petersen S, Jongen J, Petersen C, Sailer M: Radiation-induced sequelae affecting the continence organ: incidence, pathogenesis, and treatment. Dis Colon Rectum; 2007 Sep;50(9):1466-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mechanism that causes incontinence are changes in anal resting tone, squeeze pressure, and rectal volume or rectal compliance.
  • [MeSH-major] Catheterization / methods. Colorectal Neoplasms / radiotherapy. Fecal Incontinence. Hyperbaric Oxygenation / methods. Laser Therapy / methods. Radiation Injuries / complications

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17661143.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 60
  •  go-up   go-down


36. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA: Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg; 2006 Aug;76(8):715-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant progression of anal intra-epithelial neoplasia.
  • BACKGROUND: Anal intra-epithelial neoplasia (AIN) is believed to be a precursor to squamous cell carcinoma of the anus.
  • The risk of developing anal cancer in patients with AIN, although known to occur, has been thought to be relatively low.
  • [MeSH-major] Anus Neoplasms / epidemiology. Anus Neoplasms / pathology. Carcinoma in Situ / pathology. Carcinoma, Squamous Cell / epidemiology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Neoplasm Invasiveness. Retrospective Studies. Risk Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16916390.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


37. Sugita A, Kimura H, Arai K, Koganei K, Shimada H, Kitoh F, Fukushima T: [Surgical treatment for ulcerative colitis--recent advances]. Nihon Rinsho; 2005 May;63(5):859-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Standard surgical procedure is ileal pouch anal anastomosis with rectal mucosal stripping and stapled ileal pouch anal anastomosis.
  • [MeSH-minor] Colonic Neoplasms / etiology. Humans. Prednisolone / adverse effects. Pyoderma Gangrenosum / etiology. Pyoderma Gangrenosum / therapy. Quality of Life

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • Hazardous Substances Data Bank. PREDNISOLONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15881182.001).
  • [ISSN] 0047-1852
  • [Journal-full-title] Nihon rinsho. Japanese journal of clinical medicine
  • [ISO-abbreviation] Nippon Rinsho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 9PHQ9Y1OLM / Prednisolone
  • [Number-of-references] 23
  •  go-up   go-down


38. Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, Rizzello F, Castiglione F, Benazzato L, Papi C, Meucci G, Riegler G, Petruzziello C, Mocciaro F, Geremia A, Calabrese E, Cottone M, Pallone F: Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut; 2006 Feb;55(2):228-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.
  • BACKGROUND AND AIMS: The widespread use of anti-tumour necrosis factor alpha antibody (Infliximab) in Crohn's disease (CD) raises concerns about a possible cancer risk in the long term.
  • In a matched pair study, we assessed whether Infliximab is associated with an increased risk of neoplasia.
  • Cases and controls were matched for sex, age (+/-5 years), site of CD, age at diagnosis (+/-5 years), immunosuppressant use, and follow up.
  • New diagnoses of neoplasia from April 1999 to October 2004 were recorded.
  • RESULTS: Among the 404 CD-IFX, neoplasia was diagnosed in nine patients (2.22%) while among the 404 CD-C, seven patients developed neoplasia (1.73%) (odds ratio 1.33 (95% confidence interval 0.46-3.84); p=0.40).
  • In the CD-IFX group, there was one cholangiocarcinoma, three breast cancers, one skin cancer, one leukaemia, one laryngeal cancer, and two anal carcinomas.
  • Age at diagnosis of neoplasia did not differ between groups (CD-IFX v CD-C: median 50 (range 40-70 years) v 45 (27-72); p=0.50).
  • CONCLUSION: In our multicentre matched pair study, the frequency of a new diagnosis of neoplasia in CD patients treated with Infliximab was comparable with CD patients who had never received Infliximab.
  • [MeSH-major] Antibodies, Monoclonal / adverse effects. Crohn Disease / drug therapy. Gastrointestinal Agents / adverse effects. Neoplasms / chemically induced
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Child. Epidemiologic Methods. Female. Humans. Infliximab. Male. Middle Aged. Smoking / adverse effects. Tumor Necrosis Factor-alpha / antagonists & inhibitors

  • Genetic Alliance. consumer health - Crohn Disease.
  • MedlinePlus Health Information. consumer health - Cancer in Children.
  • MedlinePlus Health Information. consumer health - Crohn's Disease.
  • Hazardous Substances Data Bank. Infliximab .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2004 Feb 26;350(9):934-6 [14985492.001]
  • [Cites] Gut. 2005 Aug;54(8):1121-5 [16009685.001]
  • [Cites] Gut. 2004 Jun;53(6):849-53 [15138212.001]
  • [Cites] Gastroenterology. 2004 May;126(6):1574-81 [15168368.001]
  • [Cites] Gastroenterology. 1979 Oct;77(4 Pt 2):843-6 [467941.001]
  • [Cites] Gut. 1984 Oct;25(10):1124-5 [6479689.001]
  • [Cites] Am J Gastroenterol. 1985 Dec;80(12):978-82 [3000170.001]
  • [Cites] Lancet. 1990 Aug 11;336(8711):357-9 [1975343.001]
  • [Cites] Cancer. 1991 Apr 1;67(7):2015-9 [2004319.001]
  • [Cites] Cancer. 1991 Nov 1;68(9):2051-5 [1717133.001]
  • [Cites] Gastroenterology. 1994 Mar;106(3):643-8 [8119535.001]
  • [Cites] Gastroenterology. 1994 Dec;107(6):1675-9 [7958678.001]
  • [Cites] Lancet. 1996 Jan 27;347(8996):215-9 [8551879.001]
  • [Cites] Gastroenterology. 1997 Apr;112(4):1169-78 [9098000.001]
  • [Cites] N Engl J Med. 1997 Oct 9;337(15):1029-35 [9321530.001]
  • [Cites] Gastroenterology. 1998 Jul;115(1):182-205 [9649475.001]
  • [Cites] N Engl J Med. 1999 May 6;340(18):1398-405 [10228190.001]
  • [Cites] Gastroenterology. 1999 Oct;117(4):761-9 [10500056.001]
  • [Cites] Hepatology. 2005 Jan;41(1):5-15 [15690474.001]
  • [Cites] Gastroenterology. 2005 Mar;128(3):687-94 [15765404.001]
  • [Cites] Gut. 2005 May;54(5):617-22 [15831904.001]
  • [Cites] Gastroenterology. 2005 Jun;128(7):1812-8 [15940616.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1433-7 [10579985.001]
  • [Cites] Inflamm Bowel Dis. 2000 Feb;6(1):8-15 [10701144.001]
  • [Cites] Gastroenterology. 2000 Sep;119(3):647-53 [10982757.001]
  • [Cites] Gut. 2000 Oct;47(4):514-9 [10986211.001]
  • [Cites] Am J Gastroenterol. 2000 Sep;95(9):2308-12 [11007233.001]
  • [Cites] Cancer. 2001 Feb 15;91(4):854-62 [11241255.001]
  • [Cites] Gastroenterology. 2001 Nov;121(5):1080-7 [11677199.001]
  • [Cites] Gastroenterology. 2002 Jan;122(1):72-7 [11781282.001]
  • [Cites] Lancet. 2002 May 4;359(9317):1541-9 [12047962.001]
  • [Cites] Gastroenterology. 2002 Jun;122(7):1808-14 [12055588.001]
  • [Cites] Cancer Invest. 2003 Jun;21(3):452-64 [12901291.001]
  • [Cites] Colorectal Dis. 2003 Sep;5(5):490-5 [12925087.001]
  • [Cites] Gastroenterology. 2004 Jan;126(1):19-31 [14699483.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Feb 1;19(3):287-93 [14984375.001]
  • [Cites] N Engl J Med. 2004 Feb 26;350(9):876-85 [14985485.001]
  • [Cites] Gut. 2004 Jun;53(6):780-2 [15138201.001]
  • (PMID = 16120759.001).
  • [ISSN] 0017-5749
  • [Journal-full-title] Gut
  • [ISO-abbreviation] Gut
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Gastrointestinal Agents; 0 / Tumor Necrosis Factor-alpha; B72HH48FLU / Infliximab
  • [Other-IDs] NLM/ PMC1856527
  •  go-up   go-down


39. Hida J, Yoshifuji T, Okuno K, Matsuzaki T, Uchida T, Ishimaru E, Tokoro T, Yasutomi M, Shiozaki H: Long-term functional outcome of colonic J-pouch reconstruction after low anterior resection for rectal cancer. Surg Today; 2006;36(5):441-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Among the patients with an ultralow anastomosis (<or=4 cm from the anal verge), those in the J-group had fewer bowel movements during the day and at night, and less urgency, soiling, protective pad use, incontinence, and dissatisfaction with bowel function than those in the S-group.
  • CONCLUSION: J-pouch reconstruction after low anterior resection creates a better stool reservoir than straight anastomosis, especially when the anastomosis is less than 4 cm from the anal verge, resulting in a better quality of life 3 years after rectal cancer resection.
  • [MeSH-major] Colonic Pouches. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Surg. 1992 May-Jun;16(3):470-7 [1589983.001]
  • [Cites] Lancet. 1993 Feb 20;341(8843):457-60 [8094488.001]
  • [Cites] Dis Colon Rectum. 1995 Feb;38(2):133-8 [7851166.001]
  • [Cites] Dis Colon Rectum. 2001 Nov;44(11):1667-75 [11711740.001]
  • [Cites] Dis Colon Rectum. 1991 Apr;34(4):329-35 [2007350.001]
  • [Cites] Br J Surg. 1996 Mar;83(3):375-9 [8665198.001]
  • [Cites] N Engl J Med. 2001 Aug 30;345(9):638-46 [11547717.001]
  • [Cites] Dis Colon Rectum. 1994 Feb;37(2 Suppl):S62-8 [8313796.001]
  • [Cites] Br J Surg. 1980 Sep;67(9):655-7 [7427068.001]
  • [Cites] Br J Surg. 1986 Feb;73(2):136-8 [3947904.001]
  • [Cites] Br J Surg. 1982 Oct;69(10):613-6 [6751457.001]
  • [Cites] Surg Gynecol Obstet. 1992 Jan;174(1):27-32 [1729745.001]
  • [Cites] J Am Coll Surg. 1995 Oct;181(4):335-46 [7551328.001]
  • [Cites] Br J Surg. 1990 Mar;77(3):265-9 [2322787.001]
  • [Cites] Br J Surg. 1986 Feb;73(2):139-41 [3947905.001]
  • [Cites] Br J Surg. 2001 Dec;88(12):1623-7 [11736976.001]
  • [Cites] Dis Colon Rectum. 1988 Oct;31(10):762-6 [3168661.001]
  • [Cites] Br J Surg. 2001 Dec;88(12):1607-12 [11736973.001]
  • [Cites] Ann Surg. 1996 Jul;224(1):58-65 [8678619.001]
  • [Cites] Br J Surg. 1996 Jul;83(7):978-80 [8813791.001]
  • [Cites] Br J Surg. 1992 Oct;79(10):1082-6 [1422728.001]
  • [Cites] J Am Coll Surg. 1997 Aug;185(2):114-9 [9249077.001]
  • [Cites] Br J Surg. 1999 Sep;86(9):1176-9 [10504373.001]
  • [Cites] Dis Colon Rectum. 1996 Sep;39(9):986-91 [8797646.001]
  • [Cites] Br J Surg. 2002 Sep;89(9):1108-17 [12190675.001]
  • [Cites] Br J Surg. 2003 Aug;90(8):974-80 [12905551.001]
  • [Cites] Br J Surg. 1997 Oct;84(10):1449-51 [9361611.001]
  • [Cites] N Engl J Med. 1991 Mar 14;324(11):709-15 [1997835.001]
  • [Cites] Br J Surg. 1995 May;82(5):611-3 [7613928.001]
  • [Cites] Dis Colon Rectum. 1997 Mar;40(3):332-8 [9118750.001]
  • [Cites] Br J Surg. 1997 Oct;84(10):1437-41 [9361608.001]
  • [Cites] Br J Surg. 1991 Dec;78(12):1434-8 [1773317.001]
  • [Cites] Ann Surg. 1986 Aug;204(2):133-5 [3741004.001]
  • [Cites] Dis Colon Rectum. 1995 Apr;38(4):375-7 [7720443.001]
  • [Cites] Dis Colon Rectum. 1998 Jul;41(7):817-22; discussion 822-3 [9678365.001]
  • [Cites] Dis Colon Rectum. 1996 Nov;39(11):1286-8 [8918440.001]
  • [Cites] Dis Colon Rectum. 1998 Jun;41(6):740-6 [9645742.001]
  • [Cites] Dis Colon Rectum. 2000 Jun;43(6):793-9 [10859079.001]
  • [Cites] Dis Colon Rectum. 1992 Sep;35(9):843-6 [1511643.001]
  • [Cites] Ann Surg Oncol. 2000 Mar;7(2):125-32 [10761791.001]
  • [Cites] Dis Colon Rectum. 1998 May;41(5):558-63 [9593236.001]
  • [Cites] Br J Surg. 1995 May;82(5):608-10 [7613927.001]
  • [Cites] Eur J Surg. 2002;168(3):158-64 [12182241.001]
  • [Cites] Dis Colon Rectum. 1996 Jan;39(1):74-9 [8601361.001]
  • [Cites] Dis Colon Rectum. 1995 Apr;38(4):393-7 [7720447.001]
  • [Cites] Lancet. 1994 Sep 10;344(8924):707-11 [7915774.001]
  • [Cites] Arch Surg. 2001 Feb;136(2):216-20 [11177145.001]
  • [Cites] Br J Surg. 1999 Mar;86(3):379-84 [10201783.001]
  • [Cites] Dis Colon Rectum. 2004 Jan;47(1):48-58 [14719151.001]
  • [Cites] Ann Surg. 1987 Nov;206(5):600-5 [3675022.001]
  • [Cites] Br J Surg. 1988 Apr;75(4):318-20 [3359144.001]
  • (PMID = 16633751.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


40. Spizzirri A, Coccetta M, Cirocchi R, La Mura F, Napolitano V, Bravetti M, Giuliani D, De Sol A, Pressi E, Trastulli S, Di Patrizi MS, Avenia N, Sciannameo F: Synchronous colorectal neoplasias: our experience about laparoscopic-TEM combined treatment. World J Surg Oncol; 2010;8:105
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous colorectal neoplasias: our experience about laparoscopic-TEM combined treatment.
  • Synchronous colorectal neoplasias are defined as 2 or more primary tumors identified in the same patient and at the same time.
  • The aim of this work is to describe our experience of minimally invasive approach in patients with synchronous colorectal neoplasias.Since January 2001 till December 2009, 557 patients underwent colectomy for colorectal cancer at the Department of General and Emergency Surgery of the University of Perugia; 128 were right colon cancers, 195 were left colon cancers while 234 patients were affected by rectal cancers.
  • We performed 224 laparoscopic colectomies (112 right, 67 left colectomies and 45 anterior resections of rectum), 91 Transanal Endoscopic Microsurgical Excisions (TEM) and 53 Trans Anal Excisions (TAE).
  • In the same observation period 6 patients, 4 males and 2 females, were diagnosed with synchronous colorectal neoplasias.
  • [MeSH-major] Adenoma / surgery. Anal Canal / surgery. Anus Neoplasms / surgery. Colorectal Neoplasms / surgery. Neoplasms, Multiple Primary / surgery

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 2000 Aug;43(8):1093-9 [10950007.001]
  • [Cites] Gastroenterology. 2009 Nov;137(5):1609-20.e1-3 [19686742.001]
  • [Cites] Dis Colon Rectum. 1966 Mar-Apr;9(2):121-6 [5908769.001]
  • [Cites] Dis Colon Rectum. 1972 Jan-Feb;15(1):1-6 [5058410.001]
  • [Cites] Dis Colon Rectum. 1975 Jan-Feb;18(1):6-10 [1126258.001]
  • [Cites] Dis Colon Rectum. 1978 Jan-Feb;21(1):20-2 [639631.001]
  • [Cites] Am J Surg. 1981 Aug;142(2):274-80 [7258541.001]
  • [Cites] Jpn J Surg. 1982;12(2):117-21 [7109357.001]
  • [Cites] Dis Colon Rectum. 1982 Sep;25(6):532-8 [7117057.001]
  • [Cites] Am J Surg. 1984 Mar;147(3):330-3 [6703204.001]
  • [Cites] Br J Surg. 1984 Dec;71(12):941-3 [6498470.001]
  • [Cites] Gastroenterol Clin Biol. 1985 Apr;9(4):336-41 [3996816.001]
  • [Cites] Dis Colon Rectum. 1986 May;29(5):306-11 [3698753.001]
  • [Cites] J Surg Oncol. 1986 May;32(1):55-7 [3724192.001]
  • [Cites] Dis Colon Rectum. 1988 Jul;31(7):518-22 [3391060.001]
  • [Cites] Surg Endosc. 1988;2(2):76-80 [3413660.001]
  • [Cites] Ital J Surg Sci. 1989;19(1):23-8 [2787303.001]
  • [Cites] Dis Colon Rectum. 1994 Jun;37(6):602-3 [8200241.001]
  • [Cites] Ann Ital Chir. 1994 Mar-Apr;65(2):229-31; discussion 232 [7978768.001]
  • [Cites] Surg Laparosc Endosc. 1995 Feb;5(1):75-6 [7735548.001]
  • [Cites] J Surg Oncol. 1997 Apr;64(4):304-7 [9142187.001]
  • [Cites] Radiology. 1999 Feb;210(2):423-8 [10207425.001]
  • [Cites] Surg Endosc. 1999 Jul;13(7):710-2 [10384080.001]
  • [Cites] Gastroenterology. 1958 Jan;34(1):85-98 [13501357.001]
  • [Cites] Tech Coloproctol. 2004 Nov;8 Suppl 1:s177-9 [15655614.001]
  • [Cites] Dig Liver Dis. 2006 Mar;38(3):202-7 [16461025.001]
  • [Cites] Surg Endosc. 2006 Aug;20(8):1193-6 [16865625.001]
  • [Cites] Scand J Surg. 2009;98(1):62-7 [19447744.001]
  • [Cites] Surg Endosc. 2003 Sep;17(9):1498 [12802662.001]
  • (PMID = 21108835.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3224925
  •  go-up   go-down


41. Damin DC, Tolfo GC, Rosito MA, Spiro BL, Kliemann LM: Sentinel lymph node in patients with rectal cancer invading the anal canal. Tech Coloproctol; 2010 Jun;14(2):133-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel lymph node in patients with rectal cancer invading the anal canal.
  • BACKGROUND: To assess the feasibility of the sentinel lymph node procedure in patients with rectal cancer extending to the anal canal.
  • METHODS: Between January 2005 and April 2008, 15 patients with adenocarcinoma of the rectum with direct invasion of the anal canal and no clinical evidence of inguinal involvement were prospectively enrolled in the study.
  • CONCLUSIONS: The standardized procedure was highly effective in sampling inguinal sentinel nodes in very low rectal cancers, allowing the detection of subclinical metastatic disease.
  • Although this technique can be potentially useful for a subgroup of patients with isolated inguinal metastases, it cannot be routinely recommended for patients with rectal tumors invading the anal canal at this moment.
  • [MeSH-major] Adenocarcinoma / secondary. Anal Canal. Inguinal Canal. Rectal Neoplasms / pathology. Sentinel Lymph Node Biopsy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Predictive Value of Tests. Prospective Studies

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Surg Oncol. 2008 Aug;34(8):890-4 [18178364.001]
  • [Cites] Q J Nucl Med Mol Imaging. 2009 Feb;53(1):3-8 [18337684.001]
  • [Cites] Cancer Radiother. 2003 Nov;7 Suppl 1:85s-90s [15124549.001]
  • [Cites] Eur J Surg Oncol. 2006 Apr;32(3):247-52 [16289647.001]
  • [Cites] Gastroenterol Clin Biol. 2009 May;33(5):446-50 [19264433.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1984 Jun;10(6):811-9 [6429097.001]
  • [Cites] Cancer. 1993 Sep 15;72(6):2058-65 [8364884.001]
  • [Cites] Ann Surg Oncol. 2004 Mar;11(3 Suppl):259S-62S [15023764.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1027-9; discussion 1030-1 [12907894.001]
  • [Cites] Strahlenther Onkol. 2009 Apr;185(4):254-9 [19370429.001]
  • [Cites] Colorectal Dis. 2010 Apr;12(4):312-5 [19250258.001]
  • [Cites] Colorectal Dis. 2010 Oct;12(10 Online):e200-5 [19912287.001]
  • [Cites] Dis Colon Rectum. 1999 Nov;42(11):1464-6 [10566535.001]
  • [Cites] Am J Surg. 1994 Sep;168(3):285-7 [8080070.001]
  • [Cites] Surg Gynecol Obstet. 1989 Sep;169(3):238-42 [2672386.001]
  • [Cites] World J Urol. 2009 Apr;27(2):197-203 [18594830.001]
  • [Cites] Scand J Surg. 2002;91(4):336-8 [12558082.001]
  • [Cites] Radiother Oncol. 2001 Oct;61(1):15-22 [11578724.001]
  • [Cites] Br J Clin Pract. 1984 Sep;38(9):324-5 [6477814.001]
  • [Cites] J Surg Oncol. 1999 Mar;70(3):177-80 [10102348.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):741-7 [11597817.001]
  • [Cites] Dis Colon Rectum. 1990 Mar;33(3):212-6 [2311465.001]
  • [Cites] Dis Colon Rectum. 2003 Aug;46(8):1032-7 [12907896.001]
  • (PMID = 20424879.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


42. Shia J: An update on tumors of the anal canal. Arch Pathol Lab Med; 2010 Nov;134(11):1601-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An update on tumors of the anal canal.
  • CONTEXT: The anal canal possesses complex anatomy and histology and gives rise to a variety of tumor types.
  • Challenging issues remain with regard to both the pathologic diagnosis and the clinical management of these tumors.
  • OBJECTIVES: To provide an updated overview of the histogenesis, clinical and pathologic characteristics, diagnostic terminology, and relevant clinical management of the various types of anal canal tumors.
  • DATA SOURCES: Recent literature on clinical and pathologic characteristics of anal canal tumors.
  • CONCLUSIONS: Although most anal canal tumors are of squamous lineage, a complex variety of other tumors also occurs.
  • Recognition of such diverse tumor entities will allow accurate pathologic diagnosis and most optimal clinical management.
  • [MeSH-major] Adenocarcinoma / pathology. Anal Canal / pathology. Anus Neoplasms / pathology. Carcinoma, Squamous Cell / pathology. Melanoma / pathology

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21043813.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


43. Jin HY, Ye H, Wu KL, Zhu Y, Zhang JH, Liu P, Zhang TE, Ding YJ: [Indications for colonoscopy examination and its disease distribution: a report of 5690 cases]. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May;9(3):214-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Indications for colonoscopy examination and its disease distribution: a report of 5690 cases].
  • The reasons for colonoscopy included hemafecia (26.9%), atypical abdominal pain (25.8%), diarrhea or increased frequency of stool (11.1%), anal tenesmus or discomfort (7.6%), constipation (7.0%),mucous or bloody purulent stool (3.0%), intra-rectal mass or abdominal mass on physical examination (0.9%), re- examination after colonoscopic polypectomy (10.9%), re-examination after operation for colorectal cancer(1.5%), simple health examination (2.2%).
  • Colonoscope reached the cecum in 97.7% of the cases,and at least one disease was found in 2283 cases (40.1%).
  • Among them,colorectal cancer accounted for 10.3%, colorectal polyps 19.6%, ulcerative colitis 4.3%, and Crohn's disease 0.5% respectively.
  • [MeSH-major] Colonic Diseases / diagnosis. Colonoscopy. Colorectal Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Early Diagnosis. Female. Humans. Ileocecal Valve. Male. Middle Aged. Young Adult


44. Huyghe E, Nohra J, Khedi M, Soulié M, Rischmann P, Bachaud JM, Plante P: [Severe (RTOG grades 3 or 4) long-term complications of adjuvant radiotherapy after total prostatectomy]. Prog Urol; 2006 Sep;16(4):457-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Complications sévères (grades 3 ou 4 RTOG) a long-terme de la radiothérapie adjuvante après prostatectomie totale.
  • Three patients developed gastrointestinal complications (2 cases of radiation proctitis and 1 anal stricture).
  • [MeSH-major] Postoperative Complications / etiology. Prostatectomy. Prostatic Neoplasms / radiotherapy. Prostatic Neoplasms / surgery. Radiotherapy, Conformal / adverse effects
  • [MeSH-minor] Aged. Aged, 80 and over. Anus Diseases / etiology. Constriction, Pathologic / etiology. Cystitis / etiology. Humans. Male. Middle Aged. Proctitis / etiology. Radiotherapy / adverse effects. Radiotherapy, Adjuvant / adverse effects. Severity of Illness Index. Time Factors. Urethral Stricture / etiology

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17069039.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


45. Chen LW, Yu BM, Zhang M, Fu J, Fei CS, Shen Y: [Diagnostic significance and management principles of colorectal intraepithelial neoplasia]. Zhonghua Wai Ke Za Zhi; 2009 Jul 1;47(13):992-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic significance and management principles of colorectal intraepithelial neoplasia].
  • OBJECTIVE: To discuss the significance of pathological diagnosis of colorectal intraepithelial neoplasia and its treatment principles.
  • METHODS: One hundred and fifty-eight cases with colorectal tumors were treated between January 2004 and June 2008, among them 73 cases of tumors were diagnosed as low grade intraepithelial neoplasia and 89 tumors as high grade intraepithelial neoplasia on biopsy.
  • RESULTS: With postoperative pathological examination, 109 cases (67.3%) were identified as infiltrative adenocarcinoma, among them 80 cases (89.9%) had been diagnosed as high grade intraepithelial neoplasia and the other 29 cases (39.7%) had been diagnosed as low grade intraepithelial neoplasia before the operation.
  • CONCLUSIONS: We should pay more attention to tumors with a diagnosis of intraepithelial neoplasia due to its high potential of malignancy.
  • When the lesion was highly suspected to be malignant, and the resection of the tumor would save the anal sphincter, the tumor should be treated with segmental resection.
  • If the tumor could be confirmed as a infiltrating one then a curative resection is the first choice.
  • [MeSH-major] Carcinoma in Situ / diagnosis. Carcinoma in Situ / surgery. Colorectal Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19957809.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


46. Li X, Chen H, Dai J, Gao Y, Ge Z: Predictive role of capsule endoscopy on the insertion route of double-balloon enteroscopy. Endoscopy; 2009 Sep;41(9):762-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on our previous retrospective evaluation, a cut-off value of 0.6 was adopted, and the oral or anal approach was selected when the index was < or = 0.6 or > 0.6, respectively.
  • [MeSH-major] Capsule Endoscopy. Endoscopy, Gastrointestinal / methods. Intestinal Diseases / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Humans. Intestinal Neoplasms / diagnosis. Middle Aged. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright Georg Thieme Verlag KG Stuttgart. New York.
  • [CommentIn] Endoscopy. 2011 Jan;43(1):38-41 [21108176.001]
  • (PMID = 19662592.001).
  • [ISSN] 1438-8812
  • [Journal-full-title] Endoscopy
  • [ISO-abbreviation] Endoscopy
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


47. Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG: Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys; 2010 Dec 1;78(5):1413-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
  • PURPOSE: Intensity-modulated radiation therapy (IMRT) has the potential to reduce toxicities associated with chemoradiotherapy in the treatment of anal cancer.
  • This study reports the results of using IMRT in the treatment of anal cancer.
  • METHODS AND MATERIALS: Records of patients with anal malignancies treated with IMRT at Duke University were reviewed.
  • RESULTS: Forty-seven patients with anal malignancy (89% canal, 11% perianal skin) were treated with IMRT between August 2006 and September 2008.
  • CONCLUSIONS: IMRT-based chemoradiotherapy for anal cancer results in significant reductions in normal tissue dose and acute toxicities versus historic controls treated without IMRT, leading to reduced rates of toxicity-related treatment interruption.
  • Early disease-related outcomes seem encouraging.
  • IMRT is emerging as a standard therapy for anal cancer.
  • [MeSH-major] Anus Neoplasms / radiotherapy. Radiotherapy, Intensity-Modulated / adverse effects
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Adolescent. Adult. Aged. Aged, 80 and over. Anemia / etiology. Carcinoma, Squamous Cell / radiotherapy. Diarrhea / etiology. Female. Humans. Leukopenia / etiology. Male. Melanoma / radiotherapy. Middle Aged. Neuroendocrine Tumors / radiotherapy. Radiotherapy Dosage. Rhabdomyosarcoma / radiotherapy. Sarcoma / radiotherapy. Thrombocytopenia / etiology. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20231064.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Abbas A, Yang G, Fakih M: Management of anal cancer in 2010. Part 2: current treatment standards and future directions. Oncology (Williston Park); 2010 Apr 30;24(5):417-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of anal cancer in 2010. Part 2: current treatment standards and future directions.
  • The treatment of anal squamous cell cancer with definitive chemoradiation is the gold-standard therapy for localized anal cancer, primarily because of its sphincter-saving and colostomy-sparing potential.
  • In the concluding part of this review, we consider the data on chemoradiation with 5-FU/mitomycin vs radiation alone, chemoradiation with 5-FU/mitomycin vs chemoradiation with 5-FU alone, neoadjuvant chemotherapy with cisplatin/5-FU followed by cisplatin/5-FU plus radiation vs mitomycin/5-FU plus radiation, the addition of induction or maintenance chemotherapy to chemoradiation, the effect of overall treatment time on tumor control, whether chemotherapy can be eliminated for early-stage anal cancer, and the impact of human immunodeficiency virus infection on treatment.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Anus Neoplasms / drug therapy. Anus Neoplasms / radiotherapy. Carcinoma, Squamous Cell / drug therapy. Carcinoma, Squamous Cell / radiotherapy

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Oncology (Williston Park). 2010 Apr 30;24(5):427-30 [20480742.001]
  • [CommentIn] Oncology (Williston Park). 2010 Apr 30;24(5):424-7 [20480741.001]
  • (PMID = 20480740.001).
  • [ISSN] 0890-9091
  • [Journal-full-title] Oncology (Williston Park, N.Y.)
  • [ISO-abbreviation] Oncology (Williston Park, N.Y.)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 50SG953SK6 / Mitomycin; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  • [Number-of-references] 52
  •  go-up   go-down


49. Verma R, Zacharaki EI, Ou Y, Cai H, Chawla S, Lee SK, Melhem ER, Wolf R, Davatzikos C: Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol; 2008 Aug;15(8):966-77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images.
  • RATIONALE AND OBJECTIVES: Treatment of brain neoplasms can greatly benefit from better delineation of bulk neoplasm boundary and the extent and degree of more subtle neoplastic infiltration.
  • The purpose of this study is to quantify the multiparametric imaging profile of neoplasms by integrating structural MRI and DTI via statistical image analysis methods to potentially capture complex and subtle tissue characteristics that are not obvious from any individual image or parameter.
  • This is incorporated into a nonlinear pattern classification technique to create a multiparametric probabilistic tissue characterization, which is applied to data from 14 patients with newly diagnosed primary high-grade neoplasms who have not received any therapy before imaging.
  • RESULTS: Preliminary results demonstrate that this multiparametric tissue characterization helps to better differentiate among neoplasm, edema, and healthy tissue, and to identify tissue that is likely to progress to neoplasm in the future.
  • CONCLUSION: This approach has potential applications in treatment, aiding computer-assisted surgery by determining the spatial distributions of healthy and neoplastic tissue, as well as in identifying tissue that is relatively more prone to tumor recurrence.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Magn Reson Imaging. 2006 Nov;24(9):1131-42 [17071335.001]
  • [Cites] J Magn Reson Imaging. 2006 Oct;24(4):709-24 [16958058.001]
  • [Cites] Artif Intell Med. 2001 Jan-Mar;21(1-3):43-63 [11154873.001]
  • [Cites] Radiology. 2001 Feb;218(2):586-91 [11161183.001]
  • [Cites] J Magn Reson Imaging. 2001 Apr;13(4):534-46 [11276097.001]
  • [Cites] IEEE Trans Med Imaging. 2001 Jan;20(1):45-57 [11293691.001]
  • [Cites] Med Image Anal. 2001 Jun;5(2):143-56 [11516708.001]
  • [Cites] Ann Neurol. 2002 Mar;51(3):377-80 [11891834.001]
  • [Cites] Pediatr Neurosurg. 2003 Jul;39(1):39-43 [12784077.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Feb;25(2):201-9 [14970018.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Mar;25(3):356-69 [15037456.001]
  • [Cites] Med Image Anal. 2004 Sep;8(3):275-83 [15450222.001]
  • [Cites] Neuroimage. 2004;23 Suppl 1:S208-19 [15501092.001]
  • [Cites] Radiology. 1988 Dec;169(3):779-85 [3187000.001]
  • [Cites] Radiology. 1994 Apr;191(1):41-51 [8134596.001]
  • [Cites] Neuroradiology. 1997 Jul;39(7):483-9 [9258924.001]
  • [Cites] IEEE Trans Med Imaging. 1998 Apr;17(2):187-201 [9688151.001]
  • [Cites] Radiology. 2005 Jan;234(1):218-25 [15564394.001]
  • [Cites] Top Magn Reson Imaging. 2004 Oct;15(5):315-24 [15627005.001]
  • [Cites] Neuroimage. 2005 Jun;26(2):317-29 [15907293.001]
  • [Cites] Arch Gen Psychiatry. 2005 Nov;62(11):1218-27 [16275809.001]
  • [Cites] Surg Neurol. 2006 May;65(5):472-7; discussion 477 [16630907.001]
  • [Cites] Radiology. 2006 May;239(2):506-13 [16641355.001]
  • [Cites] Radiology. 2006 Jun;239(3):632-49 [16714455.001]
  • [Cites] Neuroimage. 2006 Jun;31(2):531-42 [16478665.001]
  • [Cites] Neuroimage. 2007 Feb 1;34(3):949-56 [17166744.001]
  • (PMID = 18620117.001).
  • [ISSN] 1076-6332
  • [Journal-full-title] Academic radiology
  • [ISO-abbreviation] Acad Radiol
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / NS042645-04; United States / NINDS NIH HHS / NS / R01 NS042645-06A2; United States / NINDS NIH HHS / NS / R01 NS042645-04; United States / NINDS NIH HHS / NS / NS042645-06A2; United States / NINDS NIH HHS / NS / R01 NS042645-05; United States / NINDS NIH HHS / NS / R01 NS042645; United States / NINDS NIH HHS / NS / NS042645-05
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] AU0V1LM3JT / Gadolinium
  • [Other-IDs] NLM/ NIHMS60430; NLM/ PMC2596598
  •  go-up   go-down


50. Mariolis-Sapsakos T, Malamitsi J, Yakoumakis E, Orfanos F: Is sentinel node mapping useful in anorectal melanoma? Hell J Nucl Med; 2008 Jan-Apr;11(1):39-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Anorectal melanoma (AM) is a rare disease and few guidelines have been established regarding its therapeutic management.
  • Under rigid proctoscopy the anal scar received four submucosal injections of technetium-99m-sulfur nanocolloid of 29.6 MBq each.
  • [MeSH-major] Lymph Nodes / pathology. Lymph Nodes / radionuclide imaging. Melanoma / radionuclide imaging. Melanoma / secondary. Rectal Neoplasms / pathology. Rectal Neoplasms / radionuclide imaging. Sentinel Lymph Node Biopsy / methods. Technetium Tc 99m Aggregated Albumin

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18392226.001).
  • [ISSN] 1790-5427
  • [Journal-full-title] Hellenic journal of nuclear medicine
  • [ISO-abbreviation] Hell J Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0 / Technetium Tc 99m Aggregated Albumin; 0 / technetium Tc 99m nanocolloid
  •  go-up   go-down


51. Kovar JL, Volcheck W, Sevick-Muraca E, Simpson MA, Olive DM: Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem; 2009 Jan 15;384(2):254-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant neoplasms exhibit an elevated rate of glycolysis over normal cells.
  • This characteristic can be exploited for optical imaging of tumors in mice.
  • In all cases, tumors were clearly imaged with good signal-to-noise characteristics.
  • These data indicate that IRDye 800CW 2-DG is a broadly applicable optical imaging agent for in vivo imaging of neoplasms in mice.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 2-DEOXY-D-GLUCOSE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 1977 Dec 23;198(4323):1264-7 [929199.001]
  • [Cites] Mol Endocrinol. 2003 Jul;17(7):1230-9 [12702734.001]
  • [Cites] Biochem J. 1991 Apr 1;275 ( Pt 1):145-50 [2018470.001]
  • [Cites] Annu Rev Biophys Biophys Chem. 1991;20:1-28 [1867711.001]
  • [Cites] Biochem J. 1992 Feb 1;281 ( Pt 3):809-17 [1536656.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10393-9 [1587825.001]
  • [Cites] J Nucl Med. 1994 Nov;35(11):1842-50 [7965167.001]
  • [Cites] J Nucl Med. 1995 Sep;36(9):1625-32 [7658223.001]
  • [Cites] J Nucl Med. 1996 Feb;37(2):394-9 [8667082.001]
  • [Cites] J Nucl Med. 1996 Jun;37(6):1042-7 [8683298.001]
  • [Cites] Biochem J. 1996 Aug 15;318 ( Pt 1):203-5 [8761472.001]
  • [Cites] J Biol Chem. 1996 Sep 20;271(38):23111-6 [8798502.001]
  • [Cites] Cancer Res. 1999 Sep 15;59(18):4709-14 [10493529.001]
  • [Cites] Science. 1956 Feb 24;123(3191):309-14 [13298683.001]
  • [Cites] J Cell Physiol. 2005 Mar;202(3):654-62 [15389572.001]
  • [Cites] J Nucl Med Technol. 2005 Sep;33(3):145-55; quiz 162-3 [16145222.001]
  • [Cites] Mol Imaging Biol. 2005 Nov-Dec;7(6):388-92 [16284704.001]
  • [Cites] Bioconjug Chem. 2006 May-Jun;17(3):662-9 [16704203.001]
  • [Cites] Am J Pathol. 2006 Oct;169(4):1415-26 [17003496.001]
  • [Cites] Orthop Nurs. 2007 Jan-Feb;26(1):33 [17273106.001]
  • [Cites] J Biomed Opt. 2007 Mar-Apr;12(2):024017 [17477732.001]
  • [Cites] Anal Biochem. 2007 Aug 1;367(1):1-12 [17521598.001]
  • [Cites] J Nucl Med. 2007 Sep;48(9):1501-10 [17785729.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16504-9 [17925435.001]
  • [Cites] Eur Urol. 2007 Dec;52(6):1700-8 [17646044.001]
  • [Cites] Bioconjug Chem. 2003 Jul-Aug;14(4):709-14 [12862422.001]
  • [Cites] Curr Opin Chem Biol. 2003 Oct;7(5):626-34 [14580568.001]
  • [Cites] Clin Cancer Res. 2004 Apr 1;10(7):2245-52 [15073099.001]
  • [Cites] Dis Markers. 2003-2004;19(2-3):107-21 [15096708.001]
  • [Cites] Physiol Res. 1999;48(6):401-10 [10783904.001]
  • [Cites] Neoplasia. 2000 Jan-Apr;2(1-2):26-40 [10933066.001]
  • [Cites] Neoplasia. 2000 Sep-Oct;2(5):388-417 [11191107.001]
  • [Cites] J Nucl Med. 2001 May;42(5 Suppl):1S-93S [11483694.001]
  • [Cites] Acad Radiol. 2002 Aug;9 Suppl 2:S320-2 [12188261.001]
  • [Cites] J Neurochem. 1977 May;28(5):897-916 [864466.001]
  • [Cites] Biophys J. 2004 Nov;87(5):2990-9 [15326030.001]
  • [Cites] J Biol Chem. 1990 Oct 25;265(30):18172-9 [2211693.001]
  • (PMID = 18938129.001).
  • [ISSN] 1096-0309
  • [Journal-full-title] Analytical biochemistry
  • [ISO-abbreviation] Anal. Biochem.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA106584-02; United States / NCI NIH HHS / CA / CA106584-04; United States / NCI NIH HHS / CA / R01 CA106584-03; United States / NCI NIH HHS / CA / CA106584-03; United States / NCI NIH HHS / CA / CA106584-01A1; United States / NCI NIH HHS / CA / R01 CA106584-01A1; United States / NCI NIH HHS / CA / R01 CA106584-02; United States / NCI NIH HHS / CA / R01 CA106584-04; United States / NCI NIH HHS / CA / R01 CA106584
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorescent Dyes; 0 / IRDye 800CW 2-DG; 0 / IRDye800; 0 / Indoles; 9G2MP84A8W / Deoxyglucose
  • [Other-IDs] NLM/ NIHMS109324; NLM/ PMC2720560
  •  go-up   go-down


52. Tonus C, Neupert G, Glaser HJ, Stienecker K: [Double balloon enteroscopy. First surgical experience]. Chirurg; 2008 May;79(5):474-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The approach was oral in 75 cases and anal in 31.
  • RESULTS: Complete small intestine inspection could be performed completely orally in seven of 106 examinations; and in most cases a combined oral/anal approach was required.
  • Further findings included diverticulum (6.7%), changes related to Crohn's disease (4.0%), small intestinal tumors (4.0%), extraluminar disorders (2.6%), stenoses (1.3%), and others (8.0%).
  • [MeSH-major] Endoscopes, Gastrointestinal. Gastrointestinal Diseases / diagnosis. Gastrointestinal Hemorrhage / etiology. Gastrointestinal Neoplasms / diagnosis. Intestinal Obstruction / etiology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Equipment Design. Female. Humans. Male. Middle Aged. Recurrence. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • MedlinePlus Health Information. consumer health - Intestinal Obstruction.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Gastroenterol. 2007 Mar;102(3):527-35 [17222315.001]
  • [Cites] Endoscopy. 2005 Jun;37(6):591-3 [15933937.001]
  • [Cites] Endoscopy. 2003 Dec;35(12):985-91 [14648408.001]
  • [Cites] Gastrointest Endosc. 2001 Feb;53(2):216-20 [11174299.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):82-5 [16429360.001]
  • [Cites] Endoscopy. 2001 Mar;33(3):227-30 [11293754.001]
  • [Cites] Gastrointest Endosc. 2005 Oct;62(4):545-50 [16185969.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):42-8 [16429354.001]
  • [Cites] Endoscopy. 2004 Dec;36(12):1067-73 [15578296.001]
  • [Cites] Gastrointest Endosc. 1986 Dec;32(6):381-4 [3492404.001]
  • [Cites] Gastrointest Endosc. 2005 Jul;62(1):62-70 [15990821.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):49-58 [16429355.001]
  • [Cites] Adv Surg. 1989;22:141-77 [2645744.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Nov;2(11):1010-6 [15551254.001]
  • [Cites] Endoscopy. 2001 Aug;33(8):658-61 [11490380.001]
  • [Cites] Gastrointest Endosc. 2005 Sep;62(3):392-8 [16111958.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):59-66 [16429356.001]
  • [Cites] Br J Surg. 1991 Feb;78(2):192-5 [2015470.001]
  • [Cites] Am J Gastroenterol. 2006 Jan;101(1):52-7 [16405533.001]
  • [Cites] Endoscopy. 2006 Jan;38(1):67-72 [16429357.001]
  • [Cites] Endoscopy. 2002 Sep;34(9):685-9 [12195324.001]
  • (PMID = 18209985.001).
  • [ISSN] 0009-4722
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


53. Funahashi K: [Current status of sentinel lymph node-based nodal ultrastaging in colorectal cancer]. Nihon Geka Gakkai Zasshi; 2009 Mar;110(2):73-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a review of the literature, tracer, technique, tumor-related factors (location and size of tumor, T stage, status of lymph node metastasis), neoadjuvant chemoradiation therapy, and body mass index were important factors in the accurate diagnosis of SLNs in colorectal cancer.
  • However, further prospective multicenter trials are warranted to evaluate the ultimate clinical relevance of SLN diagnosis in colorectal cancer including anal cancer.
  • [MeSH-major] Colorectal Neoplasms / pathology. Neoplasm Staging / methods. Sentinel Lymph Node Biopsy

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19348197.001).
  • [ISSN] 0301-4894
  • [Journal-full-title] Nihon Geka Gakkai zasshi
  • [ISO-abbreviation] Nihon Geka Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 26
  •  go-up   go-down


54. Khan GN, Siddiqui M, Ben-Josef E, Zalupski MM: An unusual case of small cell carcinoma of the anal canal. Am J Clin Oncol; 2009 Oct;32(5):543-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of small cell carcinoma of the anal canal.
  • [MeSH-major] Anal Canal / pathology. Anus Neoplasms / diagnosis. Carcinoma, Small Cell / diagnosis

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23061097.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF Jr: Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol; 2010 Nov 20;28(33):4935-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with HIV/AIDS-related lymphoma (n = 932) were predominantly diagnosed with DLBCL and had significantly and substantially elevated risks for second anal cancer (SIR = 120.50) and Kaposi's sarcoma (SIR = 138.90).

  • Genetic Alliance. consumer health - Chronic Lymphocytic Leukemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):925-33 [15824165.001]
  • [Cites] Am J Epidemiol. 2010 Feb 1;171(3):267-76 [20047977.001]
  • [Cites] Br J Cancer. 2005 Jul 11;93(1):159-66 [15970927.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2402-6 [16214923.001]
  • [Cites] N Engl J Med. 2005 Nov 17;353(20):2135-47 [16291983.001]
  • [Cites] Lung Cancer. 2005 Dec;50(3):419-20 [16125820.001]
  • [Cites] J Clin Oncol. 2006 Apr 1;24(10):1568-74 [16520465.001]
  • [Cites] Cancer. 2006 Jul 1;107(1):108-15 [16708354.001]
  • [Cites] Haematologica. 2006 Nov;91(11):1481-8 [17043014.001]
  • [Cites] Leuk Lymphoma. 2006 Nov;47(11):2314-20 [17107903.001]
  • [Cites] AIDS. 2007 Jan 11;21(2):207-13 [17197812.001]
  • [Cites] Int J Cancer. 2007 Mar 1;120(5):1099-102 [17131330.001]
  • [Cites] Cancer Causes Control. 2007 Mar;18(2):135-42 [17235495.001]
  • [Cites] Int J Cancer. 2007 Jul 1;121(1):151-6 [17351903.001]
  • [Cites] Blood. 2007 Jun 1;109(11):4617-26 [17311989.001]
  • [Cites] Blood. 2007 Jul 15;110(2):695-708 [17389762.001]
  • [Cites] Lancet. 2007 Jul 7;370(9581):59-67 [17617273.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):144-54 [17708556.001]
  • [Cites] Cancer Causes Control. 2008 Feb;19(1):43-50 [17906957.001]
  • [Cites] Haematologica. 2008 Mar;93(3):398-404 [18268277.001]
  • [Cites] Clin Gastroenterol Hepatol. 2008 Apr;6(4):451-8 [18387498.001]
  • [Cites] Blood. 2008 Apr 15;111(8):4029-38 [18263783.001]
  • [Cites] J Clin Oncol. 2008 Apr 10;26(11):1850-7 [18347006.001]
  • [Cites] Expert Rev Anticancer Ther. 2008 Apr;8(4):605-15 [18402527.001]
  • [Cites] Int J Cancer. 2008 Jul 1;123(1):187-94 [18435450.001]
  • [Cites] Expert Opin Pharmacother. 2008 Jun;9(9):1481-94 [18518779.001]
  • [Cites] Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix [18954744.001]
  • [Cites] Blood. 2008 Dec 15;112(13):5150-60 [18796628.001]
  • [Cites] Blood. 2009 Jan 29;113(5):1175-83 [18971419.001]
  • [Cites] J Clin Oncol. 1999 Aug;17(8):2454-60 [10561309.001]
  • [Cites] Cancer. 2001 Feb 15;91(4):874-80 [11241258.001]
  • [Cites] J Clin Oncol. 2001 Mar 15;19(6):1610-8 [11250989.001]
  • [Cites] J Natl Cancer Inst. 2002 Feb 6;94(3):182-92 [11830608.001]
  • [Cites] Semin Oncol. 2002 Feb;29(1 Suppl 2):10-24 [11842384.001]
  • [Cites] J Clin Oncol. 2002 Sep 15;20(18):3878-84 [12228208.001]
  • [Cites] Br J Cancer. 2003 Jan 13;88(1):74-8 [12556962.001]
  • [Cites] Med Oncol. 2003;20(3):211-20 [14514970.001]
  • [Cites] Eur J Cancer. 2004 Feb;40(3):383-9 [14746857.001]
  • [Cites] Blood. 2004 Feb 15;103(4):1222-8 [14576060.001]
  • [Cites] Cancer. 2004 May 1;100(9):1902-8 [15112271.001]
  • [Cites] J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1083-91 [15247562.001]
  • [Cites] J Natl Cancer Inst. 1992 Sep 16;84(18):1422-7 [1512794.001]
  • [Cites] Eur J Haematol. 1994 Oct;53(4):218-22 [7957806.001]
  • [Cites] J Natl Cancer Inst. 1995 Apr 5;87(7):524-30 [7707439.001]
  • [Cites] J Clin Oncol. 1996 Feb;14(2):565-71 [8636772.001]
  • [Cites] Int J Cancer. 1997 Nov 27;73(5):645-50 [9398040.001]
  • [Cites] Cancer. 2005 Jan 15;103(2):216-28 [15578683.001]
  • [Cites] N Engl J Med. 2009 Feb 12;360(7):659-67 [19213679.001]
  • [Cites] J Natl Cancer Inst. 2009 Feb 18;101(4):248-55 [19211444.001]
  • [Cites] J Clin Oncol. 2009 Feb 20;27(6):904-10 [19114699.001]
  • [Cites] Nat Genet. 2009 Aug;41(8):873-5 [19620980.001]
  • [Cites] J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30 [19648510.001]
  • [Cites] Blood. 2005 Jun 15;105(12):4573-5 [15741224.001]
  • (PMID = 20940199.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3020697
  •  go-up   go-down


56. Fesneau M, Champeaux-Orange E, Hennequin C: [Anal cancer]. Cancer Radiother; 2010 Nov;14 Suppl 1:S120-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Anal cancer].
  • [Transliterated title] Cancer du canal anal.
  • Anal canal epidermoid carcinomas represent 1.2% of digestive cancers and 6% of ano-rectal cancers.
  • For localized diseases, the treatment is based on radiotherapy with or without chemotherapy (5-FU and cisplatin or mitomycin), according to tumour and nodal extension.
  • The recommended treatment dose is 45 Gy in the anal canal, the mesorectum, pararectal lymph nodes, and inguinal lymph nodes.
  • An additional dose of 15 to 20 Gy is delivered in the initial tumour for good responders.
  • The objective of this work is to summarize the epidemiological and radio-anatomic and prognostic characteristics of this tumour.
  • [MeSH-major] Anus Neoplasms / radiotherapy. Carcinoma, Squamous Cell / radiotherapy. Radiotherapy Dosage

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 21129654.001).
  • [ISSN] 1769-6658
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


57. Ramírez-Marrero FA, Smit E, De La Torre-Feliciano T, Pérez-Irizarry J, Miranda S, Cruz M, Figueroa-Vallés NR, Crespo CJ, Nazario CM: Risk of cancer among Hispanics with AIDS compared with the general population in Puerto Rico: 1987-2003. P R Health Sci J; 2010 Sep;29(3):256-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: A total of 612 cancers were identified after 3 months of AIDS diagnosis: 409 (66.7%) AIDS related and 203 (33.1%) non-AIDS related.
  • Non-AIDS related cancers with higher risk during the HAART availability were: oropharyngeal, anal, liver, larynx, eye and orbit, Hodgkin lymphoma, and vaginal.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / complications. Hispanic Americans. Neoplasms / epidemiology. Neoplasms / etiology

  • Genetic Alliance. consumer health - AIDS-HIV.
  • MedlinePlus Health Information. consumer health - Hispanic American Health.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20799513.001).
  • [ISSN] 0738-0658
  • [Journal-full-title] Puerto Rico health sciences journal
  • [ISO-abbreviation] P R Health Sci J
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA096257; United States / NCI NIH HHS / CA / P20 CA096256
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Puerto Rico
  •  go-up   go-down


58. Mell LK, Schomas DA, Salama JK, Devisetty K, Aydogan B, Miller RC, Jani AB, Kindler HL, Mundt AJ, Roeske JC, Chmura SJ: Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys; 2008 Apr 1;70(5):1431-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
  • PURPOSE: To test the hypothesis that the volume of pelvic bone marrow (PBM) receiving 10 and 20 Gy or more (PBM-V(10) and PBM-V(20)) is associated with acute hematologic toxicity (HT) in anal cancer patients treated with concurrent chemoradiotherapy.
  • METHODS AND MATERIALS: We analyzed 48 consecutive anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiation therapy.
  • The median radiation dose to gross tumor and regional lymph nodes was 50.4 and 45 Gy, respectively.
  • RESULTS: Twenty patients (42%) had Stage T3-4 disease; 15 patients (31%) were node positive.
  • CONCLUSION: This analysis supports the hypothesis that increased low-dose radiation to PBM is associated with acute HT during chemoradiotherapy for anal cancer.
  • Techniques to limit bone marrow irradiation may reduce HT in anal cancer patients.
  • [MeSH-major] Anus Neoplasms / drug therapy. Anus Neoplasms / radiotherapy. Bone Marrow / radiation effects

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17996390.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Validation Studies
  • [Publication-country] United States
  • [Chemical-registry-number] 50SG953SK6 / Mitomycin; U3P01618RT / Fluorouracil
  •  go-up   go-down


59. Gaja F, Trecca A: [Evaluation of the efficacy of a new graduated anal dilator in the treatment of acute anal fissures]. Chir Ital; 2007 Jul-Aug;59(4):545-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Evaluation of the efficacy of a new graduated anal dilator in the treatment of acute anal fissures].
  • [Transliterated title] Nuovo dilatatore anale graduato per la terapia della ragade anale: studio clinico.
  • Dilatation of the anal sphincter with anal dilators for the treatment of acute anal fissure is efficacious, economic and safe but not always correctly executed with a negative repercussions on the technical results.
  • Our study was aimed at comparing the efficacy of new graduated dilator with a progressively graduated diameter, using a standard treatment schedule, or a free schedule in comparison with the use of multiple classic dilators currently available for the resolution of anal fissures.
  • A series of 60 patients, 35 female and 25 male, with a clinical diagnosis of acute anal fissure in the absence of a hypotonic anal sphincter, abscess or perianal fistula, hemorrhoidal thrombosis, chronic inflammatory bowel diseases or lower gastrointestinal neoplasms were preliminarily evaluated with the solid sphere test and randomly divided into three groups: the first was treated with the new graduated dilator with a standard treatment schedule (20 patients); the second was treated with multiple anal dilators (20, 23, 27 mm) (20 patients) using a standard treatment schedule, and the third group (20 patients) was treated with the new graduated dilator according to a free treatment schedule.
  • After four weeks of treatment, 91% of all patients showed resolution of the anal fissure.
  • The use of the graduated anal dilator according to a free treatment schedule seems to induce lasting resolution of acute anal fissures with similar results to those achieved using traditional multiple dilators, while proving better tolerated by the patients.
  • [MeSH-major] Dilatation / instrumentation. Fissure in Ano / therapy
  • [MeSH-minor] Acute Disease. Adult. Female. Humans. Male. Manometry. Middle Aged. Rome. Surveys and Questionnaires. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17966778.001).
  • [ISSN] 0009-4773
  • [Journal-full-title] Chirurgia italiana
  • [ISO-abbreviation] Chir Ital
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial
  • [Publication-country] Italy
  •  go-up   go-down


60. Menkarios C, Azria D, Laliberté B, Moscardo CL, Gourgou S, Lemanski C, Dubois JB, Aillères N, Fenoglietto P: Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol; 2007;2:41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans.
  • BACKGROUND: To compare the dosimetric advantage of three different intensity-modulated radiation therapy (IMRT) plans to a three dimensional (3D) conventional radiation treatment for anal cancer with regards to organs-at-risk (OAR) avoidance, including iliac bone marrow.
  • METHODS: Five patients with T1-3 N0-1 anal cancer and five with T4 and/or N2-3 tumors were selected.
  • Clinical tumor volume (CTV) included tumor, anal canal and inguinal, peri-rectal, and internal/external iliac nodes (plus pre-sacral nodes for T4/N2-3 tumors).
  • CONCLUSION: IMRT is superior to 3D conformal radiation treatment for anal carcinoma with respect to OAR sparing, including bone marrow sparing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2006 Oct;176(4 Pt 1):1415-9 [16952647.001]
  • [Cites] Prostate Cancer Prostatic Dis. 2007;10(1):82-6 [16983394.001]
  • [Cites] Radiother Oncol. 2007 Feb;82(2):160-6 [17222931.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1394-400 [17276620.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1153-60 [2599903.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1319-39 [7713791.001]
  • [Cites] Cancer. 1995 Nov 15;76(10):1731-6 [8625041.001]
  • [Cites] J Clin Oncol. 1996 Sep;14(9):2527-39 [8823332.001]
  • [Cites] Lancet. 1996 Oct 19;348(9034):1049-54 [8874455.001]
  • [Cites] J Clin Oncol. 1996 Dec;14(12):3121-5 [8955657.001]
  • [Cites] J Clin Oncol. 1997 May;15(5):2040-9 [9164216.001]
  • [Cites] Ann Oncol. 1997 Jun;8(6):575-81 [9261527.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):651-7 [9336145.001]
  • [Cites] Radiother Oncol. 1998 Mar;46(3):249-56 [9572617.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16 [11240231.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):675-80 [11395235.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):695-704 [11395238.001]
  • [Cites] J Urol. 2001 Sep;166(3):876-81 [11490237.001]
  • [Cites] Radiother Oncol. 2001 Dec;61(3):275-80 [11730997.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1388-96 [12459361.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):823-31 [12788191.001]
  • [Cites] Oncology. 2003;65(1):14-22 [12837978.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):516-21 [12957265.001]
  • [Cites] Phys Med Biol. 1961 Jan;5:255-8 [13726497.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42 [15752894.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):274-81 [16111597.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):354-61 [16168830.001]
  • (PMID = 18005443.001).
  • [ISSN] 1748-717X
  • [Journal-full-title] Radiation oncology (London, England)
  • [ISO-abbreviation] Radiat Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2204019
  •  go-up   go-down


61. Lanteri R, Aliotta I, Racalbuto A, Licata A: Anal GIST in older old patient: a case report. G Chir; 2005 Apr;26(4):135-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anal GIST in older old patient: a case report.
  • It is generally difficult to determine if they are to be considered as a benign or malignant neoplastic disease.
  • We present the case of a patient with recurrence of anal GIST who was examined 8 years after the first treatment.
  • During rectal exploration we found a mass spreading inside the lumen 3 cm from the anal verge.
  • Colonoscopy showed that the tumour, which was 7 x 5 cm in size, was inside the wall with normal mucosa.
  • The patient was discharged 5 days after surgery and is alive; she only showed a small local recurrence of disease 30 months after treatment.
  • Histological examination confirmed that the tumour was a GIST This case provides the basis for a discussion about characteristics and the evolution of this group of pathologies.
  • [MeSH-major] Anus Neoplasms / surgery. Gastrointestinal Stromal Tumors / surgery. Neoplasm Recurrence, Local
  • [MeSH-minor] Aged. Aged, 80 and over. Female. Humans. Neoplasm Staging. Treatment Outcome

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16035248.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


62. Van der Kwast TH, Zlotta AR, Fleshner N, Jewett M, Lopez-Beltran A, Montironi R: Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology. Anal Quant Cytol Histol; 2008 Dec;30(6):309-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.
  • Since the introduction of the World Health Organization (WHO) 1973 terminology for bladder cancer, noninvasive epithelial bladder tumors have consistently been labeled bladder carcinomas.
  • In the WHO 2004 classification the removal of the "carcinoma" label from a small subset of noninvasive bladder carcinomas with indolent behavior created the entity of papillary urothelial neoplasms of low malignant potential, but the remaining noninvasive carcinomas of the urothelial tract retained this label.
  • In line with the tendency during the last few decades to label flat precancerous lesions of various organs intraepithelial neoplasms, we may now also refer to dysplasia and carcinoma in situ of the urinary tract as low and high grade intraurothelial neoplasia, respectively.

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19160695.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Nonose R, Priolli DG, Cardinalli IA, Máximo FR, Galvão PS, Martinez CA: Epithelioid hemangioma of the colon: a case report. Sao Paulo Med J; 2008 Sep;126(5):294-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Epithelioid hemangioma or angiolymphoid hyperplasia with eosinophilia is an uncommon benign vascular neoplasm that is usually located on the face or neck.
  • Neoplasia of the colon was clinically suspected and she underwent colonoscopy.
  • This demonstrated the presence of a vegetating sessile lesion of approximately 5 cm in diameter, at a distance of 36 cm from the anal margin.
  • A biopsy collected during the examination suggested a diagnosis of neoplasia of vascular origin.
  • After surgical resection, histopathological examination of the resected specimen confirmed the diagnosis of epithelioid hemangioma of the colon, which was backed up by the immunohistochemical panel (factor VIII, Ki-67, CD-34).
  • Despite the rarity of neoplasia of vascular origin, this possibility should be considered in the differential diagnosis for colorectal tumors.
  • [MeSH-major] Angiolymphoid Hyperplasia with Eosinophilia / pathology. Colon / pathology. Hemangioma / pathology. Sigmoid Neoplasms / pathology
  • [MeSH-minor] Abdominal Pain. Adult. Colonoscopy. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19099166.001).
  • [ISSN] 1806-9460
  • [Journal-full-title] São Paulo medical journal = Revista paulista de medicina
  • [ISO-abbreviation] Sao Paulo Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


64. Ohtsuki Y, Watanabe R, Kimura M, Okamoto T, Murakami S, Mizukami Y, Takeji M, Okada Y, Hayashi Y, Lee GH, Furihata M: Immunohistochemical and electron microscopic studies of a case of duodenal gangliocytic paraganglioma. Med Mol Morphol; 2009 Dec;42(4):245-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Gangliocytic paraganglioma (GPG) is a rare tumor, occurring almost exclusively in the duodenum.
  • In the present case, a submucosal tumor 2.5 x 2 x 1.5 cm in size was located on the anal side of the papilla of Vater, with clear margins and without capsule on cut-surface examination.
  • Tumor cells included three types of cells: ganglion-like cells (GCs), endocrine cells (ECs), and Schwann cells (SCs).
  • The histogenesis of GPG most likely involves proliferation and differentiation of pluripotent stem cells in the duodenal crypts in the duodenum as a true tumor, although it is also possible that the retroperitoneal components of both GCs and SCs proliferate, together with ECs, from ventral primordial tissue of the pancreas in the duodenum.
  • [MeSH-major] Duodenal Neoplasms. Paraganglioma

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Pathol. 1986 Nov;86(5):559-65 [2877566.001]
  • [Cites] Hum Pathol. 2004 Oct;35(10):1288-91 [15492999.001]
  • [Cites] Am J Pathol. 1957 Sep-Oct;33(5):953-65 [13458330.001]
  • [Cites] J Gastrointest Surg. 2007 Oct;11(10):1351-4 [17653595.001]
  • [Cites] Med Mol Morphol. 2006 Dec;39(4):214-20 [17187185.001]
  • [Cites] Med Mol Morphol. 2007 Dec;40(4):221-5 [18085383.001]
  • [Cites] Lancet. 1978 Dec 2;2(8101):1200-1 [82163.001]
  • [Cites] Am J Gastroenterol. 1992 Sep;87(9):1216-8 [1519587.001]
  • [Cites] Cancer. 1971 Jan;27(1):61-7 [4099700.001]
  • [Cites] Dig Dis Sci. 2007 Jun;52(6):1400-4 [17415650.001]
  • [Cites] Am J Surg Pathol. 1985 Jan;9(1):31-41 [2578747.001]
  • [Cites] Cancer. 1989 Jun 15;63(12):2540-5 [2655873.001]
  • [Cites] Histopathology. 1993 Apr;22(4):399-401 [8514287.001]
  • [Cites] J Clin Gastroenterol. 2007 Aug;41(7):661-6 [17667049.001]
  • [Cites] Arch Pathol Lab Med. 2003 Mar;127(3):e139-41 [12653602.001]
  • [Cites] Am J Surg Pathol. 1977 Sep;1(3):207-16 [920868.001]
  • [Cites] Ann Diagn Pathol. 2005 Jun;9(3):143-7 [15944956.001]
  • [Cites] Am J Surg Pathol. 2001 May;25(5):688-93 [11342785.001]
  • [Cites] J Neurosurg. 1972 May;36(5):652-8 [5026551.001]
  • [Cites] Ann Chir. 2003 Jun;128(5):336-8 [12878073.001]
  • [Cites] Am J Clin Pathol. 1989 Jul;92(1):1-9 [2750701.001]
  • (PMID = 20033372.001).
  • [ISSN] 1860-1499
  • [Journal-full-title] Medical molecular morphology
  • [ISO-abbreviation] Med Mol Morphol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


65. Lim JF, Tjandra JJ, Hiscock R, Chao MW, Gibbs P: Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency. Dis Colon Rectum; 2006 Jan;49(1):12-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients who had rectal cancer with a distal margin within 6 cm of the anal verge had the anus included in the field of radiotherapy (Group A, n = 26).
  • Patients who had rectal cancer with a distal margin 6 to 12 cm from the anal verge had shielding of the anus during radiotherapy (Group B, n = 40).
  • The maximum resting anal pressures were unchanged after chemoradiation.
  • The maximum squeeze anal pressures were reduced (mean = 166.5-157.5 mmHg) after chemoradiation.
  • These 18 patients similarly had a worsened median Wexner continence score (range, 0-3) and maximum squeeze anal pressures (mean = 165.5-144 mmHg).
  • The results obtained were independent of tumor response to chemoradiation.
  • [MeSH-major] Adenocarcinoma / therapy. Fluorouracil / therapeutic use. Leucovorin / therapeutic use. Motor Neurons. Peripheral Nervous System Diseases / etiology. Rectal Neoplasms / therapy. Rectum / innervation

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Peripheral Nerve Disorders.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16292664.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 12001-76-2 / Vitamin B Complex; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


66. Atallah S, Albert M, Larach S: Transanal minimally invasive surgery: a giant leap forward. Surg Endosc; 2010 Sep;24(9):2200-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report the clinical application of this technique and present preliminary data that show TAMIS to be an effective tool for resection of both malignant and benign lesions of the rectum.
  • Patients with biopsy-proven malignant lesions were required to undergo endorectal ultrasound preoperatively to determine tumor stage.
  • To perform TAMIS, a single-incision laparoscopic surgery port (SILS Port, Covidien) is introduced into the anal canal by applying steady manual pressure.
  • The average distance from the anal verge was 9.3 cm and the mean tumor diameter confirmed by pathology measured 2.93 cm.
  • [MeSH-major] Laparoscopy / methods. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal. Biopsy. Endosonography. Female. Humans. Male. Middle Aged. Minimally Invasive Surgical Procedures. Neoplasm Staging. Treatment Outcome

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Colorectal Dis. 2008 Oct;23(10):1013-6 [18607608.001]
  • [Cites] World J Surg. 2009 May;33(5):1015-9 [19116734.001]
  • [Cites] Dis Colon Rectum. 2002 May;45(5):601-4 [12004207.001]
  • [Cites] Dis Colon Rectum. 2009 Jun;52(6):1107-13 [19581854.001]
  • [Cites] Colorectal Dis. 2007 Jul;9(6):553-8 [17573752.001]
  • [Cites] Colorectal Dis. 2008 Oct;10(8):823-6 [18684153.001]
  • [Cites] Surg Endosc. 2009 Jul;23(7):1419-27 [19347400.001]
  • [Cites] Surg Endosc. 2010 Feb;24(2):445-9 [19565297.001]
  • [Cites] Dis Colon Rectum. 2008 Jul;51(7):1026-30; discussion 1030-1 [18481147.001]
  • [Cites] Asian J Surg. 2006 Oct;29(4):227-32 [17098653.001]
  • [Cites] Gastrointest Endosc. 2009 Jul;70(1):193-4 [19559847.001]
  • [Cites] Leber Magen Darm. 1985 Nov;15(6):271-9 [4079630.001]
  • [Cites] J Gastrointest Surg. 2009 Sep;13(9):1733-40 [19412642.001]
  • [Cites] Hepatogastroenterology. 2003 Sep-Oct;50(53):1376-80 [14571741.001]
  • [Cites] Minerva Chir. 2009 Aug;64(4):355-64 [19648856.001]
  • [Cites] Surg Technol Int. 2009 Apr;18:19-25 [19579186.001]
  • [Cites] Urology. 2009 Oct;74(4):805-12 [19643465.001]
  • [Cites] Colorectal Dis. 2006 Nov;8(9):795-9 [17032328.001]
  • [Cites] Ann Surg Oncol. 2003 Nov;10(9):1106-11 [14597451.001]
  • [Cites] Int Semin Surg Oncol. 2006 May 04;3:13 [16674824.001]
  • [Cites] Dis Colon Rectum. 1996 Sep;39(9):969-76 [8797643.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2000 Dec;10(6):372-8 [11147912.001]
  • [Cites] Colorectal Dis. 2007 Mar;9(3):229-34 [17298620.001]
  • [Cites] Ann Surg. 2009 May;249(5):776-82 [19387326.001]
  • [Cites] J Laparoendosc Adv Surg Tech A. 2009 Aug;19(4):495-9 [19630589.001]
  • [Cites] Surg Endosc. 2009 May;23(5):1138-41 [19263120.001]
  • [Cites] Colorectal Dis. 2006 Sep;8(7):581-5 [16919110.001]
  • [Cites] Arch Surg. 2009 Feb;144(2):173-9; discussion 179 [19221330.001]
  • [Cites] Dis Colon Rectum. 2005 Feb;48(2):270-84 [15711865.001]
  • (PMID = 20174935.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


67. Solaz Moreno E, Vallalta Morales M, Silla Búrdalo G, Cervera Miguel JI, Díaz Beveridge R, Rayón Martín JM: [Primary melanoma of the rectum: an infrequent neoplasia with an atypical presentation]. Clin Transl Oncol; 2005 May;7(4):171-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary melanoma of the rectum: an infrequent neoplasia with an atypical presentation].
  • [Transliterated title] Melanoma primario de recto: una neoplasia infrecuente con una forma de presentación atípica.
  • The main clinical presentations are local symptoms such as rectal bleeding, anal mass or pain, or a change in bowel habits.
  • The tumour is frequently mistaken for benign conditions as haemorrhoids or rectal polyps.
  • Despite this, the disease has a very poor prognosis and 10% of patients survive 5 years.
  • [MeSH-major] Melanoma / diagnosis. Rectal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Melanoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Expert Opin Pharmacother. 2003 Dec;4(12):2205-11 [14640919.001]
  • [Cites] Dis Colon Rectum. 1997 Jun;40(6):661-8 [9194459.001]
  • [Cites] Dis Colon Rectum. 1999 Sep;42(9):1203-8 [10496563.001]
  • [Cites] Br J Cancer. 2003 Dec 1;89(11):2019-22 [14647131.001]
  • [Cites] Cancer. 2004 Apr 1;100(7):1478-83 [15042682.001]
  • [Cites] Eur J Surg. 2000 Jul;166(7):583-4 [10965842.001]
  • [Cites] Gastroenterology. 1993 Jan;104(1):174-8 [8419240.001]
  • [Cites] Cancer. 1998 Oct 15;83(8):1664-78 [9781962.001]
  • [Cites] Dis Colon Rectum. 1995 Feb;38(2):146-51 [7851168.001]
  • [Cites] Expert Opin Investig Drugs. 2003 Sep;12(9):1545-58 [12943498.001]
  • [Cites] Cancer. 1988 Apr 1;61(7):1364-70 [3345491.001]
  • [Cites] Cancer. 1981 Apr 1;47(7):1891-900 [6164474.001]
  • (PMID = 15960927.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


68. Rivoire M, Malerba M, Gandini A: [Rectal cancer margin]. Bull Cancer; 2008 Dec;95(12):1177-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • During previous years surgeons and pathologists have focused mainly on distal longitudinal margin as the main parameter for anal conservation.
  • [MeSH-major] Rectal Neoplasms / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Humans. Laparoscopy. Neoadjuvant Therapy. Neoplasm Recurrence, Local. Neoplasm, Residual. Prognosis. Rectum / pathology. Rectum / surgery

  • Genetic Alliance. consumer health - Rectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19091651.001).
  • [ISSN] 1769-6917
  • [Journal-full-title] Bulletin du cancer
  • [ISO-abbreviation] Bull Cancer
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 48
  •  go-up   go-down


69. Assenat E, Thézenas S, Samalin E, Bibeau F, Portales F, Azria D, Quenet F, Rouanet P, Saint Aubert B, Senesse P: The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal adenocarcinoma. Endoscopy; 2007 Apr;39(4):309-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND AND STUDY AIMS: The aim of this study was to assess whether preoperative endorectal ultrasound (ERUS) is able to predict histological infiltration of the external anal sphincter or the levator ani muscle in patients with a lower-third rectal neoplasm and so the possibility of treatment by sphincter-saving surgery.
  • PATIENTS AND METHODS: Between May 1996 and May 2003, 66 patients with a lower-third rectal neoplasm that was staged as uT2 or greater were entered into a prospective evaluation of ERUS.
  • An abdominoperineal resection was performed mainly when the lower extent of the tumor was within 3.5 cm from the anal verge (P = 0.011), but no correlation was observed between the lateral clearance determined by ERUS 1 and the histological clearance (P = 0.091).
  • With regard to the performance of ERUS 2 for predicting histological infiltration of the external anal sphincter or the levator ani muscle, the sensitivity was 100%, the negative predictive value was 100%, the specificity was 87%, and the positive predictive value was 53%.
  • In a multivariate analysis, the histological clearance and tumor T stage were statistically correlated with disease-free survival (P = 0.035 and P = 0.05, respectively).
  • [MeSH-major] Adenocarcinoma / surgery. Adenocarcinoma / ultrasonography. Endosonography. Rectal Neoplasms / surgery. Rectal Neoplasms / ultrasonography
  • [MeSH-minor] Anal Canal / pathology. Humans. Multivariate Analysis. Neoadjuvant Therapy. Neoplasm Invasiveness. Neoplasm Staging. Prospective Studies. Sensitivity and Specificity. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17354183.001).
  • [ISSN] 1438-8812
  • [Journal-full-title] Endoscopy
  • [ISO-abbreviation] Endoscopy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


70. Shiozawa M, Nishimura K, Nonaka T, Yoshii T, Nakayama N, Motohashi O, Takagi S, Nakayama Y, Akaike M: [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas]. Gan To Kagaku Ryoho; 2010 Dec;37(13):2941-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
  • We report three cases of anal canal squamous cell carcinoma treated with radiotherapy combined with S-1 and mitomycin C(MMC).
  • These results suggested that this treatment schedule was safe and effective for anal canal carcinomas.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Anus Neoplasms / therapy. Carcinoma, Squamous Cell / therapy
  • [MeSH-minor] Administration, Oral. Aged. Anal Canal. Antibiotics, Antineoplastic / administration & dosage. Antimetabolites, Antineoplastic / administration & dosage. Combined Modality Therapy. Female. Fluorouracil / administration & dosage. Humans. Injections, Intravenous. Middle Aged. Mitomycin / administration & dosage. Radiotherapy Dosage

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160276.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Antimetabolites, Antineoplastic; 50SG953SK6 / Mitomycin; U3P01618RT / Fluorouracil
  •  go-up   go-down


71. Mongardini M, Iachetta RP, Cola A, Maturo A, Giofrè M, Custureri F: [Low rectovaginal fistula treated with platelet-rich plasma (PRP)]. G Chir; 2009 Nov-Dec;30(11-12):507-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The suggested treatments include trans-anal access or combined trans-anal and vaginal access.
  • We present the case of a woman with complicated iatrogenic fistula treated by a combined trans-anal and vaginal access, interposition of buccal mucosa and opposition of PRP (platelet rich plasma).
  • [MeSH-minor] Aged. Brachytherapy / adverse effects. Carcinoma, Endometrioid / radiotherapy. Carcinoma, Endometrioid / surgery. Combined Modality Therapy. Endometrial Neoplasms / radiotherapy. Endometrial Neoplasms / surgery. Female. Gels. Humans. Hysterectomy. Iatrogenic Disease. Mouth Mucosa / transplantation. Suture Techniques. Transplantation, Heterotopic. Wound Healing / drug effects

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20109382.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Gels
  •  go-up   go-down


72. Seo Y, Kinsella MT, Reynolds HL, Chipman G, Remick SC, Kinsella TJ: Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. Int J Radiat Oncol Biol Phys; 2009 Sep 1;75(1):143-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
  • PURPOSE: Information is limited as to how we should treat invasive anal squamous cell carcinoma (SCC) in patients with chronic immunosuppression, since the majority of clinical studies to date have excluded such patients.
  • The objective of this study is to compare treatment outcomes in immunocompetent (IC) versus immunodeficient (ID) patients with invasive anal SCC treated similarly with combined modality therapy.
  • There were no significant differences in tumor size, T stage, N stage, chemotherapy doses, or radiation doses between the two groups.
  • RESULTS: With a median follow-up of 3.1 years, no differences were found in overall survival, disease-specific survival, and colostomy-free survival.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Anus Neoplasms / drug therapy. Anus Neoplasms / radiotherapy. Carcinoma, Squamous Cell / drug therapy. Carcinoma, Squamous Cell / radiotherapy. Radiotherapy, Conformal

  • Genetic Alliance. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19203845.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 50SG953SK6 / Mitomycin; U3P01618RT / Fluorouracil
  •  go-up   go-down


73. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA: Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst; 2009 Aug 19;101(16):1120-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Although risk of human papillomavirus (HPV)-associated cancers of the anus, cervix, oropharynx, penis, vagina, and vulva is increased among persons with AIDS, the etiologic role of immunosuppression is unclear and incidence trends for these cancers over time, particularly after the introduction of highly active antiretroviral therapy in 1996, are not well described.
  • RESULTS: Among persons with AIDS, we observed statistically significantly elevated risk of all HPV-associated in situ (SIRs ranged from 8.9, 95% CI = 8.0 to 9.9, for cervical cancer to 68.6, 95% CI = 59.7 to 78.4, for anal cancer among men) and invasive (SIRs ranged from 1.6, 95% CI = 1.2 to 2.1, for oropharyngeal cancer to 34.6, 95% CI = 30.8 to 38.8, for anal cancer among men) cancers.
  • During 1996-2004, low CD4 T-cell count was associated with statistically significantly increased risk of invasive anal cancer among men (relative risk [RR] per decline of 100 CD4 T cells per cubic millimeter = 1.34, 95% CI = 1.08 to 1.66, P = .006) and non-statistically significantly increased risk of in situ vagina or vulva cancer (RR = 1.52, 95% CI = 0.99 to 2.35, P = .055) and of invasive cervical cancer (RR = 1.32, 95% CI = 0.96 to 1.80, P = .077).
  • Among men, incidence (per 100 000 person-years) of in situ and invasive anal cancer was statistically significantly higher during 1996-2004 than during 1990-1995 (61% increase for in situ cancers, 18.3 cases vs 29.5 cases, respectively; RR = 1.71, 95% CI = 1.24 to 2.35, P < .001; and 104% increase for invasive cancers, 20.7 cases vs 42.3 cases, respectively; RR = 2.03, 95% CI = 1.54 to 2.68, P < .001).
  • The increasing incidence for anal cancer during 1996-2004 indicates that prolonged survival may be associated with increased risk of certain HPV-associated cancers.


74. De Toma G, Cavallaro G, Bitonti A, Polistena A, Onesti MG, Scuderi N: Surgical management of perianal giant condyloma acuminatum (Buschke-Löwenstein tumor). Report of three cases. Eur Surg Res; 2006;38(4):418-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of perianal giant condyloma acuminatum (Buschke-Löwenstein tumor). Report of three cases.
  • Giant condyloma acuminatum (GCA) is a slow-growing, large, cauliflower-like tumor located in the anogenital region.
  • This tumor has a locally destructive behavior, a high recurrence rate and occasional transformation to squamous cell carcinoma.
  • There is no general agreement on the choice of treatment for this tumor.
  • Loop colostomy, considered mandatory by several authors in order to minimize wound contamination risk, does not appear to be necessary (except in cases of anal canal involvement beyond the dentate line) if a combination of bowel cleansing, non-fiber diet and loperamide can be administered.
  • [MeSH-major] Anus Neoplasms / surgery. Condylomata Acuminata / surgery
  • [MeSH-minor] Adult. Aged. Anal Canal / pathology. Female. Humans. Male. Middle Aged. Skin Transplantation

  • Genetic Alliance. consumer health - Buschke Lowenstein Tumor.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - Genital Warts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16902304.001).
  • [ISSN] 0014-312X
  • [Journal-full-title] European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes
  • [ISO-abbreviation] Eur Surg Res
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


75. Bass G, O'Mahony CA, Smith R, Dennison MS, Goss JA: Biliary epithelial metastasis of squamous carcinoma of the anus. Ir J Med Sci; 2010 Dec;179(4):605-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biliary epithelial metastasis of squamous carcinoma of the anus.
  • INTRODUCTION: The liver and biliary tree are common sites of initial metastasis for many primary tumors.
  • However, we recently encountered a patient who presented with biliary-tree tumor encasement as a first metastasis from squamous carcinoma of the anus.
  • CONCLUSIONS: As obstructive jaundice is a relatively common presenting sign in the emergency room and in general surgical clinics, we thus recommend early consideration of metastatic disease as a differential diagnosis in patients post-chemoradiotherapy for anal carcinoma who present with obstructive jaundice.
  • [MeSH-major] Anus Neoplasms / pathology. Biliary Tract Neoplasms / secondary. Carcinoma, Squamous Cell / secondary
  • [MeSH-minor] Bile Ducts / pathology. Common Bile Duct Neoplasms. Dilatation, Pathologic. Epithelium / pathology. Female. Humans. Jaundice, Obstructive / etiology. Jejunostomy. Middle Aged. Pancreatic Ducts / pathology

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dig Dis Sci. 2008 Oct;53(10):2822-5 [18274902.001]
  • [Cites] Am J Clin Pathol. 2001 Dec;116(6):823-30 [11764070.001]
  • [Cites] Dis Colon Rectum. 1974 May-Jun;17(3):354-6 [4830803.001]
  • [Cites] Am J Surg. 1977 Aug;134(2):263-9 [889044.001]
  • [Cites] Intern Med J. 2002 Sep-Oct;32(9-10):491 [12380705.001]
  • [Cites] Hepatogastroenterology. 2002 Jan-Feb;49(43):100-3 [11941929.001]
  • (PMID = 20734157.001).
  • [ISSN] 1863-4362
  • [Journal-full-title] Irish journal of medical science
  • [ISO-abbreviation] Ir J Med Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


76. Canda AE, Terzi C, Gorken IB, Oztop I, Sokmen S, Fuzun M: Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients. Int J Colorectal Dis; 2010 Feb;25(2):197-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients.
  • Significant reduction in anal canal resting pressures and squeeze pressures, Wexner score, and FIQL score were observed immediately after the completion of preoperative chemoradiotherapy.
  • [MeSH-major] Anal Canal / drug effects. Anal Canal / radiation effects. Antimetabolites, Antineoplastic / adverse effects. Fecal Incontinence / etiology. Fluorouracil / adverse effects. Quality of Life. Rectal Neoplasms / drug therapy. Rectal Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Anal Cancer.
  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 2006 Mar;49(3):345-52 [16532369.001]
  • [Cites] Dis Colon Rectum. 2000 Jan;43(1):9-16; discussion 16-7 [10813117.001]
  • [Cites] N Engl J Med. 2001 Aug 30;345(9):638-46 [11547717.001]
  • [Cites] Br J Surg. 1985 Nov;72(11):875-8 [4063752.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):51-7 [9747819.001]
  • [Cites] Dis Colon Rectum. 2006 Jan;49(1):12-9 [16292664.001]
  • [Cites] Int J Colorectal Dis. 2007 Nov;22(11):1311-7 [17497160.001]
  • [Cites] N Engl J Med. 1997 Apr 3;336(14):1016-7 [9077384.001]
  • [Cites] Radiother Oncol. 2005 Sep;76(3):241-50 [16165238.001]
  • [Cites] Dis Colon Rectum. 1993 Jan;36(1):77-97 [8416784.001]
  • [Cites] Int J Colorectal Dis. 2008 Jan;23(1):37-45 [17805549.001]
  • [Cites] Arch Surg. 2001 Feb;136(2):192-6 [11177140.001]
  • [Cites] Lancet. 1986 Jun 28;1(8496):1479-82 [2425199.001]
  • [Cites] Arch Surg. 2003 Mar;138(3):257-61 [12611569.001]
  • [Cites] Dis Colon Rectum. 1998 May;41(5):543-9; discussion 549-51 [9593234.001]
  • [Cites] Dis Colon Rectum. 2003 Nov;46(11):1492-7 [14605568.001]
  • [Cites] Am J Surg. 2008 May;195(5):611-5; discussion 615 [18367144.001]
  • [Cites] Br J Surg. 1993 Jul;80(7):933-5 [8369944.001]
  • [Cites] Dis Colon Rectum. 2004 Dec;47(12):2025-31 [15657650.001]
  • [Cites] Dis Colon Rectum. 1993 Jun;36(6):564-72 [8500374.001]
  • [Cites] Lancet. 1997 Aug 23;350(9077):564 [9284785.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1731-40 [15496622.001]
  • [Cites] Dis Colon Rectum. 2002 Jul;45(7):895-903 [12130878.001]
  • [Cites] Dis Colon Rectum. 2001 Aug;44(8):1113-22 [11535850.001]
  • [Cites] Cochrane Database Syst Rev. 2007 Apr 18;(2):CD002102 [17443515.001]
  • (PMID = 19784660.001).
  • [ISSN] 1432-1262
  • [Journal-full-title] International journal of colorectal disease
  • [ISO-abbreviation] Int J Colorectal Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


77. Bean SM, Meara RS, Vollmer RT, Conner MG, Crowe DR, Novak L, Eltoum IA, Robboy SJ, Chhieng DC: p16 Improves interobserver agreement in diagnosis of anal intraepithelial neoplasia. J Low Genit Tract Dis; 2009 Jul;13(3):145-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] p16 Improves interobserver agreement in diagnosis of anal intraepithelial neoplasia.
  • OBJECTIVES: Evaluation of anal intraepithelial neoplasia (AIN) is subjective.
  • MATERIALS AND METHODS: Seventy-seven anal specimens were retrieved.
  • Fair agreement was observed using H&E diagnosis alone (kappa = 0.38, S = 0.56).
  • CONCLUSIONS: Interobserver agreement for diagnosis of AIN was fair when based solely on H&E preparation. p16 alone improved interobserver agreement and demonstrated superior agreement when compared with H&E, Ki-67, and H&E/p16/Ki-67 combined.
  • [MeSH-major] Anus Neoplasms / diagnosis. Carcinoma in Situ / diagnosis. DNA, Neoplasm / analysis. Gene Expression Regulation, Neoplastic. Genes, p16 / physiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antigens, Neoplasm / analysis. Biopsy. Clinical Competence. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Observer Variation. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19550211.001).
  • [ISSN] 1526-0976
  • [Journal-full-title] Journal of lower genital tract disease
  • [ISO-abbreviation] J Low Genit Tract Dis
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / DNA, Neoplasm
  •  go-up   go-down


78. Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM, Burk RD, Strickler HD, Greenblatt RM, Palefsky JM: Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS; 2009 Jan 2;23(1):59-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
  • OBJECTIVES: To study anal intraepithelial neoplasia and its associations with anal and cervical human papillomavirus (HPV), cervical neoplasia, host immune status, and demographic and behavioral risk factors in women with and at risk for HIV infection.
  • METHODS: In 2001-2003 participants were interviewed, received a gynecological examination, anal and cervical cytology testing and, if abnormal, colposcopy-guided or anoscopy-guided biopsy of visible lesions.
  • Exfoliated cervical and anal specimens were assessed for HPV using PCR and type-specific HPV probing.
  • Logistic regression analyses were performed, and odds ratios (ORs) estimated risks for anal intraepithelial neoplasia.
  • Low-grade anal intraepithelial neoplasia was present in 12% of HIV-infected and 5% of HIV-uninfected women.
  • High-grade anal intraepithelial neoplasia was present in 9% of HIV-infected and 1% of HIV-uninfected women.
  • In adjusted analyses among HIV-infected women, the risk factors for low-grade anal intraepithelial neoplasia were younger age [OR = 0.59, 95% confidence interval (CI) = 0.36-0.97], history of receptive anal intercourse (OR = 3.2, 95% CI = 1.5-6.8), anal HPV (oncogenic types only OR = 11, 95% CI = 1.2-103; oncogenic and nononcogenic types OR = 11, 95% CI = 1.3-96), and cervical HPV (oncogenic and nononcogenic types OR = 3.5, 95% CI = 1.1-11).
  • In multivariable analyses among HIV-infected women, the only significant risk factor for high-grade anal intraepithelial neoplasia was anal HPV infection (oncogenic and nononcogenic types OR = 7.6, 95% CI = 1.5-38).
  • CONCLUSION: Even in the era of highly active antiviral therapy, the prevalence of anal intraepithelial neoplasia was 16% in HIV-infected women.
  • After controlling for potential confounders, several risk factors for low-grade anal intraepithelial neoplasia differed from risk factors for high-grade anal intraepithelial neoplasia.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - Anal Cancer.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • COS Scholar Universe. author profiles.
  • HIV InSite. treatment guidelines - Women and HIV .
  • HIV InSite. treatment guidelines - Human Herpesvirus-8 .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS. 1999 May 7;13(7):839-43 [10357384.001]
  • [Cites] J Natl Cancer Inst. 1994 Nov 16;86(22):1711-6 [7966400.001]
  • [Cites] Sex Transm Infect. 2005 Apr;81(2):142-6 [15800092.001]
  • [Cites] Lancet Oncol. 2005 Apr;6(4):204 [15830458.001]
  • [Cites] AIDS. 2005 Sep 2;19(13):1407-14 [16103772.001]
  • [Cites] Clin Diagn Lab Immunol. 2005 Sep;12(9):1013-9 [16148165.001]
  • [Cites] APMIS. 2007 Mar;115(3):195-203 [17367464.001]
  • [Cites] Lancet Oncol. 2007 Apr;8(4):311-6 [17395104.001]
  • [Cites] Am J Epidemiol. 2007 May 15;165(10):1143-53 [17344204.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1107-14 [17548671.001]
  • [Cites] J Natl Cancer Inst. 2007 Jun 20;99(12):962-72 [17565153.001]
  • [Cites] AIDS. 2007 Jul 11;21(11):1457-65 [17589192.001]
  • [Cites] J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10 [10995805.001]
  • [Cites] J Infect Dis. 2001 Feb 1;183(3):383-91 [11133369.001]
  • [Cites] JAMA. 2001 Apr 4;285(13):1736-45 [11277828.001]
  • [Cites] J Natl Cancer Inst. 2001 Jun 6;93(11):843-9 [11390533.001]
  • [Cites] Sex Transm Infect. 2001 Oct;77(5):327-31 [11588276.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2002 May;16(3):231-40 [12195562.001]
  • [Cites] N Engl J Med. 2003 Feb 6;348(6):518-27 [12571259.001]
  • [Cites] Ann Intern Med. 2003 Mar 18;138(6):453-9 [12639077.001]
  • [Cites] J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):527-33 [12679705.001]
  • [Cites] Br J Cancer. 2003 Jul 7;89(1):94-100 [12838307.001]
  • [Cites] Hematol Oncol Clin North Am. 2003 Jun;17(3):673-96, v [12852650.001]
  • [Cites] Biotechniques. 1995 Oct;19(4):566-8 [8777045.001]
  • [Cites] J Infect Dis. 1996 Oct;174(4):679-89 [8843203.001]
  • [Cites] Am J Epidemiol. 1996 Nov 15;144(10):916-23 [8916502.001]
  • [Cites] J Natl Cancer Inst. 1999 Feb 3;91(3):226-36 [10037100.001]
  • [Cites] J Natl Cancer Inst. 1999 Apr 21;91(8):708-15 [10218509.001]
  • [Cites] Cancer. 2004 Jul 15;101(2):270-80 [15241823.001]
  • [Cites] N Engl J Med. 1987 Oct 15;317(16):973-7 [2821396.001]
  • [Cites] J Natl Cancer Inst. 1989 Nov 15;81(22):1726-31 [2810388.001]
  • [Cites] Lancet. 1991 Sep 14;338(8768):657-9 [1679474.001]
  • [Cites] Am J Epidemiol. 1992 Jan 15;135(2):180-9 [1311142.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):223-8 [8318874.001]
  • [Cites] Obstet Gynecol. 1994 Feb;83(2):205-11 [8290181.001]
  • [Cites] Lancet. 1994 Mar 12;343(8898):636-9 [7906812.001]
  • [Cites] Expert Opin Pharmacother. 2004 Dec;5(12):2479-84 [15571466.001]
  • [Cites] Int J Cancer. 1996 Nov 27;68(5):559-64 [8938134.001]
  • [Cites] J Clin Microbiol. 1997 Jun;35(6):1304-10 [9163434.001]
  • [Cites] J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 15;14(5):415-22 [9170415.001]
  • [Cites] J Infect Dis. 1998 Feb;177(2):361-7 [9466522.001]
  • [Cites] Epidemiology. 1998 Mar;9(2):117-25 [9504278.001]
  • [Cites] Lancet. 1998 Jun 20;351(9119):1833-9 [9652666.001]
  • [Cites] AIDS. 1998 Jul 9;12(10):1177-84 [9677167.001]
  • (PMID = 19050387.001).
  • [ISSN] 1473-5571
  • [Journal-full-title] AIDS (London, England)
  • [ISO-abbreviation] AIDS
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / U01-AI-42590; United States / NIAID NIH HHS / AI / U01 AI031834; United States / NCI NIH HHS / CA / R01 CA 88739; United States / NIAID NIH HHS / AI / U01 AI035004; United States / NICHD NIH HHS / HD / U01-HD-32632; United States / NCI NIH HHS / CA / R01 CA088739; United States / NCRR NIH HHS / RR / UL1 RR024131; United States / NIAID NIH HHS / AI / U01 AI034989; United States / NIAID NIH HHS / AI / U01-AI-34994; United States / NIAID NIH HHS / AI / U01-AI-35004; United States / NCI NIH HHS / CA / CA088739-05S1; United States / NIAID NIH HHS / AI / U01-AI-31834; United States / NIAID NIH HHS / AI / U01 AI034994; United States / NIAID NIH HHS / AI / U01 AI034989-15; United States / NCI NIH HHS / CA / R01 CA088739-05S1; United States / NIAID NIH HHS / AI / U01-AI-34993; United States / NCI NIH HHS / CA / R01 CA085178; United States / NIAID NIH HHS / AI / U01 AI034993; United States / NIAID NIH HHS / AI / U01-AI-34989; United States / NICHD NIH HHS / HD / U01 HD032632; United States / NIAID NIH HHS / AI / U01 AI042590
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS84186; NLM/ PMC2614220
  •  go-up   go-down


79. Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H: Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol; 2007 Sep;33(7):854-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: Studies analysing the outcome after resection of low rectal cancer that has not infiltrated the anal sphincter reveal poorer long-term outcomes after abdominoperineal resections (APR) in comparison with low anterior resections (LAR).
  • RESULTS: Univariate analysis revealed that patients undergoing APR had a higher local recurrence rate (p = 0.022) and shorter disease-free survival (p < 0.001) than patients undergoing LAR, while hospital volume showed merely a tendency to impact the local recurrence rate (p = 0.060).
  • With regard to disease-free survival, no dependence on hospital volume was to be found (p = 0.201).
  • Multivariate analysis revealed an independent impact of hospital volume on local recurrence rate, while disease-free survival was influenced by the type of surgical procedure performed.
  • The type of procedure does not affect the local recurrence rate but the disease free survival.
  • [MeSH-major] Digestive System Surgical Procedures / statistics & numerical data. Hospitals / statistics & numerical data. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal / surgery. Disease-Free Survival. Female. Follow-Up Studies. Germany / epidemiology. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Prospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Rectal Cancer.
  • MedlinePlus Health Information. consumer health - Health Facilities.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17933024.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


80. Wang H, Fu CG, Zheng JM, Gong HF, Tao LY, Yu ED, Zhang W, Liu LJ, Hao LQ, Meng RG: [Impact of meticulousness of pathologists on lymph node harvest after radical resection of invasive rectal carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov;12(6):569-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Excluded criteria were recurrent colorectal tumor, Tis tumor, R(1) or R(2) resection, tumor resection transanally or endoscopically, the cases enrolled in other prospective research, synchronous diseases affecting the surgical procedure for the rectal cancer (familial adenomatous polyposis, synchronous colorectal carcinoma) and rectal cancer receiving neoadjuvant chemoradiation.
  • There were no significant differences in gender (46/76 vs 86/156, P=0.436), age (58.1+/-1.3 vs 59.2+/-1.1, P=0.527), distance from tumor to anal verge (7.4+/-0.4 vs 7.1+/-0.3, P=0.761), proportion of sphincter-sparing surgery (67/76 vs 140/156, P=0.715), ratio of well and moderate differentiated tumors (68/76 vs 125/156, P=0.074) and overall TNM stage (P=0.167) between the two groups.
  • [MeSH-major] Biopsy. Lymph Node Excision. Lymph Nodes / pathology. Rectal Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Male. Middle Aged. Neoplasm Staging. Postoperative Period. Rectum / pathology. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Biopsy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19921565.001).
  • [ISSN] 1671-0274
  • [Journal-full-title] Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
  • [ISO-abbreviation] Zhonghua Wei Chang Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


81. Krand O, Yalti T, Tellioglu G, Kara M, Berber I, Titiz MI: Use of smooth muscle plasty after intersphincteric rectal resection to replace a partially resected internal anal sphincter: long-term follow-up. Dis Colon Rectum; 2009 Nov;52(11):1895-901
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Use of smooth muscle plasty after intersphincteric rectal resection to replace a partially resected internal anal sphincter: long-term follow-up.
  • PURPOSE: Patients with very low rectal cancer were treated by intersphincteric rectal resection employing partial internal anal sphincter resection.
  • They then underwent smooth muscle plasty to restore internal anal sphincter function.
  • PATIENTS AND METHODS: Patients were selected if their biopsies revealed well-differentiated or moderately well-differentiated very low rectal tumors with distal tumor margins that permitted preservation of part of the internal anal sphincter.
  • RESULTS: Forty-seven patients with T2 to T3 very low rectal carcinomas underwent intersphincteric rectal resection and smooth muscle plasty that extended into the anal canal.
  • The five-year overall and disease-free survival rates were 85% and 82%, respectively.
  • Six months, one year, and two years after intersphincteric rectal resection, 80%, 87%, and 89%, respectively, had good continence (Kirwan I and II).
  • CONCLUSION: Providing neodjuvant treatment and preserving at least half of the functional internal anal sphincter mass produces acceptable oncological and functional outcomes in patients undergoing intersphincteric rectal resection for very low rectal cancer.
  • [MeSH-major] Anal Canal / surgery. Digestive System Surgical Procedures / methods. Muscle, Smooth / surgery. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Biopsy. Female. Follow-Up Studies. Humans. Ileostomy. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Recurrence, Local. Surveys and Questionnaires. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19966639.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. McCourt M, Armitage J, Monson JR: Rectal cancer. Surgeon; 2009 Jun;7(3):162-9